type: Article
authors:
  - type: Person
    affiliations:
      - type: Organization
        address: 'Cambridge, United Kingdom'
        name: Cancer Research United Kingdom Cambridge Institute
    familyNames:
      - Zyner
    givenNames:
      - Katherine
      - G
  - type: Person
    affiliations:
      - type: Organization
        address: 'Cambridge, United Kingdom'
        name: Cancer Research United Kingdom Cambridge Institute
    familyNames:
      - Mulhearn
    givenNames:
      - Darcie
      - S
  - type: Person
    affiliations:
      - type: Organization
        address: 'Cambridge, United Kingdom'
        name: Department of Chemistry
    familyNames:
      - Adhikari
    givenNames:
      - Santosh
  - type: Person
    affiliations:
      - type: Organization
        address: 'Cambridge, United Kingdom'
        name: Cancer Research United Kingdom Cambridge Institute
    familyNames:
      - Martínez
      - Cuesta
    givenNames:
      - Sergio
  - type: Person
    affiliations:
      - type: Organization
        address: 'Cambridge, United Kingdom'
        name: Department of Chemistry
    familyNames:
      - Di
      - Antonio
    givenNames:
      - Marco
  - type: Person
    affiliations:
      - type: Organization
        address: 'Cambridge, United Kingdom'
        name: Cancer Research United Kingdom Cambridge Institute
    familyNames:
      - Erard
    givenNames:
      - Nicolas
  - type: Person
    affiliations:
      - type: Organization
        address: 'Cambridge, United Kingdom'
        name: Cancer Research United Kingdom Cambridge Institute
    familyNames:
      - Hannon
    givenNames:
      - Gregory
      - J
  - type: Person
    affiliations:
      - type: Organization
        address: 'Cambridge, United Kingdom'
        name: Cancer Research United Kingdom Cambridge Institute
    familyNames:
      - Tannahill
    givenNames:
      - David
  - type: Person
    affiliations:
      - type: Organization
        address: 'Cambridge, United Kingdom'
        name: Cancer Research United Kingdom Cambridge Institute
      - type: Organization
        address: 'Cambridge, United Kingdom'
        name: Department of Chemistry
      - type: Organization
        address: 'Cambridge, United Kingdom'
        name: School of Clinical Medicine
    emails:
      - sb10031@cam.ac.uk
    familyNames:
      - Balasubramanian
    givenNames:
      - Shankar
description:
  - type: Paragraph
    content:
      - >-
        G-quadruplexes (G4) are alternative nucleic acid structures involved in
        transcription, translation and replication. Aberrant G4 formation and
        stabilisation is linked to genome instability and cancer. G4 ligand
        treatment disrupts key biological processes leading to cell death. To
        discover genes and pathways involved with G4s and gain mechanistic
        insights into G4 biology, we present the first unbiased genome-wide
        study to systematically identify human genes that promote cell death
        when silenced by shRNA in the presence of G4-stabilising small
        molecules. Many novel genetic vulnerabilities were revealed opening up
        new therapeutic possibilities in cancer, which we exemplified by an
        orthogonal pharmacological inhibition approach that phenocopies gene
        silencing. We find that targeting the WEE1 cell cycle kinase or USP1
        deubiquitinase in combination with G4 ligand treatment enhances cell
        killing. We also identify new genes and pathways regulating or
        interacting with G4s and demonstrate that the DDX42 DEAD-box helicase is
        a newly discovered G4-binding protein.
isPartOf:
  type: PublicationVolume
  isPartOf:
    type: Periodical
    issn:
      - 2050-084X
    publisher:
      type: Organization
      name: 'eLife Sciences Publications, Ltd'
    title: eLife
  volumeNumber: '8'
references:
  - type: Article
    id: bib1
    authors:
      - type: Person
        familyNames:
          - Abed
        givenNames:
          - DA
      - type: Person
        familyNames:
          - Goldstein
        givenNames:
          - M
      - type: Person
        familyNames:
          - Albanyan
        givenNames:
          - H
      - type: Person
        familyNames:
          - Jin
        givenNames:
          - H
      - type: Person
        familyNames:
          - Hu
        givenNames:
          - L
    datePublished: '2015'
    isPartOf:
      type: PublicationVolume
      pageEnd: 299
      pageStart: 285
      title: Acta Pharmaceutica Sinica B
      volumeNumber: 5
    title: >-
      Discovery of direct inhibitors of Keap1-Nrf2 protein-protein interaction
      as potential therapeutic and preventive agents
  - type: Article
    id: bib2
    authors:
      - type: Person
        familyNames:
          - Andrews
        givenNames:
          - S
    datePublished: '2010'
    title: ''
  - type: Article
    id: bib3
    authors:
      - type: Person
        familyNames:
          - Ashburner
        givenNames:
          - M
      - type: Person
        familyNames:
          - Ball
        givenNames:
          - CA
      - type: Person
        familyNames:
          - Blake
        givenNames:
          - JA
      - type: Person
        familyNames:
          - Botstein
        givenNames:
          - D
      - type: Person
        familyNames:
          - Butler
        givenNames:
          - H
      - type: Person
        familyNames:
          - Cherry
        givenNames:
          - JM
      - type: Person
        familyNames:
          - Davis
        givenNames:
          - AP
      - type: Person
        familyNames:
          - Dolinski
        givenNames:
          - K
      - type: Person
        familyNames:
          - Dwight
        givenNames:
          - SS
      - type: Person
        familyNames:
          - Eppig
        givenNames:
          - JT
      - type: Person
        familyNames:
          - Harris
        givenNames:
          - MA
      - type: Person
        familyNames:
          - Hill
        givenNames:
          - DP
      - type: Person
        familyNames:
          - Issel-Tarver
        givenNames:
          - L
      - type: Person
        familyNames:
          - Kasarskis
        givenNames:
          - A
      - type: Person
        familyNames:
          - Lewis
        givenNames:
          - S
      - type: Person
        familyNames:
          - Matese
        givenNames:
          - JC
      - type: Person
        familyNames:
          - Richardson
        givenNames:
          - JE
      - type: Person
        familyNames:
          - Ringwald
        givenNames:
          - M
      - type: Person
        familyNames:
          - Rubin
        givenNames:
          - GM
      - type: Person
        familyNames:
          - Sherlock
        givenNames:
          - G
    datePublished: '2000'
    isPartOf:
      type: PublicationVolume
      pageEnd: 34
      pageStart: 25
      title: Nature Genetics
      volumeNumber: 25
    title: >-
      Gene ontology: tool for the unification of biology. The Gene Ontology
      Consortium
  - type: Article
    id: bib4
    authors:
      - type: Person
        familyNames:
          - Azorsa
        givenNames:
          - DO
      - type: Person
        familyNames:
          - Gonzales
        givenNames:
          - IM
      - type: Person
        familyNames:
          - Basu
        givenNames:
          - GD
      - type: Person
        familyNames:
          - Choudhary
        givenNames:
          - A
      - type: Person
        familyNames:
          - Arora
        givenNames:
          - S
      - type: Person
        familyNames:
          - Bisanz
        givenNames:
          - KM
      - type: Person
        familyNames:
          - Kiefer
        givenNames:
          - JA
      - type: Person
        familyNames:
          - Henderson
        givenNames:
          - MC
      - type: Person
        familyNames:
          - Trent
        givenNames:
          - JM
      - type: Person
        familyNames:
          - Von
          - Hoff
        givenNames:
          - DD
      - type: Person
        familyNames:
          - Mousses
        givenNames:
          - S
    datePublished: '2009'
    isPartOf:
      type: PublicationVolume
      title: Journal of Translational Medicine
      volumeNumber: 7
    title: >-
      Synthetic lethal RNAi screening identifies sensitizing targets for
      gemcitabine therapy in pancreatic cancer
  - type: Article
    id: bib5
    authors:
      - type: Person
        familyNames:
          - Backert
        givenNames:
          - S
      - type: Person
        familyNames:
          - Gelos
        givenNames:
          - M
      - type: Person
        familyNames:
          - Kobalz
        givenNames:
          - U
      - type: Person
        familyNames:
          - Hanski
        givenNames:
          - ML
      - type: Person
        familyNames:
          - Böhm
        givenNames:
          - C
      - type: Person
        familyNames:
          - Mann
        givenNames:
          - B
      - type: Person
        familyNames:
          - Lövin
        givenNames:
          - 'N'
      - type: Person
        familyNames:
          - Gratchev
        givenNames:
          - A
      - type: Person
        familyNames:
          - Mansmann
        givenNames:
          - U
      - type: Person
        familyNames:
          - Moyer
        givenNames:
          - MP
      - type: Person
        familyNames:
          - Riecken
        givenNames:
          - EO
      - type: Person
        familyNames:
          - Hanski
        givenNames:
          - C
    datePublished: '1999'
    isPartOf:
      type: PublicationVolume
      pageEnd: 874
      pageStart: 868
      title: International Journal of Cancer
      volumeNumber: 82
    title: >-
      Differential gene expression in colon carcinoma cells and tissues detected
      with a cDNA array
  - type: Article
    id: bib6
    authors:
      - type: Person
        familyNames:
          - Bajrami
        givenNames:
          - I
      - type: Person
        familyNames:
          - Frankum
        givenNames:
          - JR
      - type: Person
        familyNames:
          - Konde
        givenNames:
          - A
      - type: Person
        familyNames:
          - Miller
        givenNames:
          - RE
      - type: Person
        familyNames:
          - Rehman
        givenNames:
          - FL
      - type: Person
        familyNames:
          - Brough
        givenNames:
          - R
      - type: Person
        familyNames:
          - Campbell
        givenNames:
          - J
      - type: Person
        familyNames:
          - Sims
        givenNames:
          - D
      - type: Person
        familyNames:
          - Rafiq
        givenNames:
          - R
      - type: Person
        familyNames:
          - Hooper
        givenNames:
          - S
      - type: Person
        familyNames:
          - Chen
        givenNames:
          - L
      - type: Person
        familyNames:
          - Kozarewa
        givenNames:
          - I
      - type: Person
        familyNames:
          - Assiotis
        givenNames:
          - I
      - type: Person
        familyNames:
          - Fenwick
        givenNames:
          - K
      - type: Person
        familyNames:
          - Natrajan
        givenNames:
          - R
      - type: Person
        familyNames:
          - Lord
        givenNames:
          - CJ
      - type: Person
        familyNames:
          - Ashworth
        givenNames:
          - A
    datePublished: '2014'
    isPartOf:
      type: PublicationVolume
      pageEnd: 297
      pageStart: 287
      title: Cancer Research
      volumeNumber: 74
    title: >-
      Genome-wide profiling of genetic synthetic lethality identifies CDK12 as a
      novel determinant of PARP1/2 inhibitor sensitivity
  - type: Article
    id: bib7
    authors:
      - type: Person
        familyNames:
          - Balasubramanian
        givenNames:
          - S
      - type: Person
        familyNames:
          - Hurley
        givenNames:
          - LH
      - type: Person
        familyNames:
          - Neidle
        givenNames:
          - S
    datePublished: '2011'
    isPartOf:
      type: PublicationVolume
      pageEnd: 275
      pageStart: 261
      title: Nature Reviews Drug Discovery
      volumeNumber: 10
    title: 'Targeting G-quadruplexes in gene promoters: a novel anticancer strategy?'
  - type: Article
    id: bib8
    authors:
      - type: Person
        familyNames:
          - Barber
        givenNames:
          - TD
      - type: Person
        familyNames:
          - McManus
        givenNames:
          - K
      - type: Person
        familyNames:
          - Yuen
        givenNames:
          - KW
      - type: Person
        familyNames:
          - Reis
        givenNames:
          - M
      - type: Person
        familyNames:
          - Parmigiani
        givenNames:
          - G
      - type: Person
        familyNames:
          - Shen
        givenNames:
          - D
      - type: Person
        familyNames:
          - Barrett
        givenNames:
          - I
      - type: Person
        familyNames:
          - Nouhi
        givenNames:
          - 'Y'
      - type: Person
        familyNames:
          - Spencer
        givenNames:
          - F
      - type: Person
        familyNames:
          - Markowitz
        givenNames:
          - S
      - type: Person
        familyNames:
          - Velculescu
        givenNames:
          - VE
      - type: Person
        familyNames:
          - Kinzler
        givenNames:
          - KW
      - type: Person
        familyNames:
          - Vogelstein
        givenNames:
          - B
      - type: Person
        familyNames:
          - Lengauer
        givenNames:
          - C
      - type: Person
        familyNames:
          - Hieter
        givenNames:
          - P
    datePublished: '2008'
    isPartOf:
      type: PublicationVolume
      pageEnd: 3448
      pageStart: 3443
      title: PNAS
      volumeNumber: 105
    title: >-
      Chromatid cohesion defects may underlie chromosome instability in human
      colorectal cancers
  - type: Article
    id: bib9
    authors:
      - type: Person
        familyNames:
          - Bennett
        givenNames:
          - RL
      - type: Person
        familyNames:
          - Swaroop
        givenNames:
          - A
      - type: Person
        familyNames:
          - Troche
        givenNames:
          - C
      - type: Person
        familyNames:
          - Licht
        givenNames:
          - JD
    datePublished: '2017'
    isPartOf:
      type: PublicationVolume
      title: Cold Spring Harbor Perspectives in Medicine
      volumeNumber: 7
    title: >-
      The role of nuclear Receptor-Binding SET domain family histone lysine
      methyltransferases in cancer
  - type: Article
    id: bib10
    authors:
      - type: Person
        familyNames:
          - Besnard
        givenNames:
          - E
      - type: Person
        familyNames:
          - Babled
        givenNames:
          - A
      - type: Person
        familyNames:
          - Lapasset
        givenNames:
          - L
      - type: Person
        familyNames:
          - Milhavet
        givenNames:
          - O
      - type: Person
        familyNames:
          - Parrinello
        givenNames:
          - H
      - type: Person
        familyNames:
          - Dantec
        givenNames:
          - C
      - type: Person
        familyNames:
          - Marin
        givenNames:
          - JM
      - type: Person
        familyNames:
          - Lemaitre
        givenNames:
          - JM
    datePublished: '2012'
    isPartOf:
      type: PublicationVolume
      pageEnd: 844
      pageStart: 837
      title: Nature Structural & Molecular Biology
      volumeNumber: 19
    title: >-
      Unraveling cell type-specific and reprogrammable human replication origin
      signatures associated with G-quadruplex consensus motifs
  - type: Article
    id: bib11
    authors:
      - type: Person
        familyNames:
          - Biffi
        givenNames:
          - G
      - type: Person
        familyNames:
          - Tannahill
        givenNames:
          - D
      - type: Person
        familyNames:
          - McCafferty
        givenNames:
          - J
      - type: Person
        familyNames:
          - Balasubramanian
        givenNames:
          - S
    datePublished: '2013'
    isPartOf:
      type: PublicationVolume
      pageEnd: 186
      pageStart: 182
      title: Nature Chemistry
      volumeNumber: 5
    title: Quantitative visualization of DNA G-quadruplex structures in human cells
  - type: Article
    id: bib12
    authors:
      - type: Person
        familyNames:
          - Biffi
        givenNames:
          - G
      - type: Person
        familyNames:
          - Tannahill
        givenNames:
          - D
      - type: Person
        familyNames:
          - Miller
        givenNames:
          - J
      - type: Person
        familyNames:
          - Howat
        givenNames:
          - WJ
      - type: Person
        familyNames:
          - Balasubramanian
        givenNames:
          - S
    datePublished: '2014'
    isPartOf:
      type: PublicationVolume
      title: PLOS ONE
      volumeNumber: 9
    title: >-
      Elevated levels of G-quadruplex formation in human stomach and liver
      cancer tissues
  - type: Article
    id: bib13
    authors:
      - type: Person
        familyNames:
          - Bindea
        givenNames:
          - G
      - type: Person
        familyNames:
          - Mlecnik
        givenNames:
          - B
      - type: Person
        familyNames:
          - Hackl
        givenNames:
          - H
      - type: Person
        familyNames:
          - Charoentong
        givenNames:
          - P
      - type: Person
        familyNames:
          - Tosolini
        givenNames:
          - M
      - type: Person
        familyNames:
          - Kirilovsky
        givenNames:
          - A
      - type: Person
        familyNames:
          - Fridman
        givenNames:
          - WH
      - type: Person
        familyNames:
          - Pagès
        givenNames:
          - F
      - type: Person
        familyNames:
          - Trajanoski
        givenNames:
          - Z
      - type: Person
        familyNames:
          - Galon
        givenNames:
          - J
    datePublished: '2009'
    isPartOf:
      type: PublicationVolume
      pageEnd: 1093
      pageStart: 1091
      title: Bioinformatics
      volumeNumber: 25
    title: >-
      ClueGO: a cytoscape plug-in to decipher functionally grouped gene ontology
      and pathway annotation networks
  - type: Article
    id: bib14
    authors:
      - type: Person
        familyNames:
          - Bindea
        givenNames:
          - G
      - type: Person
        familyNames:
          - Galon
        givenNames:
          - J
      - type: Person
        familyNames:
          - Mlecnik
        givenNames:
          - B
    datePublished: '2013'
    isPartOf:
      type: PublicationVolume
      pageEnd: 663
      pageStart: 661
      title: Bioinformatics
      volumeNumber: 29
    title: >-
      CluePedia cytoscape plugin: pathway insights using integrated experimental
      and in silico data
  - type: Article
    id: bib15
    authors:
      - type: Person
        familyNames:
          - Bochman
        givenNames:
          - ML
      - type: Person
        familyNames:
          - Paeschke
        givenNames:
          - K
      - type: Person
        familyNames:
          - Zakian
        givenNames:
          - VA
    datePublished: '2012'
    isPartOf:
      type: PublicationVolume
      pageEnd: 780
      pageStart: 770
      title: Nature Reviews Genetics
      volumeNumber: 13
    title: >-
      DNA secondary structures: stability and function of G-quadruplex
      structures
  - type: Article
    id: bib16
    authors:
      - type: Person
        familyNames:
          - Brázda
        givenNames:
          - V
      - type: Person
        familyNames:
          - Hároníková
        givenNames:
          - L
      - type: Person
        familyNames:
          - Liao
        givenNames:
          - JC
      - type: Person
        familyNames:
          - Fojta
        givenNames:
          - M
    datePublished: '2014'
    isPartOf:
      type: PublicationVolume
      pageEnd: 17517
      pageStart: 17493
      title: International Journal of Molecular Sciences
      volumeNumber: 15
    title: DNA and RNA quadruplex-binding proteins
  - type: Article
    id: bib17
    authors:
      - type: Person
        familyNames:
          - Brosh
        givenNames:
          - RM
    datePublished: '2013'
    isPartOf:
      type: PublicationVolume
      pageEnd: 558
      pageStart: 542
      title: Nature Reviews Cancer
      volumeNumber: 13
    title: DNA helicases involved in DNA repair and their roles in cancer
  - type: Article
    id: bib18
    authors:
      - type: Person
        familyNames:
          - Bryant
        givenNames:
          - HE
      - type: Person
        familyNames:
          - Schultz
        givenNames:
          - 'N'
      - type: Person
        familyNames:
          - Thomas
        givenNames:
          - HD
      - type: Person
        familyNames:
          - Parker
        givenNames:
          - KM
      - type: Person
        familyNames:
          - Flower
        givenNames:
          - D
      - type: Person
        familyNames:
          - Lopez
        givenNames:
          - E
      - type: Person
        familyNames:
          - Kyle
        givenNames:
          - S
      - type: Person
        familyNames:
          - Meuth
        givenNames:
          - M
      - type: Person
        familyNames:
          - Curtin
        givenNames:
          - NJ
      - type: Person
        familyNames:
          - Helleday
        givenNames:
          - T
    datePublished: '2005'
    isPartOf:
      type: PublicationVolume
      pageEnd: 917
      pageStart: 913
      title: Nature
      volumeNumber: 434
    title: >-
      Specific killing of BRCA2-deficient tumours with inhibitors of
      poly(ADP-ribose) polymerase
  - type: Article
    id: bib19
    authors:
      - type: Person
        familyNames:
          - Bugaut
        givenNames:
          - A
      - type: Person
        familyNames:
          - Balasubramanian
        givenNames:
          - S
    datePublished: '2012'
    isPartOf:
      type: PublicationVolume
      pageEnd: 4741
      pageStart: 4727
      title: Nucleic Acids Research
      volumeNumber: 40
    title: '5''-UTR RNA G-quadruplexes: translation regulation and targeting'
  - type: Article
    id: bib20
    authors:
      - type: Person
        familyNames:
          - Cammas
        givenNames:
          - A
      - type: Person
        familyNames:
          - Millevoi
        givenNames:
          - S
    datePublished: '2016'
    isPartOf:
      type: PublicationVolume
      title: Nucleic Acids Research
      volumeNumber: 9
    title: 'RNA G-quadruplexes: emerging mechanisms in disease'
  - type: Article
    id: bib21
    authors:
      - type: Person
        familyNames:
          - Carbone
        givenNames:
          - M
      - type: Person
        familyNames:
          - Yang
        givenNames:
          - H
      - type: Person
        familyNames:
          - Pass
        givenNames:
          - HI
      - type: Person
        familyNames:
          - Krausz
        givenNames:
          - T
      - type: Person
        familyNames:
          - Testa
        givenNames:
          - JR
      - type: Person
        familyNames:
          - Gaudino
        givenNames:
          - G
    datePublished: '2013'
    isPartOf:
      type: PublicationVolume
      pageEnd: 159
      pageStart: 153
      title: Nature Reviews Cancer
      volumeNumber: 13
    title: BAP1 and cancer
  - type: Article
    id: bib22
    authors:
      - type: Person
        familyNames:
          - Chakraborty
        givenNames:
          - P
      - type: Person
        familyNames:
          - Grosse
        givenNames:
          - F
    datePublished: '2011'
    isPartOf:
      type: PublicationVolume
      pageEnd: 665
      pageStart: 654
      title: DNA Repair
      volumeNumber: 10
    title: >-
      Human DHX9 helicase preferentially unwinds RNA-containing displacement
      loops (R-loops) and G-quadruplexes
  - type: Article
    id: bib23
    authors:
      - type: Person
        familyNames:
          - Chambers
        givenNames:
          - VS
      - type: Person
        familyNames:
          - Marsico
        givenNames:
          - G
      - type: Person
        familyNames:
          - Boutell
        givenNames:
          - JM
      - type: Person
        familyNames:
          - Di
          - Antonio
        givenNames:
          - M
      - type: Person
        familyNames:
          - Smith
        givenNames:
          - GP
      - type: Person
        familyNames:
          - Balasubramanian
        givenNames:
          - S
    datePublished: '2015'
    isPartOf:
      type: PublicationVolume
      pageEnd: 881
      pageStart: 877
      title: Nature Biotechnology
      volumeNumber: 33
    title: >-
      High-throughput sequencing of DNA G-quadruplex structures in the human
      genome
  - type: Article
    id: bib24
    authors:
      - type: Person
        familyNames:
          - Chan
        givenNames:
          - DA
      - type: Person
        familyNames:
          - Giaccia
        givenNames:
          - AJ
    datePublished: '2011'
    isPartOf:
      type: PublicationVolume
      pageEnd: 364
      pageStart: 351
      title: Nature Reviews Drug Discovery
      volumeNumber: 10
    title: Harnessing synthetic lethal interactions in anticancer drug discovery
  - type: Article
    id: bib25
    authors:
      - type: Person
        familyNames:
          - Chen
        givenNames:
          - D
      - type: Person
        familyNames:
          - Frezza
        givenNames:
          - M
      - type: Person
        familyNames:
          - Schmitt
        givenNames:
          - S
      - type: Person
        familyNames:
          - Kanwar
        givenNames:
          - J
      - type: Person
        familyNames:
          - Dou
        givenNames:
          - QP
    datePublished: '2011'
    isPartOf:
      type: PublicationVolume
      pageEnd: 253
      pageStart: 239
      title: Current Cancer Drug Targets
      volumeNumber: 11
    title: >-
      Bortezomib as the first proteasome inhibitor anticancer drug: current
      status and future perspectives
  - type: Article
    id: bib26
    authors:
      - type: Person
        familyNames:
          - Chen
        givenNames:
          - J
      - type: Person
        familyNames:
          - Dexheimer
        givenNames:
          - TS
      - type: Person
        familyNames:
          - Ai
        givenNames:
          - 'Y'
      - type: Person
        familyNames:
          - Liang
        givenNames:
          - Q
      - type: Person
        familyNames:
          - Villamil
        givenNames:
          - MA
      - type: Person
        familyNames:
          - Inglese
        givenNames:
          - J
      - type: Person
        familyNames:
          - Maloney
        givenNames:
          - DJ
      - type: Person
        familyNames:
          - Jadhav
        givenNames:
          - A
      - type: Person
        familyNames:
          - Simeonov
        givenNames:
          - A
      - type: Person
        familyNames:
          - Zhuang
        givenNames:
          - Z
    datePublished: '2011'
    isPartOf:
      type: PublicationVolume
      pageEnd: 1400
      pageStart: 1390
      title: Chemistry & Biology
      volumeNumber: 18
    title: >-
      Selective and cell-active inhibitors of the USP1/ UAF1 deubiquitinase
      complex reverse cisplatin resistance in non-small cell lung cancer cells
  - type: Article
    id: bib27
    authors:
      - type: Person
        familyNames:
          - Chen
        givenNames:
          - MC
      - type: Person
        familyNames:
          - Tippana
        givenNames:
          - R
      - type: Person
        familyNames:
          - Demeshkina
        givenNames:
          - NA
      - type: Person
        familyNames:
          - Murat
        givenNames:
          - P
      - type: Person
        familyNames:
          - Balasubramanian
        givenNames:
          - S
      - type: Person
        familyNames:
          - Myong
        givenNames:
          - S
      - type: Person
        familyNames:
          - Ferré-D'Amaré
        givenNames:
          - AR
    datePublished: '2018'
    isPartOf:
      type: PublicationVolume
      pageEnd: 469
      pageStart: 465
      title: Nature
      volumeNumber: 558
    title: Structural basis of G-quadruplex unfolding by the DEAH/RHA helicase DHX36
  - type: Article
    id: bib28
    authors:
      - type: Person
        familyNames:
          - Cheung
        givenNames:
          - PK
      - type: Person
        familyNames:
          - Horhant
        givenNames:
          - D
      - type: Person
        familyNames:
          - Bandy
        givenNames:
          - LE
      - type: Person
        familyNames:
          - Zamiri
        givenNames:
          - M
      - type: Person
        familyNames:
          - Rabea
        givenNames:
          - SM
      - type: Person
        familyNames:
          - Karagiosov
        givenNames:
          - SK
      - type: Person
        familyNames:
          - Matloobi
        givenNames:
          - M
      - type: Person
        familyNames:
          - McArthur
        givenNames:
          - S
      - type: Person
        familyNames:
          - Harrigan
        givenNames:
          - PR
      - type: Person
        familyNames:
          - Chabot
        givenNames:
          - B
      - type: Person
        familyNames:
          - Grierson
        givenNames:
          - DS
    datePublished: '2016'
    isPartOf:
      type: PublicationVolume
      pageEnd: 1879
      pageStart: 1869
      title: Journal of Medicinal Chemistry
      volumeNumber: 59
    title: >-
      A parallel synthesis approach to the identification of novel
      Diheteroarylamide-Based compounds blocking HIV replication: potential
      inhibitors of HIV-1 Pre-mRNA alternative splicing
  - type: Article
    id: bib29
    authors:
      - type: Person
        familyNames:
          - Coussens
        givenNames:
          - NP
      - type: Person
        familyNames:
          - Kales
        givenNames:
          - SC
      - type: Person
        familyNames:
          - Henderson
        givenNames:
          - MJ
      - type: Person
        familyNames:
          - Lee
        givenNames:
          - OW
      - type: Person
        familyNames:
          - Horiuchi
        givenNames:
          - KY
      - type: Person
        familyNames:
          - Wang
        givenNames:
          - 'Y'
      - type: Person
        familyNames:
          - Hall
        givenNames:
          - MD
    datePublished: '2017'
    isPartOf:
      type: PublicationVolume
      title: bioRxiv
    title: >-
      Small molecule inhibitors of the human histone lysine methyltransferase
      NSD2 / WHSC1 / MMSET identified from a quantitative High-Throughput screen
      with nucleosome substrate
  - type: Article
    id: bib30
    authors:
      - type: Person
        familyNames:
          - Creacy
        givenNames:
          - SD
      - type: Person
        familyNames:
          - Routh
        givenNames:
          - ED
      - type: Person
        familyNames:
          - Iwamoto
        givenNames:
          - F
      - type: Person
        familyNames:
          - Nagamine
        givenNames:
          - 'Y'
      - type: Person
        familyNames:
          - Akman
        givenNames:
          - SA
      - type: Person
        familyNames:
          - Vaughn
        givenNames:
          - JP
    datePublished: '2008'
    isPartOf:
      type: PublicationVolume
      pageEnd: 34634
      pageStart: 34626
      title: Journal of Biological Chemistry
      volumeNumber: 283
    title: >-
      G4 resolvase 1 binds both DNA and RNA tetramolecular quadruplex with high
      affinity and is the major source of tetramolecular quadruplex G4-DNA and
      G4-RNA resolving activity in HeLa cell lysates
  - type: Article
    id: bib31
    authors:
      - type: Person
        familyNames:
          - Crozat
        givenNames:
          - A
      - type: Person
        familyNames:
          - Aman
        givenNames:
          - P
      - type: Person
        familyNames:
          - Mandahl
        givenNames:
          - 'N'
      - type: Person
        familyNames:
          - Ron
        givenNames:
          - D
    datePublished: '1993'
    isPartOf:
      type: PublicationVolume
      pageEnd: 644
      pageStart: 640
      title: Nature
      volumeNumber: 363
    title: Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma
  - type: Article
    id: bib32
    authors:
      - type: Person
        familyNames:
          - Dai
        givenNames:
          - Z
      - type: Person
        familyNames:
          - Sheridan
        givenNames:
          - JM
      - type: Person
        familyNames:
          - Gearing
        givenNames:
          - LJ
      - type: Person
        familyNames:
          - Moore
        givenNames:
          - DL
      - type: Person
        familyNames:
          - Su
        givenNames:
          - S
      - type: Person
        familyNames:
          - Wormald
        givenNames:
          - S
      - type: Person
        familyNames:
          - Wilcox
        givenNames:
          - S
      - type: Person
        familyNames:
          - O'Connor
        givenNames:
          - L
      - type: Person
        familyNames:
          - Dickins
        givenNames:
          - RA
      - type: Person
        familyNames:
          - Blewitt
        givenNames:
          - ME
      - type: Person
        familyNames:
          - Ritchie
        givenNames:
          - ME
    datePublished: '2014'
    isPartOf:
      type: PublicationVolume
      pageStart: 95
      title: F1000Research
      volumeNumber: 3
    title: >-
      edgeR: a versatile tool for the analysis of shRNA-seq and CRISPR-Cas9
      genetic screens
  - type: Article
    id: bib33
    authors:
      - type: Person
        familyNames:
          - Damerla
        givenNames:
          - RR
      - type: Person
        familyNames:
          - Knickelbein
        givenNames:
          - KE
      - type: Person
        familyNames:
          - Strutt
        givenNames:
          - S
      - type: Person
        familyNames:
          - Liu
        givenNames:
          - FJ
      - type: Person
        familyNames:
          - Wang
        givenNames:
          - H
      - type: Person
        familyNames:
          - Opresko
        givenNames:
          - PL
    datePublished: '2012'
    isPartOf:
      type: PublicationVolume
      pageEnd: 3044
      pageStart: 3036
      title: Cell Cycle
      volumeNumber: 11
    title: >-
      Werner syndrome protein suppresses the formation of large deletions during
      the replication of human telomeric sequences
  - type: Article
    id: bib34
    authors:
      - type: Person
        familyNames:
          - De
          - Cian
        givenNames:
          - A
      - type: Person
        familyNames:
          - Cristofari
        givenNames:
          - G
      - type: Person
        familyNames:
          - Reichenbach
        givenNames:
          - P
      - type: Person
        familyNames:
          - De
          - Lemos
        givenNames:
          - E
      - type: Person
        familyNames:
          - Monchaud
        givenNames:
          - D
      - type: Person
        familyNames:
          - Teulade-Fichou
        givenNames:
          - MP
      - type: Person
        familyNames:
          - Shin-Ya
        givenNames:
          - K
      - type: Person
        familyNames:
          - Lacroix
        givenNames:
          - L
      - type: Person
        familyNames:
          - Lingner
        givenNames:
          - J
      - type: Person
        familyNames:
          - Mergny
        givenNames:
          - JL
    datePublished: '2007'
    isPartOf:
      type: PublicationVolume
      pageEnd: 17352
      pageStart: 17347
      title: PNAS
      volumeNumber: 104
    title: >-
      Reevaluation of telomerase inhibition by quadruplex ligands and their
      mechanisms of action
  - type: Article
    id: bib35
    authors:
      - type: Person
        familyNames:
          - De
          - Cian
        givenNames:
          - A
      - type: Person
        familyNames:
          - Delemos
        givenNames:
          - E
      - type: Person
        familyNames:
          - Mergny
        givenNames:
          - JL
      - type: Person
        familyNames:
          - Teulade-Fichou
        givenNames:
          - MP
      - type: Person
        familyNames:
          - Monchaud
        givenNames:
          - D
    datePublished: '2007'
    isPartOf:
      type: PublicationVolume
      pageEnd: 1857
      pageStart: 1856
      title: Journal of the American Chemical Society
      volumeNumber: 129
    title: Highly efficient G-quadruplex recognition by bisquinolinium compounds
  - type: Article
    id: bib36
    authors:
      - type: Person
        familyNames:
          - Demagny
        givenNames:
          - H
      - type: Person
        familyNames:
          - De
          - Robertis
        givenNames:
          - EM
    datePublished: '2016'
    isPartOf:
      type: PublicationVolume
      title: Molecular & Cellular Oncology
      volumeNumber: 3
    title: >-
      Point mutations in the tumor suppressor Smad4/DPC4 enhance its
      phosphorylation by GSK3 and reversibly inactivate TGF-β signaling
  - type: Article
    id: bib37
    authors:
      - type: Person
        familyNames:
          - Di
          - Veroli
        givenNames:
          - GY
      - type: Person
        familyNames:
          - Fornari
        givenNames:
          - C
      - type: Person
        familyNames:
          - Wang
        givenNames:
          - D
      - type: Person
        familyNames:
          - Mollard
        givenNames:
          - S
      - type: Person
        familyNames:
          - Bramhall
        givenNames:
          - JL
      - type: Person
        familyNames:
          - Richards
        givenNames:
          - FM
      - type: Person
        familyNames:
          - Jodrell
        givenNames:
          - DI
    datePublished: '2016'
    isPartOf:
      type: PublicationVolume
      pageEnd: 2868
      pageStart: 2866
      title: Bioinformatics
      volumeNumber: 32
    title: >-
      Combenefit: an interactive platform for the analysis and visualization of
      drug combinations
  - type: Article
    id: bib38
    authors:
      - type: Person
        familyNames:
          - Dos
          - Santos
        givenNames:
          - PC
      - type: Person
        familyNames:
          - Panero
        givenNames:
          - J
      - type: Person
        familyNames:
          - Stanganelli
        givenNames:
          - C
      - type: Person
        familyNames:
          - Palau
          - Nagore
        givenNames:
          - V
      - type: Person
        familyNames:
          - Stella
        givenNames:
          - F
      - type: Person
        familyNames:
          - Bezares
        givenNames:
          - R
      - type: Person
        familyNames:
          - Slavutsky
        givenNames:
          - I
    datePublished: '2017'
    isPartOf:
      type: PublicationVolume
      title: PLOS ONE
      volumeNumber: 12
    title: >-
      Dysregulation of H/ACA ribonucleoprotein components in chronic lymphocytic
      leukemia
  - type: Article
    id: bib39
    authors:
      - type: Person
        familyNames:
          - Dvinge
        givenNames:
          - H
      - type: Person
        familyNames:
          - Kim
        givenNames:
          - E
      - type: Person
        familyNames:
          - Abdel-Wahab
        givenNames:
          - O
      - type: Person
        familyNames:
          - Bradley
        givenNames:
          - RK
    datePublished: '2016'
    isPartOf:
      type: PublicationVolume
      pageEnd: 430
      pageStart: 413
      title: Nature Reviews Cancer
      volumeNumber: 16
    title: RNA splicing factors as oncoproteins and tumour suppressors
  - type: Article
    id: bib40
    authors:
      - type: Person
        familyNames:
          - Edelmann
        givenNames:
          - MJ
      - type: Person
        familyNames:
          - Nicholson
        givenNames:
          - B
      - type: Person
        familyNames:
          - Kessler
        givenNames:
          - BM
    datePublished: '2011'
    isPartOf:
      type: PublicationVolume
      title: Expert Reviews in Molecular Medicine
      volumeNumber: 13
    title: >-
      Pharmacological targets in the ubiquitin system offer new ways of treating
      cancer, neurodegenerative disorders and infectious diseases
  - type: Article
    id: bib41
    authors:
      - type: Person
        familyNames:
          - Farmer
        givenNames:
          - H
      - type: Person
        familyNames:
          - McCabe
        givenNames:
          - 'N'
      - type: Person
        familyNames:
          - Lord
        givenNames:
          - CJ
      - type: Person
        familyNames:
          - Tutt
        givenNames:
          - AN
      - type: Person
        familyNames:
          - Johnson
        givenNames:
          - DA
      - type: Person
        familyNames:
          - Richardson
        givenNames:
          - TB
      - type: Person
        familyNames:
          - Santarosa
        givenNames:
          - M
      - type: Person
        familyNames:
          - Dillon
        givenNames:
          - KJ
      - type: Person
        familyNames:
          - Hickson
        givenNames:
          - I
      - type: Person
        familyNames:
          - Knights
        givenNames:
          - C
      - type: Person
        familyNames:
          - Martin
        givenNames:
          - NM
      - type: Person
        familyNames:
          - Jackson
        givenNames:
          - SP
      - type: Person
        familyNames:
          - Smith
        givenNames:
          - GC
      - type: Person
        familyNames:
          - Ashworth
        givenNames:
          - A
    datePublished: '2005'
    isPartOf:
      type: PublicationVolume
      pageEnd: 921
      pageStart: 917
      title: Nature
      volumeNumber: 434
    title: >-
      Targeting the DNA repair defect in BRCA mutant cells as a therapeutic
      strategy
  - type: Article
    id: bib42
    authors:
      - type: Person
        familyNames:
          - Finn
        givenNames:
          - RD
      - type: Person
        familyNames:
          - Coggill
        givenNames:
          - P
      - type: Person
        familyNames:
          - Eberhardt
        givenNames:
          - RY
      - type: Person
        familyNames:
          - Eddy
        givenNames:
          - SR
      - type: Person
        familyNames:
          - Mistry
        givenNames:
          - J
      - type: Person
        familyNames:
          - Mitchell
        givenNames:
          - AL
      - type: Person
        familyNames:
          - Potter
        givenNames:
          - SC
      - type: Person
        familyNames:
          - Punta
        givenNames:
          - M
      - type: Person
        familyNames:
          - Qureshi
        givenNames:
          - M
      - type: Person
        familyNames:
          - Sangrador-Vegas
        givenNames:
          - A
      - type: Person
        familyNames:
          - Salazar
        givenNames:
          - GA
      - type: Person
        familyNames:
          - Tate
        givenNames:
          - J
      - type: Person
        familyNames:
          - Bateman
        givenNames:
          - A
    datePublished: '2016'
    isPartOf:
      type: PublicationVolume
      title: Nucleic Acids Research
      volumeNumber: 44
    title: 'The pfam protein families database: towards a more sustainable future'
  - type: Article
    id: bib43
    authors:
      - type: Person
        familyNames:
          - Forbes
        givenNames:
          - SA
      - type: Person
        familyNames:
          - Beare
        givenNames:
          - D
      - type: Person
        familyNames:
          - Gunasekaran
        givenNames:
          - P
      - type: Person
        familyNames:
          - Leung
        givenNames:
          - K
      - type: Person
        familyNames:
          - Bindal
        givenNames:
          - 'N'
      - type: Person
        familyNames:
          - Boutselakis
        givenNames:
          - H
      - type: Person
        familyNames:
          - Ding
        givenNames:
          - M
      - type: Person
        familyNames:
          - Bamford
        givenNames:
          - S
      - type: Person
        familyNames:
          - Cole
        givenNames:
          - C
      - type: Person
        familyNames:
          - Ward
        givenNames:
          - S
      - type: Person
        familyNames:
          - Kok
        givenNames:
          - CY
      - type: Person
        familyNames:
          - Jia
        givenNames:
          - M
      - type: Person
        familyNames:
          - De
        givenNames:
          - T
      - type: Person
        familyNames:
          - Teague
        givenNames:
          - JW
      - type: Person
        familyNames:
          - Stratton
        givenNames:
          - MR
      - type: Person
        familyNames:
          - McDermott
        givenNames:
          - U
      - type: Person
        familyNames:
          - Campbell
        givenNames:
          - PJ
    datePublished: '2015'
    isPartOf:
      type: PublicationVolume
      title: Nucleic Acids Research
      volumeNumber: 43
    title: >-
      COSMIC: exploring the world's knowledge of somatic mutations in human
      cancer
  - type: Article
    id: bib44
    authors:
      - type: Person
        familyNames:
          - Froimchuk
        givenNames:
          - E
      - type: Person
        familyNames:
          - Jang
        givenNames:
          - 'Y'
      - type: Person
        familyNames:
          - Ge
        givenNames:
          - K
    datePublished: '2017'
    isPartOf:
      type: PublicationVolume
      pageEnd: 342
      pageStart: 337
      title: Gene
      volumeNumber: 627
    title: Histone H3 lysine 4 methyltransferase KMT2D
  - type: Article
    id: bib45
    authors:
      - type: Person
        familyNames:
          - Gao
        givenNames:
          - C
      - type: Person
        familyNames:
          - Pang
        givenNames:
          - L
      - type: Person
        familyNames:
          - Ren
        givenNames:
          - C
      - type: Person
        familyNames:
          - Ma
        givenNames:
          - T
    datePublished: '2012'
    isPartOf:
      type: PublicationVolume
      pageEnd: 1738
      pageStart: 1733
      title: Medical Oncology
      volumeNumber: 29
    title: >-
      Decreased expression of Nedd4L correlates with poor prognosis in gastric
      cancer patient
  - type: Article
    id: bib46
    authors:
      - type: Person
        familyNames:
          - García-Santisteban
        givenNames:
          - I
      - type: Person
        familyNames:
          - Peters
        givenNames:
          - GJ
      - type: Person
        familyNames:
          - Giovannetti
        givenNames:
          - E
      - type: Person
        familyNames:
          - Rodríguez
        givenNames:
          - JA
    datePublished: '2013'
    isPartOf:
      type: PublicationVolume
      title: Molecular Cancer
      volumeNumber: 12
    title: >-
      USP1 deubiquitinase: cellular functions, regulatory mechanisms and
      emerging potential as target in cancer therapy
  - type: Article
    id: bib47
    authors:
      - type: Person
        familyNames:
          - Giri
        givenNames:
          - B
      - type: Person
        familyNames:
          - Smaldino
        givenNames:
          - PJ
      - type: Person
        familyNames:
          - Thys
        givenNames:
          - RG
      - type: Person
        familyNames:
          - Creacy
        givenNames:
          - SD
      - type: Person
        familyNames:
          - Routh
        givenNames:
          - ED
      - type: Person
        familyNames:
          - Hantgan
        givenNames:
          - RR
      - type: Person
        familyNames:
          - Lattmann
        givenNames:
          - S
      - type: Person
        familyNames:
          - Nagamine
        givenNames:
          - 'Y'
      - type: Person
        familyNames:
          - Akman
        givenNames:
          - SA
      - type: Person
        familyNames:
          - Vaughn
        givenNames:
          - JP
    datePublished: '2011'
    isPartOf:
      type: PublicationVolume
      pageEnd: 7178
      pageStart: 7161
      title: Nucleic Acids Research
      volumeNumber: 39
    title: G4 resolvase 1 tightly binds and unwinds unimolecular G4-DNA
  - type: Article
    id: bib48
    authors:
      - type: Person
        familyNames:
          - González
        givenNames:
          - V
      - type: Person
        familyNames:
          - Hurley
        givenNames:
          - LH
    datePublished: '2010'
    isPartOf:
      type: PublicationVolume
      pageEnd: 129
      pageStart: 111
      title: Annual Review of Pharmacology and Toxicology
      volumeNumber: 50
    title: 'The c-MYC NHE III(1): function and regulation'
  - type: Article
    id: bib49
    authors:
      - type: Person
        familyNames:
          - Gordon
        givenNames:
          - A
      - type: Person
        familyNames:
          - Hannon
        givenNames:
          - G
    datePublished: '2010'
    isPartOf:
      type: PublicationVolume
      title: "\_FASTQ/A Short-Reads Pre-Processing Tools"
    title: ''
  - type: Article
    id: bib50
    authors:
      - type: Person
        familyNames:
          - Griffith
        givenNames:
          - M
      - type: Person
        familyNames:
          - Griffith
        givenNames:
          - OL
      - type: Person
        familyNames:
          - Coffman
        givenNames:
          - AC
      - type: Person
        familyNames:
          - Weible
        givenNames:
          - JV
      - type: Person
        familyNames:
          - McMichael
        givenNames:
          - JF
      - type: Person
        familyNames:
          - Spies
        givenNames:
          - NC
      - type: Person
        familyNames:
          - Koval
        givenNames:
          - J
      - type: Person
        familyNames:
          - Das
        givenNames:
          - I
      - type: Person
        familyNames:
          - Callaway
        givenNames:
          - MB
      - type: Person
        familyNames:
          - Eldred
        givenNames:
          - JM
      - type: Person
        familyNames:
          - Miller
        givenNames:
          - CA
      - type: Person
        familyNames:
          - Subramanian
        givenNames:
          - J
      - type: Person
        familyNames:
          - Govindan
        givenNames:
          - R
      - type: Person
        familyNames:
          - Kumar
        givenNames:
          - RD
      - type: Person
        familyNames:
          - Bose
        givenNames:
          - R
      - type: Person
        familyNames:
          - Ding
        givenNames:
          - L
      - type: Person
        familyNames:
          - Walker
        givenNames:
          - JR
      - type: Person
        familyNames:
          - Larson
        givenNames:
          - DE
      - type: Person
        familyNames:
          - Dooling
        givenNames:
          - DJ
      - type: Person
        familyNames:
          - Smith
        givenNames:
          - SM
      - type: Person
        familyNames:
          - Ley
        givenNames:
          - TJ
      - type: Person
        familyNames:
          - Mardis
        givenNames:
          - ER
      - type: Person
        familyNames:
          - Wilson
        givenNames:
          - RK
    datePublished: '2013'
    isPartOf:
      type: PublicationVolume
      pageEnd: 1210
      pageStart: 1209
      title: Nature Methods
      volumeNumber: 10
    title: 'DGIdb: mining the druggable genome'
  - type: Article
    id: bib51
    authors:
      - type: Person
        familyNames:
          - Guzmán
        givenNames:
          - C
      - type: Person
        familyNames:
          - Bagga
        givenNames:
          - M
      - type: Person
        familyNames:
          - Kaur
        givenNames:
          - A
      - type: Person
        familyNames:
          - Westermarck
        givenNames:
          - J
      - type: Person
        familyNames:
          - Abankwa
        givenNames:
          - D
    datePublished: '2014'
    isPartOf:
      type: PublicationVolume
      title: PLOS ONE
      volumeNumber: 9
    title: >-
      ColonyArea: an ImageJ plugin to automatically quantify colony formation in
      clonogenic assays
  - type: Article
    id: bib52
    authors:
      - type: Person
        familyNames:
          - Hahn
        givenNames:
          - SA
      - type: Person
        familyNames:
          - Schutte
        givenNames:
          - M
      - type: Person
        familyNames:
          - Hoque
        givenNames:
          - AT
      - type: Person
        familyNames:
          - Moskaluk
        givenNames:
          - CA
      - type: Person
        familyNames:
          - da
          - Costa
        givenNames:
          - LT
      - type: Person
        familyNames:
          - Rozenblum
        givenNames:
          - E
      - type: Person
        familyNames:
          - Weinstein
        givenNames:
          - CL
      - type: Person
        familyNames:
          - Fischer
        givenNames:
          - A
      - type: Person
        familyNames:
          - Yeo
        givenNames:
          - CJ
      - type: Person
        familyNames:
          - Hruban
        givenNames:
          - RH
      - type: Person
        familyNames:
          - Kern
        givenNames:
          - SE
    datePublished: '1996'
    isPartOf:
      type: PublicationVolume
      pageEnd: 353
      pageStart: 350
      title: Science
      volumeNumber: 271
    title: 'DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1'
  - type: Article
    id: bib53
    authors:
      - type: Person
        familyNames:
          - Halder
        givenNames:
          - R
      - type: Person
        familyNames:
          - Riou
        givenNames:
          - JF
      - type: Person
        familyNames:
          - Teulade-Fichou
        givenNames:
          - MP
      - type: Person
        familyNames:
          - Frickey
        givenNames:
          - T
      - type: Person
        familyNames:
          - Hartig
        givenNames:
          - JS
    datePublished: '2012'
    isPartOf:
      type: PublicationVolume
      title: BMC Research Notes
      volumeNumber: 5
    title: >-
      Bisquinolinium compounds induce quadruplex-specific transcriptome changes
      in HeLa S3 cell lines
  - type: Article
    id: bib54
    authors:
      - type: Person
        familyNames:
          - Hänsel-Hertsch
        givenNames:
          - R
      - type: Person
        familyNames:
          - Beraldi
        givenNames:
          - D
      - type: Person
        familyNames:
          - Lensing
        givenNames:
          - SV
      - type: Person
        familyNames:
          - Marsico
        givenNames:
          - G
      - type: Person
        familyNames:
          - Zyner
        givenNames:
          - K
      - type: Person
        familyNames:
          - Parry
        givenNames:
          - A
      - type: Person
        familyNames:
          - Di
          - Antonio
        givenNames:
          - M
      - type: Person
        familyNames:
          - Pike
        givenNames:
          - J
      - type: Person
        familyNames:
          - Kimura
        givenNames:
          - H
      - type: Person
        familyNames:
          - Narita
        givenNames:
          - M
      - type: Person
        familyNames:
          - Tannahill
        givenNames:
          - D
      - type: Person
        familyNames:
          - Balasubramanian
        givenNames:
          - S
    datePublished: '2016'
    isPartOf:
      type: PublicationVolume
      pageEnd: 1272
      pageStart: 1267
      title: Nature Genetics
      volumeNumber: 48
    title: G-quadruplex structures mark human regulatory chromatin
  - type: Article
    id: bib55
    authors:
      - type: Person
        familyNames:
          - Harrigan
        givenNames:
          - JA
      - type: Person
        familyNames:
          - Jacq
        givenNames:
          - X
      - type: Person
        familyNames:
          - Martin
        givenNames:
          - NM
      - type: Person
        familyNames:
          - Jackson
        givenNames:
          - SP
    datePublished: '2018'
    isPartOf:
      type: PublicationVolume
      pageEnd: 78
      pageStart: 57
      title: Nature Reviews Drug Discovery
      volumeNumber: 17
    title: 'Deubiquitylating enzymes and drug discovery: emerging opportunities'
  - type: Article
    id: bib56
    authors:
      - type: Person
        familyNames:
          - Henderson
        givenNames:
          - A
      - type: Person
        familyNames:
          - Wu
        givenNames:
          - 'Y'
      - type: Person
        familyNames:
          - Huang
        givenNames:
          - YC
      - type: Person
        familyNames:
          - Chavez
        givenNames:
          - EA
      - type: Person
        familyNames:
          - Platt
        givenNames:
          - J
      - type: Person
        familyNames:
          - Johnson
        givenNames:
          - FB
      - type: Person
        familyNames:
          - Brosh
        givenNames:
          - RM
      - type: Person
        familyNames:
          - Sen
        givenNames:
          - D
      - type: Person
        familyNames:
          - Lansdorp
        givenNames:
          - PM
    datePublished: '2014'
    isPartOf:
      type: PublicationVolume
      pageEnd: 869
      pageStart: 860
      title: Nucleic Acids Research
      volumeNumber: 42
    title: Detection of G-quadruplex DNA in mammalian cells
  - type: Article
    id: bib57
    authors:
      - type: Person
        familyNames:
          - Herdy
        givenNames:
          - B
      - type: Person
        familyNames:
          - Mayer
        givenNames:
          - C
      - type: Person
        familyNames:
          - Varshney
        givenNames:
          - D
      - type: Person
        familyNames:
          - Marsico
        givenNames:
          - G
      - type: Person
        familyNames:
          - Murat
        givenNames:
          - P
      - type: Person
        familyNames:
          - Taylor
        givenNames:
          - C
      - type: Person
        familyNames:
          - D'Santos
        givenNames:
          - C
      - type: Person
        familyNames:
          - Tannahill
        givenNames:
          - D
      - type: Person
        familyNames:
          - Balasubramanian
        givenNames:
          - S
    datePublished: '2018'
    isPartOf:
      type: PublicationVolume
      pageEnd: 11604
      pageStart: 11592
      title: Nucleic Acids Research
      volumeNumber: 46
    title: >-
      Analysis of NRAS RNA G-quadruplex binding proteins reveals DDX3X as a
      novel interactor of cellular G-quadruplex containing transcripts
  - type: Article
    id: bib58
    authors:
      - type: Person
        familyNames:
          - Huang
        givenNames:
          - TT
      - type: Person
        familyNames:
          - Nijman
        givenNames:
          - SMB
      - type: Person
        familyNames:
          - Mirchandani
        givenNames:
          - KD
      - type: Person
        familyNames:
          - Galardy
        givenNames:
          - PJ
      - type: Person
        familyNames:
          - Cohn
        givenNames:
          - MA
      - type: Person
        familyNames:
          - Haas
        givenNames:
          - W
      - type: Person
        familyNames:
          - Gygi
        givenNames:
          - SP
      - type: Person
        familyNames:
          - Ploegh
        givenNames:
          - HL
      - type: Person
        familyNames:
          - Bernards
        givenNames:
          - R
      - type: Person
        familyNames:
          - D'Andrea
        givenNames:
          - AD
    datePublished: '2006'
    isPartOf:
      type: PublicationVolume
      pageEnd: 347
      pageStart: 341
      title: Nature Cell Biology
      volumeNumber: 8
    title: Regulation of monoubiquitinated PCNA by DUB autocleavage
  - type: Article
    id: bib59
    authors:
      - type: Person
        familyNames:
          - Huang
        givenNames:
          - daW
      - type: Person
        familyNames:
          - Sherman
        givenNames:
          - BT
      - type: Person
        familyNames:
          - Lempicki
        givenNames:
          - RA
    datePublished: '2009'
    isPartOf:
      type: PublicationVolume
      pageEnd: 57
      pageStart: 44
      title: Nature Protocols
      volumeNumber: 4
    title: >-
      Systematic and integrative analysis of large gene lists using DAVID
      bioinformatics resources
  - type: Article
    id: bib60
    authors:
      - type: Person
        familyNames:
          - Huang
        givenNames:
          - daW
      - type: Person
        familyNames:
          - Sherman
        givenNames:
          - BT
      - type: Person
        familyNames:
          - Lempicki
        givenNames:
          - RA
    datePublished: '2009'
    isPartOf:
      type: PublicationVolume
      pageEnd: 13
      pageStart: 1
      title: Nucleic Acids Research
      volumeNumber: 37
    title: >-
      Bioinformatics enrichment tools: paths toward the comprehensive functional
      analysis of large gene lists
  - type: Article
    id: bib61
    authors:
      - type: Person
        familyNames:
          - Huang
        givenNames:
          - X
      - type: Person
        familyNames:
          - Dixit
        givenNames:
          - VM
    datePublished: '2016'
    isPartOf:
      type: PublicationVolume
      pageEnd: 498
      pageStart: 484
      title: Cell Research
      volumeNumber: 26
    title: >-
      Drugging the undruggables: exploring the ubiquitin system for drug
      development
  - type: Article
    id: bib62
    authors:
      - type: Person
        familyNames:
          - Huppert
        givenNames:
          - JL
    datePublished: '2008'
    isPartOf:
      type: PublicationVolume
      title: Chemical Society Reviews
      volumeNumber: 37
    title: >-
      Four-stranded nucleic acids: structure, function and targeting of
      G-quadruplexes
  - type: Article
    id: bib63
    authors:
      - type: Person
        familyNames:
          - Huppert
        givenNames:
          - JL
      - type: Person
        familyNames:
          - Balasubramanian
        givenNames:
          - S
    datePublished: '2007'
    isPartOf:
      type: PublicationVolume
      pageEnd: 413
      pageStart: 406
      title: Nucleic Acids Research
      volumeNumber: 35
    title: G-quadruplexes in promoters throughout the human genome
  - type: Article
    id: bib64
    authors:
      - type: Person
        familyNames:
          - Kadoch
        givenNames:
          - C
      - type: Person
        familyNames:
          - Hargreaves
        givenNames:
          - DC
      - type: Person
        familyNames:
          - Hodges
        givenNames:
          - C
      - type: Person
        familyNames:
          - Elias
        givenNames:
          - L
      - type: Person
        familyNames:
          - Ho
        givenNames:
          - L
      - type: Person
        familyNames:
          - Ranish
        givenNames:
          - J
      - type: Person
        familyNames:
          - Crabtree
        givenNames:
          - GR
    datePublished: '2013'
    isPartOf:
      type: PublicationVolume
      pageEnd: 601
      pageStart: 592
      title: Nature Genetics
      volumeNumber: 45
    title: >-
      Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes
      identifies extensive roles in human malignancy
  - type: Article
    id: bib65
    authors:
      - type: Person
        familyNames:
          - Kikuma
        givenNames:
          - T
      - type: Person
        familyNames:
          - Ohtsu
        givenNames:
          - M
      - type: Person
        familyNames:
          - Utsugi
        givenNames:
          - T
      - type: Person
        familyNames:
          - Koga
        givenNames:
          - S
      - type: Person
        familyNames:
          - Okuhara
        givenNames:
          - K
      - type: Person
        familyNames:
          - Eki
        givenNames:
          - T
      - type: Person
        familyNames:
          - Fujimori
        givenNames:
          - F
      - type: Person
        familyNames:
          - Murakami
        givenNames:
          - 'Y'
    datePublished: '2004'
    isPartOf:
      type: PublicationVolume
      pageEnd: 20698
      pageStart: 20692
      title: Journal of Biological Chemistry
      volumeNumber: 279
    title: >-
      Dbp9p, a member of the DEAD box protein family, exhibits DNA helicase
      activity
  - type: Article
    id: bib66
    authors:
      - type: Person
        familyNames:
          - Knott
        givenNames:
          - SRV
      - type: Person
        familyNames:
          - Maceli
        givenNames:
          - A
      - type: Person
        familyNames:
          - Erard
        givenNames:
          - 'N'
      - type: Person
        familyNames:
          - Chang
        givenNames:
          - K
      - type: Person
        familyNames:
          - Marran
        givenNames:
          - K
      - type: Person
        familyNames:
          - Zhou
        givenNames:
          - X
      - type: Person
        familyNames:
          - Gordon
        givenNames:
          - A
      - type: Person
        familyNames:
          - Demerdash
        givenNames:
          - OE
      - type: Person
        familyNames:
          - Wagenblast
        givenNames:
          - E
      - type: Person
        familyNames:
          - Kim
        givenNames:
          - S
      - type: Person
        familyNames:
          - Fellmann
        givenNames:
          - C
      - type: Person
        familyNames:
          - Hannon
        givenNames:
          - GJ
    datePublished: '2014'
    isPartOf:
      type: PublicationVolume
      pageEnd: 807
      pageStart: 796
      title: Molecular Cell
      volumeNumber: 56
    title: A computational algorithm to predict shRNA potency
  - type: Article
    id: bib67
    authors:
      - type: Person
        familyNames:
          - Kotake
        givenNames:
          - 'Y'
      - type: Person
        familyNames:
          - Sagane
        givenNames:
          - K
      - type: Person
        familyNames:
          - Owa
        givenNames:
          - T
      - type: Person
        familyNames:
          - Mimori-Kiyosue
        givenNames:
          - 'Y'
      - type: Person
        familyNames:
          - Shimizu
        givenNames:
          - H
      - type: Person
        familyNames:
          - Uesugi
        givenNames:
          - M
      - type: Person
        familyNames:
          - Ishihama
        givenNames:
          - 'Y'
      - type: Person
        familyNames:
          - Iwata
        givenNames:
          - M
      - type: Person
        familyNames:
          - Mizui
        givenNames:
          - 'Y'
    datePublished: '2007'
    isPartOf:
      type: PublicationVolume
      pageEnd: 575
      pageStart: 570
      title: Nature Chemical Biology
      volumeNumber: 3
    title: >-
      Splicing factor SF3b as a target of the antitumor natural product
      pladienolide
  - type: Article
    id: bib68
    authors:
      - type: Person
        familyNames:
          - Kumari
        givenNames:
          - S
      - type: Person
        familyNames:
          - Bugaut
        givenNames:
          - A
      - type: Person
        familyNames:
          - Huppert
        givenNames:
          - JL
      - type: Person
        familyNames:
          - Balasubramanian
        givenNames:
          - S
    datePublished: '2007'
    isPartOf:
      type: PublicationVolume
      pageEnd: 221
      pageStart: 218
      title: Nature Chemical Biology
      volumeNumber: 3
    title: >-
      An RNA G-quadruplex in the 5' UTR of the NRAS proto-oncogene modulates
      translation
  - type: Article
    id: bib69
    authors:
      - type: Person
        familyNames:
          - Kwok
        givenNames:
          - CK
      - type: Person
        familyNames:
          - Marsico
        givenNames:
          - G
      - type: Person
        familyNames:
          - Sahakyan
        givenNames:
          - AB
      - type: Person
        familyNames:
          - Chambers
        givenNames:
          - VS
      - type: Person
        familyNames:
          - Balasubramanian
        givenNames:
          - S
    datePublished: '2016'
    isPartOf:
      type: PublicationVolume
      pageEnd: 844
      pageStart: 841
      title: Nature Methods
      volumeNumber: 13
    title: >-
      rG4-seq reveals widespread formation of G-quadruplex structures in the
      human transcriptome
  - type: Article
    id: bib70
    authors:
      - type: Person
        familyNames:
          - Langmead
        givenNames:
          - B
      - type: Person
        familyNames:
          - Salzberg
        givenNames:
          - SL
    datePublished: '2012'
    isPartOf:
      type: PublicationVolume
      pageEnd: 359
      pageStart: 357
      title: Nature Methods
      volumeNumber: 9
    title: Fast gapped-read alignment with bowtie 2
  - type: Article
    id: bib71
    authors:
      - type: Person
        familyNames:
          - Le
        givenNames:
          - DD
      - type: Person
        familyNames:
          - Di
          - Antonio
        givenNames:
          - M
      - type: Person
        familyNames:
          - Chan
        givenNames:
          - LKM
      - type: Person
        familyNames:
          - Balasubramanian
        givenNames:
          - S
    datePublished: '2015'
    isPartOf:
      type: PublicationVolume
      pageEnd: 8050
      pageStart: 8048
      title: Chemical Communications
      volumeNumber: 51
    title: G-quadruplex ligands exhibit differential G-tetrad selectivity
  - type: Article
    id: bib72
    authors:
      - type: Person
        familyNames:
          - Lee
        givenNames:
          - JM
      - type: Person
        familyNames:
          - Ledermann
        givenNames:
          - JA
      - type: Person
        familyNames:
          - Kohn
        givenNames:
          - EC
    datePublished: '2014'
    isPartOf:
      type: PublicationVolume
      pageEnd: 40
      pageStart: 32
      title: Annals of Oncology
      volumeNumber: 25
    title: PARP inhibitors for BRCA1/2 mutation-associated and BRCA-like malignancies
  - type: Article
    id: bib73
    authors:
      - type: Person
        familyNames:
          - Lim
        givenNames:
          - SP
      - type: Person
        familyNames:
          - Wong
        givenNames:
          - NC
      - type: Person
        familyNames:
          - Suetani
        givenNames:
          - RJ
      - type: Person
        familyNames:
          - Ho
        givenNames:
          - K
      - type: Person
        familyNames:
          - Ng
        givenNames:
          - JL
      - type: Person
        familyNames:
          - Neilsen
        givenNames:
          - PM
      - type: Person
        familyNames:
          - Gill
        givenNames:
          - PG
      - type: Person
        familyNames:
          - Kumar
        givenNames:
          - R
      - type: Person
        familyNames:
          - Callen
        givenNames:
          - DF
    datePublished: '2012'
    isPartOf:
      type: PublicationVolume
      pageEnd: 3309
      pageStart: 3300
      title: European Journal of Cancer
      volumeNumber: 48
    title: Specific-site methylation of tumour suppressor ANKRD11 in breast Cancer
  - type: Article
    id: bib74
    authors:
      - type: Person
        familyNames:
          - Liu
        givenNames:
          - J
      - type: Person
        familyNames:
          - Shaik
        givenNames:
          - S
      - type: Person
        familyNames:
          - Dai
        givenNames:
          - X
      - type: Person
        familyNames:
          - Wu
        givenNames:
          - Q
      - type: Person
        familyNames:
          - Zhou
        givenNames:
          - X
      - type: Person
        familyNames:
          - Wang
        givenNames:
          - Z
      - type: Person
        familyNames:
          - Wei
        givenNames:
          - W
    datePublished: '2015'
    isPartOf:
      type: PublicationVolume
      pageEnd: 60
      pageStart: 50
      title: Biochimica Et Biophysica Acta (BBA) - Reviews on Cancer
      volumeNumber: 1855
    title: Targeting the ubiquitin pathway for cancer treatment
  - type: Article
    id: bib75
    authors:
      - type: Person
        familyNames:
          - Liu
        givenNames:
          - 'Y'
      - type: Person
        familyNames:
          - Liang
        givenNames:
          - 'Y'
      - type: Person
        familyNames:
          - Wishart
        givenNames:
          - D
    datePublished: '2015'
    isPartOf:
      type: PublicationVolume
      title: Nucleic Acids Research
      volumeNumber: 43
    title: >-
      PolySearch2: a significantly improved text-mining system for discovering
      associations between human diseases, genes, drugs, metabolites, toxins and
      more
  - type: Article
    id: bib76
    authors:
      - type: Person
        familyNames:
          - Liu
        givenNames:
          - HY
      - type: Person
        familyNames:
          - Zhao
        givenNames:
          - Q
      - type: Person
        familyNames:
          - Zhang
        givenNames:
          - TP
      - type: Person
        familyNames:
          - Wu
        givenNames:
          - 'Y'
      - type: Person
        familyNames:
          - Xiong
        givenNames:
          - YX
      - type: Person
        familyNames:
          - Wang
        givenNames:
          - SK
      - type: Person
        familyNames:
          - Ge
        givenNames:
          - YL
      - type: Person
        familyNames:
          - He
        givenNames:
          - JH
      - type: Person
        familyNames:
          - Lv
        givenNames:
          - P
      - type: Person
        familyNames:
          - Ou
        givenNames:
          - TM
      - type: Person
        familyNames:
          - Tan
        givenNames:
          - JH
      - type: Person
        familyNames:
          - Li
        givenNames:
          - D
      - type: Person
        familyNames:
          - Gu
        givenNames:
          - LQ
      - type: Person
        familyNames:
          - Ren
        givenNames:
          - J
      - type: Person
        familyNames:
          - Zhao
        givenNames:
          - 'Y'
      - type: Person
        familyNames:
          - Huang
        givenNames:
          - ZS
    datePublished: '2016'
    isPartOf:
      type: PublicationVolume
      pageEnd: 1270
      pageStart: 1261
      title: Cell Chemical Biology
      volumeNumber: 23
    title: >-
      Conformation selective antibody enables genome profiling and leads to
      discovery of parallel G-Quadruplex in human telomeres
  - type: Article
    id: bib77
    authors:
      - type: Person
        familyNames:
          - Lu
        givenNames:
          - MC
      - type: Person
        familyNames:
          - Ji
        givenNames:
          - JA
      - type: Person
        familyNames:
          - Jiang
        givenNames:
          - YL
      - type: Person
        familyNames:
          - Chen
        givenNames:
          - ZY
      - type: Person
        familyNames:
          - Yuan
        givenNames:
          - ZW
      - type: Person
        familyNames:
          - You
        givenNames:
          - QD
      - type: Person
        familyNames:
          - Jiang
        givenNames:
          - ZY
    datePublished: '2016'
    isPartOf:
      type: PublicationVolume
      title: Scientific Reports
      volumeNumber: 6
    title: >-
      An inhibitor of the Keap1-Nrf2 protein-protein interaction protects NCM460
      colonic cells and alleviates experimental colitis
  - type: Article
    id: bib78
    authors:
      - type: Person
        familyNames:
          - Martens-de
          - Kemp
        givenNames:
          - SR
      - type: Person
        familyNames:
          - Brink
        givenNames:
          - A
      - type: Person
        familyNames:
          - van
          - der
          - Meulen
        givenNames:
          - IH
      - type: Person
        familyNames:
          - de
          - Menezes
        givenNames:
          - RX
      - type: Person
        familyNames:
          - Te
          - Beest
        givenNames:
          - DE
      - type: Person
        familyNames:
          - Leemans
        givenNames:
          - CR
      - type: Person
        familyNames:
          - van
          - Beusechem
        givenNames:
          - VW
      - type: Person
        familyNames:
          - Braakhuis
        givenNames:
          - BJ
      - type: Person
        familyNames:
          - Brakenhoff
        givenNames:
          - RH
    datePublished: '2017'
    isPartOf:
      type: PublicationVolume
      pageEnd: 550
      pageStart: 540
      title: Molecular Cancer Therapeutics
      volumeNumber: 16
    title: >-
      The FA/BRCA pathway identified as the major predictor of cisplatin
      response in head and neck cancer by functional genomics
  - type: Article
    id: bib79
    authors:
      - type: Person
        familyNames:
          - Martínez
          - Cuesta
        givenNames:
          - S
    datePublished: '2019'
    isPartOf:
      type: PublicationVolume
      title: GitHub
    title: ''
  - type: Article
    id: bib80
    authors:
      - type: Person
        familyNames:
          - Matheson
        givenNames:
          - CJ
      - type: Person
        familyNames:
          - Backos
        givenNames:
          - DS
      - type: Person
        familyNames:
          - Reigan
        givenNames:
          - P
    datePublished: '2016'
    isPartOf:
      type: PublicationVolume
      pageEnd: 881
      pageStart: 872
      title: Trends in Pharmacological Sciences
      volumeNumber: 37
    title: Targeting WEE1 kinase in cancer
  - type: Article
    id: bib81
    authors:
      - type: Person
        familyNames:
          - Mattern
        givenNames:
          - MR
      - type: Person
        familyNames:
          - Wu
        givenNames:
          - J
      - type: Person
        familyNames:
          - Nicholson
        givenNames:
          - B
    datePublished: '2012'
    isPartOf:
      type: PublicationVolume
      pageEnd: 2021
      pageStart: 2014
      title: Biochimica Et Biophysica Acta (BBA) - Molecular Cell Research
      volumeNumber: 1823
    title: >-
      Ubiquitin-based anticancer therapy: carpet bombing with proteasome
      inhibitors vs surgical strikes with E1, E2, E3, or DUB inhibitors
  - type: Article
    id: bib82
    authors:
      - type: Person
        familyNames:
          - McCubrey
        givenNames:
          - JA
      - type: Person
        familyNames:
          - Steelman
        givenNames:
          - LS
      - type: Person
        familyNames:
          - Bertrand
        givenNames:
          - FE
      - type: Person
        familyNames:
          - Davis
        givenNames:
          - NM
      - type: Person
        familyNames:
          - Sokolosky
        givenNames:
          - M
      - type: Person
        familyNames:
          - Abrams
        givenNames:
          - SL
      - type: Person
        familyNames:
          - Montalto
        givenNames:
          - G
      - type: Person
        familyNames:
          - D'Assoro
        givenNames:
          - AB
      - type: Person
        familyNames:
          - Libra
        givenNames:
          - M
      - type: Person
        familyNames:
          - Nicoletti
        givenNames:
          - F
      - type: Person
        familyNames:
          - Maestro
        givenNames:
          - R
      - type: Person
        familyNames:
          - Basecke
        givenNames:
          - J
      - type: Person
        familyNames:
          - Rakus
        givenNames:
          - D
      - type: Person
        familyNames:
          - Gizak
        givenNames:
          - A
      - type: Person
        familyNames:
          - Demidenko
        givenNames:
          - ZN
      - type: Person
        familyNames:
          - Cocco
        givenNames:
          - L
      - type: Person
        familyNames:
          - Martelli
        givenNames:
          - AM
      - type: Person
        familyNames:
          - Cervello
        givenNames:
          - M
    datePublished: '2014'
    isPartOf:
      type: PublicationVolume
      pageEnd: 2911
      pageStart: 2881
      title: Oncotarget
      volumeNumber: 5
    title: GSK-3 as potential target for therapeutic intervention in cancer
  - type: Article
    id: bib83
    authors:
      - type: Person
        familyNames:
          - McLuckie
        givenNames:
          - KI
      - type: Person
        familyNames:
          - Di
          - Antonio
        givenNames:
          - M
      - type: Person
        familyNames:
          - Zecchini
        givenNames:
          - H
      - type: Person
        familyNames:
          - Xian
        givenNames:
          - J
      - type: Person
        familyNames:
          - Caldas
        givenNames:
          - C
      - type: Person
        familyNames:
          - Krippendorff
        givenNames:
          - BF
      - type: Person
        familyNames:
          - Tannahill
        givenNames:
          - D
      - type: Person
        familyNames:
          - Lowe
        givenNames:
          - C
      - type: Person
        familyNames:
          - Balasubramanian
        givenNames:
          - S
    datePublished: '2013'
    isPartOf:
      type: PublicationVolume
      pageEnd: 9643
      pageStart: 9640
      title: Journal of the American Chemical Society
      volumeNumber: 135
    title: >-
      G-quadruplex DNA as a molecular target for induced synthetic lethality in
      cancer cells
  - type: Article
    id: bib84
    authors:
      - type: Person
        familyNames:
          - Mendoza
        givenNames:
          - O
      - type: Person
        familyNames:
          - Bourdoncle
        givenNames:
          - A
      - type: Person
        familyNames:
          - Boulé
        givenNames:
          - JB
      - type: Person
        familyNames:
          - Brosh
        givenNames:
          - RM
      - type: Person
        familyNames:
          - Mergny
        givenNames:
          - JL
    datePublished: '2016'
    isPartOf:
      type: PublicationVolume
      pageEnd: 2006
      pageStart: 1989
      title: Nucleic Acids Research
      volumeNumber: 44
    title: G-quadruplexes and helicases
  - type: Article
    id: bib85
    authors:
      - type: Person
        familyNames:
          - Mishra
        givenNames:
          - SK
      - type: Person
        familyNames:
          - Tawani
        givenNames:
          - A
      - type: Person
        familyNames:
          - Mishra
        givenNames:
          - A
      - type: Person
        familyNames:
          - Kumar
        givenNames:
          - A
    datePublished: '2016'
    isPartOf:
      type: PublicationVolume
      title: Scientific Reports
      volumeNumber: 6
    title: >-
      G4IPDB: a database for G-quadruplex structure forming nucleic acid
      interacting proteins
  - type: Article
    id: bib86
    authors:
      - type: Person
        familyNames:
          - Morra
        givenNames:
          - F
      - type: Person
        familyNames:
          - Luise
        givenNames:
          - C
      - type: Person
        familyNames:
          - Visconti
        givenNames:
          - R
      - type: Person
        familyNames:
          - Staibano
        givenNames:
          - S
      - type: Person
        familyNames:
          - Merolla
        givenNames:
          - F
      - type: Person
        familyNames:
          - Ilardi
        givenNames:
          - G
      - type: Person
        familyNames:
          - Guggino
        givenNames:
          - G
      - type: Person
        familyNames:
          - Paladino
        givenNames:
          - S
      - type: Person
        familyNames:
          - Sarnataro
        givenNames:
          - D
      - type: Person
        familyNames:
          - Franco
        givenNames:
          - R
      - type: Person
        familyNames:
          - Monaco
        givenNames:
          - R
      - type: Person
        familyNames:
          - Zitomarino
        givenNames:
          - F
      - type: Person
        familyNames:
          - Pacelli
        givenNames:
          - R
      - type: Person
        familyNames:
          - Monaco
        givenNames:
          - G
      - type: Person
        familyNames:
          - Rocco
        givenNames:
          - G
      - type: Person
        familyNames:
          - Cerrato
        givenNames:
          - A
      - type: Person
        familyNames:
          - Linardopoulos
        givenNames:
          - S
      - type: Person
        familyNames:
          - Muller
        givenNames:
          - MT
      - type: Person
        familyNames:
          - Celetti
        givenNames:
          - A
    datePublished: '2015'
    isPartOf:
      type: PublicationVolume
      pageEnd: 2157
      pageStart: 2146
      title: International Journal of Cancer
      volumeNumber: 136
    title: New therapeutic perspectives in CCDC6 deficient lung cancer cells
  - type: Article
    id: bib87
    authors:
      - type: Person
        familyNames:
          - Moyal
        givenNames:
          - L
      - type: Person
        familyNames:
          - Lerenthal
        givenNames:
          - 'Y'
      - type: Person
        familyNames:
          - Gana-Weisz
        givenNames:
          - M
      - type: Person
        familyNames:
          - Mass
        givenNames:
          - G
      - type: Person
        familyNames:
          - So
        givenNames:
          - S
      - type: Person
        familyNames:
          - Wang
        givenNames:
          - SY
      - type: Person
        familyNames:
          - Eppink
        givenNames:
          - B
      - type: Person
        familyNames:
          - Chung
        givenNames:
          - YM
      - type: Person
        familyNames:
          - Shalev
        givenNames:
          - G
      - type: Person
        familyNames:
          - Shema
        givenNames:
          - E
      - type: Person
        familyNames:
          - Shkedy
        givenNames:
          - D
      - type: Person
        familyNames:
          - Smorodinsky
        givenNames:
          - NI
      - type: Person
        familyNames:
          - van
          - Vliet
        givenNames:
          - 'N'
      - type: Person
        familyNames:
          - Kuster
        givenNames:
          - B
      - type: Person
        familyNames:
          - Mann
        givenNames:
          - M
      - type: Person
        familyNames:
          - Ciechanover
        givenNames:
          - A
      - type: Person
        familyNames:
          - Dahm-Daphi
        givenNames:
          - J
      - type: Person
        familyNames:
          - Kanaar
        givenNames:
          - R
      - type: Person
        familyNames:
          - Hu
        givenNames:
          - MC
      - type: Person
        familyNames:
          - Chen
        givenNames:
          - DJ
      - type: Person
        familyNames:
          - Oren
        givenNames:
          - M
      - type: Person
        familyNames:
          - Shiloh
        givenNames:
          - 'Y'
    datePublished: '2011'
    isPartOf:
      type: PublicationVolume
      pageEnd: 542
      pageStart: 529
      title: Molecular Cell
      volumeNumber: 41
    title: >-
      Requirement of ATM-dependent monoubiquitylation of histone H2B for timely
      repair of DNA double-strand breaks
  - type: Article
    id: bib88
    authors:
      - type: Person
        familyNames:
          - Neidle
        givenNames:
          - S
    datePublished: '2010'
    isPartOf:
      type: PublicationVolume
      pageEnd: 1125
      pageStart: 1118
      title: FEBS Journal
      volumeNumber: 277
    title: >-
      Human telomeric G-quadruplex: the current status of telomeric
      G-quadruplexes as therapeutic targets in human cancer
  - type: Article
    id: bib89
    authors:
      - type: Person
        familyNames:
          - Neidle
        givenNames:
          - S
    datePublished: '2017'
    isPartOf:
      type: PublicationVolume
      title: Nature Reviews Chemistry
      volumeNumber: 1
    title: Quadruplex nucleic acids as targets for anticancer therapeutics
  - type: Article
    id: bib90
    authors:
      - type: Person
        familyNames:
          - Neilsen
        givenNames:
          - PM
      - type: Person
        familyNames:
          - Cheney
        givenNames:
          - KM
      - type: Person
        familyNames:
          - Li
        givenNames:
          - CW
      - type: Person
        familyNames:
          - Chen
        givenNames:
          - JD
      - type: Person
        familyNames:
          - Cawrse
        givenNames:
          - JE
      - type: Person
        familyNames:
          - Schulz
        givenNames:
          - RB
      - type: Person
        familyNames:
          - Powell
        givenNames:
          - JA
      - type: Person
        familyNames:
          - Kumar
        givenNames:
          - R
      - type: Person
        familyNames:
          - Callen
        givenNames:
          - DF
    datePublished: '2008'
    isPartOf:
      type: PublicationVolume
      pageEnd: 3552
      pageStart: 3541
      title: Journal of Cell Science
      volumeNumber: 121
    title: Identification of ANKRD11 as a p53 coactivator
  - type: Article
    id: bib91
    authors:
      - type: Person
        familyNames:
          - Nepomuceno
        givenNames:
          - T
      - type: Person
        familyNames:
          - De
          - Gregoriis
        givenNames:
          - G
      - type: Person
        familyNames:
          - de
          - Oliveira
        givenNames:
          - FMB
      - type: Person
        familyNames:
          - Suarez-Kurtz
        givenNames:
          - G
      - type: Person
        familyNames:
          - Monteiro
        givenNames:
          - A
      - type: Person
        familyNames:
          - Carvalho
        givenNames:
          - M
    datePublished: '2017'
    isPartOf:
      type: PublicationVolume
      pageStart: 1886
      title: International Journal of Molecular Sciences
      volumeNumber: 18
    title: The role of PALB2 in the DNA damage response and Cancer predisposition
  - type: Article
    id: bib92
    authors:
      - type: Person
        familyNames:
          - Nijman
        givenNames:
          - SM
      - type: Person
        familyNames:
          - Huang
        givenNames:
          - TT
      - type: Person
        familyNames:
          - Dirac
        givenNames:
          - AM
      - type: Person
        familyNames:
          - Brummelkamp
        givenNames:
          - TR
      - type: Person
        familyNames:
          - Kerkhoven
        givenNames:
          - RM
      - type: Person
        familyNames:
          - D'Andrea
        givenNames:
          - AD
      - type: Person
        familyNames:
          - Bernards
        givenNames:
          - R
    datePublished: '2005'
    isPartOf:
      type: PublicationVolume
      pageEnd: 339
      pageStart: 331
      title: Molecular Cell
      volumeNumber: 17
    title: The deubiquitinating enzyme USP1 regulates the fanconi anemia pathway
  - type: Article
    id: bib93
    authors:
      - type: Person
        familyNames:
          - Nijman
        givenNames:
          - SM
    datePublished: '2011'
    isPartOf:
      type: PublicationVolume
      pageEnd: 6
      pageStart: 1
      title: FEBS Letters
      volumeNumber: 585
    title: >-
      Synthetic lethality: general principles, utility and detection using
      genetic screens in human cells
  - type: Article
    id: bib94
    authors:
      - type: Person
        familyNames:
          - Noll
        givenNames:
          - JE
      - type: Person
        familyNames:
          - Jeffery
        givenNames:
          - J
      - type: Person
        familyNames:
          - Al-Ejeh
        givenNames:
          - F
      - type: Person
        familyNames:
          - Kumar
        givenNames:
          - R
      - type: Person
        familyNames:
          - Khanna
        givenNames:
          - KK
      - type: Person
        familyNames:
          - Callen
        givenNames:
          - DF
      - type: Person
        familyNames:
          - Neilsen
        givenNames:
          - PM
    datePublished: '2012'
    isPartOf:
      type: PublicationVolume
      pageEnd: 2848
      pageStart: 2836
      title: Oncogene
      volumeNumber: 31
    title: >-
      Mutant p53 drives multinucleation and invasion through a process that is
      suppressed by ANKRD11
  - type: Article
    id: bib95
    authors:
      - type: Person
        familyNames:
          - Pan
        givenNames:
          - J
      - type: Person
        familyNames:
          - Deng
        givenNames:
          - Q
      - type: Person
        familyNames:
          - Jiang
        givenNames:
          - C
      - type: Person
        familyNames:
          - Wang
        givenNames:
          - X
      - type: Person
        familyNames:
          - Niu
        givenNames:
          - T
      - type: Person
        familyNames:
          - Li
        givenNames:
          - H
      - type: Person
        familyNames:
          - Chen
        givenNames:
          - T
      - type: Person
        familyNames:
          - Jin
        givenNames:
          - J
      - type: Person
        familyNames:
          - Pan
        givenNames:
          - W
      - type: Person
        familyNames:
          - Cai
        givenNames:
          - X
      - type: Person
        familyNames:
          - Yang
        givenNames:
          - X
      - type: Person
        familyNames:
          - Lu
        givenNames:
          - M
      - type: Person
        familyNames:
          - Xiao
        givenNames:
          - J
      - type: Person
        familyNames:
          - Wang
        givenNames:
          - P
    datePublished: '2015'
    isPartOf:
      type: PublicationVolume
      pageEnd: 3967
      pageStart: 3957
      title: Oncogene
      volumeNumber: 34
    title: USP37 directly deubiquitinates and stabilizes c-Myc in lung cancer
  - type: Article
    id: bib96
    authors:
      - type: Person
        familyNames:
          - Parry
        givenNames:
          - D
      - type: Person
        familyNames:
          - Guzi
        givenNames:
          - T
      - type: Person
        familyNames:
          - Shanahan
        givenNames:
          - F
      - type: Person
        familyNames:
          - Davis
        givenNames:
          - 'N'
      - type: Person
        familyNames:
          - Prabhavalkar
        givenNames:
          - D
      - type: Person
        familyNames:
          - Wiswell
        givenNames:
          - D
      - type: Person
        familyNames:
          - Seghezzi
        givenNames:
          - W
      - type: Person
        familyNames:
          - Paruch
        givenNames:
          - K
      - type: Person
        familyNames:
          - Dwyer
        givenNames:
          - MP
      - type: Person
        familyNames:
          - Doll
        givenNames:
          - R
      - type: Person
        familyNames:
          - Nomeir
        givenNames:
          - A
      - type: Person
        familyNames:
          - Windsor
        givenNames:
          - W
      - type: Person
        familyNames:
          - Fischmann
        givenNames:
          - T
      - type: Person
        familyNames:
          - Wang
        givenNames:
          - 'Y'
      - type: Person
        familyNames:
          - Oft
        givenNames:
          - M
      - type: Person
        familyNames:
          - Chen
        givenNames:
          - T
      - type: Person
        familyNames:
          - Kirschmeier
        givenNames:
          - P
      - type: Person
        familyNames:
          - Lees
        givenNames:
          - EM
    datePublished: '2010'
    isPartOf:
      type: PublicationVolume
      pageEnd: 2353
      pageStart: 2344
      title: Molecular Cancer Therapeutics
      volumeNumber: 9
    title: >-
      Dinaciclib (SCH 727965), a novel and potent cyclin-dependent kinase
      inhibitor
  - type: Article
    id: bib97
    authors:
      - type: Person
        familyNames:
          - Puxeddu
        givenNames:
          - E
      - type: Person
        familyNames:
          - Zhao
        givenNames:
          - G
      - type: Person
        familyNames:
          - Stringer
        givenNames:
          - JR
      - type: Person
        familyNames:
          - Medvedovic
        givenNames:
          - M
      - type: Person
        familyNames:
          - Moretti
        givenNames:
          - S
      - type: Person
        familyNames:
          - Fagin
        givenNames:
          - JA
    datePublished: '2005'
    isPartOf:
      type: PublicationVolume
      pageEnd: 32
      pageStart: 17
      title: Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis
      volumeNumber: 570
    title: >-
      Characterization of novel non-clonal intrachromosomal rearrangements
      between the H4 and PTEN genes (H4/PTEN) in human thyroid cell lines and
      papillary thyroid cancer specimens
  - type: Article
    id: bib98
    authors:
      - type: Person
        familyNames:
          - Rao
        givenNames:
          - RC
      - type: Person
        familyNames:
          - Dou
        givenNames:
          - 'Y'
    datePublished: '2015'
    isPartOf:
      type: PublicationVolume
      pageEnd: 346
      pageStart: 334
      title: Nature Reviews Cancer
      volumeNumber: 15
    title: 'Hijacked in Cancer: the KMT2 (MLL) family of methyltransferases'
  - type: Article
    id: bib99
    authors:
      - type: Person
        familyNames:
          - Rhodes
        givenNames:
          - D
      - type: Person
        familyNames:
          - Lipps
        givenNames:
          - HJ
    datePublished: '2015'
    isPartOf:
      type: PublicationVolume
      pageEnd: 8637
      pageStart: 8627
      title: Nucleic Acids Research
      volumeNumber: 43
    title: G-quadruplexes and their regulatory roles in biology
  - type: Article
    id: bib100
    authors:
      - type: Person
        familyNames:
          - Richer
        givenNames:
          - AL
      - type: Person
        familyNames:
          - Cala
        givenNames:
          - JM
      - type: Person
        familyNames:
          - O'Brien
        givenNames:
          - K
      - type: Person
        familyNames:
          - Carson
        givenNames:
          - VM
      - type: Person
        familyNames:
          - Inge
        givenNames:
          - LJ
      - type: Person
        familyNames:
          - Whitsett
        givenNames:
          - TG
    datePublished: '2017'
    isPartOf:
      type: PublicationVolume
      pageEnd: 4672
      pageStart: 4663
      title: Cancer Research
      volumeNumber: 77
    title: >-
      WEE1 kinase inhibitor AZD1775 has preclinical efficacy in LKB1-Deficient
      Non-Small cell lung cancer
  - type: Article
    id: bib101
    authors:
      - type: Person
        familyNames:
          - Robinson
        givenNames:
          - MD
      - type: Person
        familyNames:
          - McCarthy
        givenNames:
          - DJ
      - type: Person
        familyNames:
          - Smyth
        givenNames:
          - GK
    datePublished: '2010'
    isPartOf:
      type: PublicationVolume
      pageEnd: 140
      pageStart: 139
      title: Bioinformatics
      volumeNumber: 26
    title: >-
      edgeR: a bioconductor package for differential expression analysis of
      digital gene expression data
  - type: Article
    id: bib102
    authors:
      - type: Person
        familyNames:
          - Rodriguez
        givenNames:
          - R
      - type: Person
        familyNames:
          - Müller
        givenNames:
          - S
      - type: Person
        familyNames:
          - Yeoman
        givenNames:
          - JA
      - type: Person
        familyNames:
          - Trentesaux
        givenNames:
          - C
      - type: Person
        familyNames:
          - Riou
        givenNames:
          - JF
      - type: Person
        familyNames:
          - Balasubramanian
        givenNames:
          - S
    datePublished: '2008'
    isPartOf:
      type: PublicationVolume
      pageEnd: 15759
      pageStart: 15758
      title: Journal of the American Chemical Society
      volumeNumber: 130
    title: >-
      A novel small molecule that alters shelterin integrity and triggers a
      DNA-damage response at telomeres
  - type: Article
    id: bib103
    authors:
      - type: Person
        familyNames:
          - Rodriguez
        givenNames:
          - R
      - type: Person
        familyNames:
          - Miller
        givenNames:
          - KM
      - type: Person
        familyNames:
          - Forment
        givenNames:
          - JV
      - type: Person
        familyNames:
          - Bradshaw
        givenNames:
          - CR
      - type: Person
        familyNames:
          - Nikan
        givenNames:
          - M
      - type: Person
        familyNames:
          - Britton
        givenNames:
          - S
      - type: Person
        familyNames:
          - Oelschlaegel
        givenNames:
          - T
      - type: Person
        familyNames:
          - Xhemalce
        givenNames:
          - B
      - type: Person
        familyNames:
          - Balasubramanian
        givenNames:
          - S
      - type: Person
        familyNames:
          - Jackson
        givenNames:
          - SP
    datePublished: '2012'
    isPartOf:
      type: PublicationVolume
      pageEnd: 310
      pageStart: 301
      title: Nature Chemical Biology
      volumeNumber: 8
    title: >-
      Small-molecule-induced DNA damage identifies alternative DNA structures in
      human genes
  - type: Article
    id: bib104
    authors:
      - type: Person
        familyNames:
          - Sanchez-Vega
        givenNames:
          - F
      - type: Person
        familyNames:
          - Mina
        givenNames:
          - M
      - type: Person
        familyNames:
          - Armenia
        givenNames:
          - J
      - type: Person
        familyNames:
          - Chatila
        givenNames:
          - WK
      - type: Person
        familyNames:
          - Luna
        givenNames:
          - A
      - type: Person
        familyNames:
          - La
        givenNames:
          - KC
      - type: Person
        familyNames:
          - Dimitriadoy
        givenNames:
          - S
      - type: Person
        familyNames:
          - Liu
        givenNames:
          - DL
      - type: Person
        familyNames:
          - Kantheti
        givenNames:
          - HS
      - type: Person
        familyNames:
          - Saghafinia
        givenNames:
          - S
      - type: Person
        familyNames:
          - Chakravarty
        givenNames:
          - D
      - type: Person
        familyNames:
          - Daian
        givenNames:
          - F
      - type: Person
        familyNames:
          - Gao
        givenNames:
          - Q
      - type: Person
        familyNames:
          - Bailey
        givenNames:
          - MH
      - type: Person
        familyNames:
          - Liang
        givenNames:
          - WW
      - type: Person
        familyNames:
          - Foltz
        givenNames:
          - SM
      - type: Person
        familyNames:
          - Shmulevich
        givenNames:
          - I
      - type: Person
        familyNames:
          - Ding
        givenNames:
          - L
      - type: Person
        familyNames:
          - Heins
        givenNames:
          - Z
      - type: Person
        familyNames:
          - Ochoa
        givenNames:
          - A
      - type: Person
        familyNames:
          - Gross
        givenNames:
          - B
      - type: Person
        familyNames:
          - Gao
        givenNames:
          - J
      - type: Person
        familyNames:
          - Zhang
        givenNames:
          - H
      - type: Person
        familyNames:
          - Kundra
        givenNames:
          - R
      - type: Person
        familyNames:
          - Kandoth
        givenNames:
          - C
      - type: Person
        familyNames:
          - Bahceci
        givenNames:
          - I
      - type: Person
        familyNames:
          - Dervishi
        givenNames:
          - L
      - type: Person
        familyNames:
          - Dogrusoz
        givenNames:
          - U
      - type: Person
        familyNames:
          - Zhou
        givenNames:
          - W
      - type: Person
        familyNames:
          - Shen
        givenNames:
          - H
      - type: Person
        familyNames:
          - Laird
        givenNames:
          - PW
      - type: Person
        familyNames:
          - Way
        givenNames:
          - GP
      - type: Person
        familyNames:
          - Greene
        givenNames:
          - CS
      - type: Person
        familyNames:
          - Liang
        givenNames:
          - H
      - type: Person
        familyNames:
          - Xiao
        givenNames:
          - 'Y'
      - type: Person
        familyNames:
          - Wang
        givenNames:
          - C
      - type: Person
        familyNames:
          - Iavarone
        givenNames:
          - A
      - type: Person
        familyNames:
          - Berger
        givenNames:
          - AH
      - type: Person
        familyNames:
          - Bivona
        givenNames:
          - TG
      - type: Person
        familyNames:
          - Lazar
        givenNames:
          - AJ
      - type: Person
        familyNames:
          - Hammer
        givenNames:
          - GD
      - type: Person
        familyNames:
          - Giordano
        givenNames:
          - T
      - type: Person
        familyNames:
          - Kwong
        givenNames:
          - LN
      - type: Person
        familyNames:
          - McArthur
        givenNames:
          - G
      - type: Person
        familyNames:
          - Huang
        givenNames:
          - C
      - type: Person
        familyNames:
          - Tward
        givenNames:
          - AD
      - type: Person
        familyNames:
          - Frederick
        givenNames:
          - MJ
      - type: Person
        familyNames:
          - McCormick
        givenNames:
          - F
      - type: Person
        familyNames:
          - Meyerson
        givenNames:
          - M
      - type: Person
        familyNames:
          - Van
          - Allen
        givenNames:
          - EM
      - type: Person
        familyNames:
          - Cherniack
        givenNames:
          - AD
      - type: Person
        familyNames:
          - Ciriello
        givenNames:
          - G
      - type: Person
        familyNames:
          - Sander
        givenNames:
          - C
      - type: Person
        familyNames:
          - Schultz
        givenNames:
          - 'N'
    datePublished: '2018'
    isPartOf:
      type: PublicationVolume
      pageEnd: 337
      pageStart: 321
      title: Cell
      volumeNumber: 173
    title: Oncogenic signaling pathways in the cancer genome atlas
  - type: Article
    id: bib105
    authors:
      - type: Person
        familyNames:
          - Schaffitzel
        givenNames:
          - C
      - type: Person
        familyNames:
          - Berger
        givenNames:
          - I
      - type: Person
        familyNames:
          - Postberg
        givenNames:
          - J
      - type: Person
        familyNames:
          - Hanes
        givenNames:
          - J
      - type: Person
        familyNames:
          - Lipps
        givenNames:
          - HJ
      - type: Person
        familyNames:
          - Plückthun
        givenNames:
          - A
    datePublished: '2001'
    isPartOf:
      type: PublicationVolume
      pageEnd: 8577
      pageStart: 8572
      title: PNAS
      volumeNumber: 98
    title: >-
      In vitro generated antibodies specific for telomeric guanine-quadruplex
      DNA react with stylonychia lemnae macronuclei
  - type: Article
    id: bib106
    authors:
      - type: Person
        familyNames:
          - Schutte
        givenNames:
          - M
      - type: Person
        familyNames:
          - Hruban
        givenNames:
          - RH
      - type: Person
        familyNames:
          - Hedrick
        givenNames:
          - L
      - type: Person
        familyNames:
          - Cho
        givenNames:
          - KR
      - type: Person
        familyNames:
          - Nadasdy
        givenNames:
          - GM
      - type: Person
        familyNames:
          - Weinstein
        givenNames:
          - CL
      - type: Person
        familyNames:
          - Bova
        givenNames:
          - GS
      - type: Person
        familyNames:
          - Isaacs
        givenNames:
          - WB
      - type: Person
        familyNames:
          - Cairns
        givenNames:
          - P
      - type: Person
        familyNames:
          - Nawroz
        givenNames:
          - H
      - type: Person
        familyNames:
          - Sidransky
        givenNames:
          - D
      - type: Person
        familyNames:
          - Casero
        givenNames:
          - RA
      - type: Person
        familyNames:
          - Meltzer
        givenNames:
          - PS
      - type: Person
        familyNames:
          - Hahn
        givenNames:
          - SA
      - type: Person
        familyNames:
          - Kern
        givenNames:
          - SE
    datePublished: '1996'
    isPartOf:
      type: PublicationVolume
      pageEnd: 2530
      pageStart: 2527
      title: Cancer Research
      volumeNumber: 56
    title: DPC4 gene in various tumor types
  - type: Article
    id: bib107
    authors:
      - type: Person
        familyNames:
          - Senft
        givenNames:
          - D
      - type: Person
        familyNames:
          - Qi
        givenNames:
          - J
      - type: Person
        familyNames:
          - Ronai
        givenNames:
          - ZA
    datePublished: '2018'
    isPartOf:
      type: PublicationVolume
      pageEnd: 88
      pageStart: 69
      title: Nature Reviews Cancer
      volumeNumber: 18
    title: Ubiquitin ligases in oncogenic transformation and cancer therapy
  - type: Article
    id: bib108
    authors:
      - type: Person
        familyNames:
          - Shain
        givenNames:
          - AH
      - type: Person
        familyNames:
          - Pollack
        givenNames:
          - JR
    datePublished: '2013'
    isPartOf:
      type: PublicationVolume
      title: PLOS ONE
      volumeNumber: 8
    title: 'The spectrum of SWI/SNF mutations, ubiquitous in human cancers'
  - type: Article
    id: bib109
    authors:
      - type: Person
        familyNames:
          - Shannon
        givenNames:
          - P
      - type: Person
        familyNames:
          - Markiel
        givenNames:
          - A
      - type: Person
        familyNames:
          - Ozier
        givenNames:
          - O
      - type: Person
        familyNames:
          - Baliga
        givenNames:
          - NS
      - type: Person
        familyNames:
          - Wang
        givenNames:
          - JT
      - type: Person
        familyNames:
          - Ramage
        givenNames:
          - D
      - type: Person
        familyNames:
          - Amin
        givenNames:
          - 'N'
      - type: Person
        familyNames:
          - Schwikowski
        givenNames:
          - B
      - type: Person
        familyNames:
          - Ideker
        givenNames:
          - T
    datePublished: '2003'
    isPartOf:
      type: PublicationVolume
      pageEnd: 2504
      pageStart: 2498
      title: Genome Research
      volumeNumber: 13
    title: >-
      Cytoscape: a software environment for integrated models of biomolecular
      interaction networks
  - type: Article
    id: bib110
    authors:
      - type: Person
        familyNames:
          - Shema
        givenNames:
          - E
      - type: Person
        familyNames:
          - Tirosh
        givenNames:
          - I
      - type: Person
        familyNames:
          - Aylon
        givenNames:
          - 'Y'
      - type: Person
        familyNames:
          - Huang
        givenNames:
          - J
      - type: Person
        familyNames:
          - Ye
        givenNames:
          - C
      - type: Person
        familyNames:
          - Moskovits
        givenNames:
          - 'N'
      - type: Person
        familyNames:
          - Raver-Shapira
        givenNames:
          - 'N'
      - type: Person
        familyNames:
          - Minsky
        givenNames:
          - 'N'
      - type: Person
        familyNames:
          - Pirngruber
        givenNames:
          - J
      - type: Person
        familyNames:
          - Tarcic
        givenNames:
          - G
      - type: Person
        familyNames:
          - Hublarova
        givenNames:
          - P
      - type: Person
        familyNames:
          - Moyal
        givenNames:
          - L
      - type: Person
        familyNames:
          - Gana-Weisz
        givenNames:
          - M
      - type: Person
        familyNames:
          - Shiloh
        givenNames:
          - 'Y'
      - type: Person
        familyNames:
          - Yarden
        givenNames:
          - 'Y'
      - type: Person
        familyNames:
          - Johnsen
        givenNames:
          - SA
      - type: Person
        familyNames:
          - Vojtesek
        givenNames:
          - B
      - type: Person
        familyNames:
          - Berger
        givenNames:
          - SL
      - type: Person
        familyNames:
          - Oren
        givenNames:
          - M
    datePublished: '2008'
    isPartOf:
      type: PublicationVolume
      pageEnd: 2676
      pageStart: 2664
      title: Genes & Development
      volumeNumber: 22
    title: >-
      The histone H2B-specific ubiquitin ligase RNF20/hBRE1 acts as a putative
      tumor suppressor through selective regulation of gene expression
  - type: Article
    id: bib111
    authors:
      - type: Person
        familyNames:
          - Shkreta
        givenNames:
          - L
      - type: Person
        familyNames:
          - Blanchette
        givenNames:
          - M
      - type: Person
        familyNames:
          - Toutant
        givenNames:
          - J
      - type: Person
        familyNames:
          - Wilhelm
        givenNames:
          - E
      - type: Person
        familyNames:
          - Bell
        givenNames:
          - B
      - type: Person
        familyNames:
          - Story
        givenNames:
          - BA
      - type: Person
        familyNames:
          - Balachandran
        givenNames:
          - A
      - type: Person
        familyNames:
          - Cochrane
        givenNames:
          - A
      - type: Person
        familyNames:
          - Cheung
        givenNames:
          - PK
      - type: Person
        familyNames:
          - Harrigan
        givenNames:
          - PR
      - type: Person
        familyNames:
          - Grierson
        givenNames:
          - DS
      - type: Person
        familyNames:
          - Chabot
        givenNames:
          - B
    datePublished: '2017'
    isPartOf:
      type: PublicationVolume
      pageEnd: 4067
      pageStart: 4051
      title: Nucleic Acids Research
      volumeNumber: 45
    title: >-
      Modulation of the splicing regulatory function of SRSF10 by a novel
      compound that impairs HIV-1 replication
  - type: Article
    id: bib112
    authors:
      - type: Person
        familyNames:
          - Sims
        givenNames:
          - D
      - type: Person
        familyNames:
          - Mendes-Pereira
        givenNames:
          - AM
      - type: Person
        familyNames:
          - Frankum
        givenNames:
          - J
      - type: Person
        familyNames:
          - Burgess
        givenNames:
          - D
      - type: Person
        familyNames:
          - Cerone
        givenNames:
          - M-A
      - type: Person
        familyNames:
          - Lombardelli
        givenNames:
          - C
      - type: Person
        familyNames:
          - Mitsopoulos
        givenNames:
          - C
      - type: Person
        familyNames:
          - Hakas
        givenNames:
          - J
      - type: Person
        familyNames:
          - Murugaesu
        givenNames:
          - 'N'
      - type: Person
        familyNames:
          - Isacke
        givenNames:
          - CM
      - type: Person
        familyNames:
          - Fenwick
        givenNames:
          - K
      - type: Person
        familyNames:
          - Assiotis
        givenNames:
          - I
      - type: Person
        familyNames:
          - Kozarewa
        givenNames:
          - I
      - type: Person
        familyNames:
          - Zvelebil
        givenNames:
          - M
      - type: Person
        familyNames:
          - Ashworth
        givenNames:
          - A
      - type: Person
        familyNames:
          - Lord
        givenNames:
          - CJ
    datePublished: '2011'
    isPartOf:
      type: PublicationVolume
      title: Genome Biology
      volumeNumber: 12
    title: >-
      High-throughput RNA interference screening using pooled shRNA libraries
      and next generation sequencing
  - type: Article
    id: bib113
    authors:
      - type: Person
        familyNames:
          - Soucy
        givenNames:
          - TA
      - type: Person
        familyNames:
          - Smith
        givenNames:
          - PG
      - type: Person
        familyNames:
          - Milhollen
        givenNames:
          - MA
      - type: Person
        familyNames:
          - Berger
        givenNames:
          - AJ
      - type: Person
        familyNames:
          - Gavin
        givenNames:
          - JM
      - type: Person
        familyNames:
          - Adhikari
        givenNames:
          - S
      - type: Person
        familyNames:
          - Brownell
        givenNames:
          - JE
      - type: Person
        familyNames:
          - Burke
        givenNames:
          - KE
      - type: Person
        familyNames:
          - Cardin
        givenNames:
          - DP
      - type: Person
        familyNames:
          - Critchley
        givenNames:
          - S
      - type: Person
        familyNames:
          - Cullis
        givenNames:
          - CA
      - type: Person
        familyNames:
          - Doucette
        givenNames:
          - A
      - type: Person
        familyNames:
          - Garnsey
        givenNames:
          - JJ
      - type: Person
        familyNames:
          - Gaulin
        givenNames:
          - JL
      - type: Person
        familyNames:
          - Gershman
        givenNames:
          - RE
      - type: Person
        familyNames:
          - Lublinsky
        givenNames:
          - AR
      - type: Person
        familyNames:
          - McDonald
        givenNames:
          - A
      - type: Person
        familyNames:
          - Mizutani
        givenNames:
          - H
      - type: Person
        familyNames:
          - Narayanan
        givenNames:
          - U
      - type: Person
        familyNames:
          - Olhava
        givenNames:
          - EJ
      - type: Person
        familyNames:
          - Peluso
        givenNames:
          - S
      - type: Person
        familyNames:
          - Rezaei
        givenNames:
          - M
      - type: Person
        familyNames:
          - Sintchak
        givenNames:
          - MD
      - type: Person
        familyNames:
          - Talreja
        givenNames:
          - T
      - type: Person
        familyNames:
          - Thomas
        givenNames:
          - MP
      - type: Person
        familyNames:
          - Traore
        givenNames:
          - T
      - type: Person
        familyNames:
          - Vyskocil
        givenNames:
          - S
      - type: Person
        familyNames:
          - Weatherhead
        givenNames:
          - GS
      - type: Person
        familyNames:
          - Yu
        givenNames:
          - J
      - type: Person
        familyNames:
          - Zhang
        givenNames:
          - J
      - type: Person
        familyNames:
          - Dick
        givenNames:
          - LR
      - type: Person
        familyNames:
          - Claiborne
        givenNames:
          - CF
      - type: Person
        familyNames:
          - Rolfe
        givenNames:
          - M
      - type: Person
        familyNames:
          - Bolen
        givenNames:
          - JB
      - type: Person
        familyNames:
          - Langston
        givenNames:
          - SP
    datePublished: '2009'
    isPartOf:
      type: PublicationVolume
      pageEnd: 736
      pageStart: 732
      title: Nature
      volumeNumber: 458
    title: An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer
  - type: Article
    id: bib114
    authors:
      - type: Person
        familyNames:
          - Spillare
        givenNames:
          - EA
      - type: Person
        familyNames:
          - Wang
        givenNames:
          - XW
      - type: Person
        familyNames:
          - von
          - Kobbe
        givenNames:
          - C
      - type: Person
        familyNames:
          - Bohr
        givenNames:
          - VA
      - type: Person
        familyNames:
          - Hickson
        givenNames:
          - ID
      - type: Person
        familyNames:
          - Harris
        givenNames:
          - CC
    datePublished: '2006'
    isPartOf:
      type: PublicationVolume
      pageEnd: 2123
      pageStart: 2119
      title: Oncogene
      volumeNumber: 25
    title: Redundancy of DNA helicases in p53-mediated apoptosis
  - type: Article
    id: bib115
    authors:
      - type: Person
        familyNames:
          - Szklarczyk
        givenNames:
          - D
      - type: Person
        familyNames:
          - Morris
        givenNames:
          - JH
      - type: Person
        familyNames:
          - Cook
        givenNames:
          - H
      - type: Person
        familyNames:
          - Kuhn
        givenNames:
          - M
      - type: Person
        familyNames:
          - Wyder
        givenNames:
          - S
      - type: Person
        familyNames:
          - Simonovic
        givenNames:
          - M
      - type: Person
        familyNames:
          - Santos
        givenNames:
          - A
      - type: Person
        familyNames:
          - Doncheva
        givenNames:
          - NT
      - type: Person
        familyNames:
          - Roth
        givenNames:
          - A
      - type: Person
        familyNames:
          - Bork
        givenNames:
          - P
      - type: Person
        familyNames:
          - Jensen
        givenNames:
          - LJ
      - type: Person
        familyNames:
          - von
          - Mering
        givenNames:
          - C
    datePublished: '2017'
    isPartOf:
      type: PublicationVolume
      title: Nucleic Acids Research
      volumeNumber: 45
    title: >-
      The STRING database in 2017: quality-controlled protein–protein
      association networks, made broadly accessible
  - type: Article
    id: bib116
    authors:
      - type: Person
        familyNames:
          - Takahama
        givenNames:
          - K
      - type: Person
        familyNames:
          - Takada
        givenNames:
          - A
      - type: Person
        familyNames:
          - Tada
        givenNames:
          - S
      - type: Person
        familyNames:
          - Shimizu
        givenNames:
          - M
      - type: Person
        familyNames:
          - Sayama
        givenNames:
          - K
      - type: Person
        familyNames:
          - Kurokawa
        givenNames:
          - R
      - type: Person
        familyNames:
          - Oyoshi
        givenNames:
          - T
    datePublished: '2013'
    isPartOf:
      type: PublicationVolume
      pageEnd: 350
      pageStart: 341
      title: Chemistry & Biology
      volumeNumber: 20
    title: >-
      Regulation of telomere length by G-quadruplex telomere DNA- and
      TERRA-binding protein TLS/FUS
  - type: Article
    id: bib117
    authors: []
    datePublished: '2017'
    isPartOf:
      type: PublicationVolume
      title: Nucleic Acids Research
      volumeNumber: 45
    title: 'UniProt: the universal protein knowledgebase'
  - type: Article
    id: bib118
    authors:
      - type: Person
        familyNames:
          - Uhlmann-Schiffler
        givenNames:
          - H
      - type: Person
        familyNames:
          - Jalal
        givenNames:
          - C
      - type: Person
        familyNames:
          - Stahl
        givenNames:
          - H
    datePublished: '2006'
    isPartOf:
      type: PublicationVolume
      pageEnd: 22
      pageStart: 10
      title: Nucleic Acids Research
      volumeNumber: 34
    title: Ddx42p--a human DEAD box protein with RNA chaperone activities
  - type: Article
    id: bib119
    authors:
      - type: Person
        familyNames:
          - Valton
        givenNames:
          - AL
      - type: Person
        familyNames:
          - Prioleau
        givenNames:
          - MN
    datePublished: '2016'
    isPartOf:
      type: PublicationVolume
      pageEnd: 706
      pageStart: 697
      title: Trends in Genetics
      volumeNumber: 32
    title: 'G-Quadruplexes in DNA replication: a problem or a necessity?'
  - type: Article
    id: bib120
    authors:
      - type: Person
        familyNames:
          - Vaughn
        givenNames:
          - JP
      - type: Person
        familyNames:
          - Creacy
        givenNames:
          - SD
      - type: Person
        familyNames:
          - Routh
        givenNames:
          - ED
      - type: Person
        familyNames:
          - Joyner-Butt
        givenNames:
          - C
      - type: Person
        familyNames:
          - Jenkins
        givenNames:
          - GS
      - type: Person
        familyNames:
          - Pauli
        givenNames:
          - S
      - type: Person
        familyNames:
          - Nagamine
        givenNames:
          - 'Y'
      - type: Person
        familyNames:
          - Akman
        givenNames:
          - SA
    datePublished: '2005'
    isPartOf:
      type: PublicationVolume
      pageEnd: 38120
      pageStart: 38117
      title: Journal of Biological Chemistry
      volumeNumber: 280
    title: >-
      The DEXH protein product of the DHX36 gene is the major source of
      tetramolecular quadruplex G4-DNA resolving activity in HeLa cell lysates
  - type: Article
    id: bib121
    authors:
      - type: Person
        familyNames:
          - Wang
        givenNames:
          - JC
    datePublished: '2002'
    isPartOf:
      type: PublicationVolume
      pageEnd: 440
      pageStart: 430
      title: Nature Reviews Molecular Cell Biology
      volumeNumber: 3
    title: 'Cellular roles of DNA topoisomerases: a molecular perspective'
  - type: Article
    id: bib122
    authors:
      - type: Person
        familyNames:
          - Wang
        givenNames:
          - YY
      - type: Person
        familyNames:
          - Yang
        givenNames:
          - YX
      - type: Person
        familyNames:
          - Zhe
        givenNames:
          - H
      - type: Person
        familyNames:
          - He
        givenNames:
          - ZX
      - type: Person
        familyNames:
          - Zhou
        givenNames:
          - SF
    datePublished: '2014'
    isPartOf:
      type: PublicationVolume
      pageEnd: 2088
      pageStart: 2075
      title: 'Drug Design, Development and Therapy'
      volumeNumber: 8
    title: >-
      Bardoxolone methyl (CDDO-Me) as a therapeutic agent: an update on its
      pharmacokinetic and pharmacodynamic properties
  - type: Article
    id: bib123
    authors:
      - type: Person
        familyNames:
          - Wang
        givenNames:
          - 'Y'
      - type: Person
        familyNames:
          - Yang
        givenNames:
          - J
      - type: Person
        familyNames:
          - Wild
        givenNames:
          - AT
      - type: Person
        familyNames:
          - Wu
        givenNames:
          - WH
      - type: Person
        familyNames:
          - Shah
        givenNames:
          - R
      - type: Person
        familyNames:
          - Danussi
        givenNames:
          - C
      - type: Person
        familyNames:
          - Riggins
        givenNames:
          - GJ
      - type: Person
        familyNames:
          - Kannan
        givenNames:
          - K
      - type: Person
        familyNames:
          - Sulman
        givenNames:
          - EP
      - type: Person
        familyNames:
          - Chan
        givenNames:
          - TA
      - type: Person
        familyNames:
          - Huse
        givenNames:
          - JT
    datePublished: '2019'
    isPartOf:
      type: PublicationVolume
      pageStart: 943
      title: Nature Communications
      volumeNumber: 10
    title: >-
      G-quadruplex DNA drives genomic instability and represents a targetable
      molecular abnormality in ATRX-deficient malignant glioma
  - type: Article
    id: bib124
    authors:
      - type: Person
        familyNames:
          - Watson
        givenNames:
          - LA
      - type: Person
        familyNames:
          - Solomon
        givenNames:
          - LA
      - type: Person
        familyNames:
          - Li
        givenNames:
          - JR
      - type: Person
        familyNames:
          - Jiang
        givenNames:
          - 'Y'
      - type: Person
        familyNames:
          - Edwards
        givenNames:
          - M
      - type: Person
        familyNames:
          - Shin-ya
        givenNames:
          - K
      - type: Person
        familyNames:
          - Beier
        givenNames:
          - F
      - type: Person
        familyNames:
          - Bérubé
        givenNames:
          - NG
    datePublished: '2013'
    isPartOf:
      type: PublicationVolume
      pageEnd: 2063
      pageStart: 2049
      title: Journal of Clinical Investigation
      volumeNumber: 123
    title: >-
      Atrx deficiency induces telomere dysfunction, endocrine defects, and
      reduced life span
  - type: Article
    id: bib125
    authors:
      - type: Person
        familyNames:
          - Wei
        givenNames:
          - W
      - type: Person
        familyNames:
          - Lin
        givenNames:
          - HK
    datePublished: '2012'
    isPartOf:
      type: PublicationVolume
      title: Frontiers in Oncology
      volumeNumber: 2
    title: >-
      The key role of ubiquitination and sumoylation in signaling and cancer: a
      research topic
  - type: Article
    id: bib126
    authors:
      - type: Person
        familyNames:
          - Will
        givenNames:
          - CL
      - type: Person
        familyNames:
          - Urlaub
        givenNames:
          - H
      - type: Person
        familyNames:
          - Achsel
        givenNames:
          - T
      - type: Person
        familyNames:
          - Gentzel
        givenNames:
          - M
      - type: Person
        familyNames:
          - Wilm
        givenNames:
          - M
      - type: Person
        familyNames:
          - Lührmann
        givenNames:
          - R
    datePublished: '2002'
    isPartOf:
      type: PublicationVolume
      pageEnd: 4988
      pageStart: 4978
      title: The EMBO Journal
      volumeNumber: 21
    title: >-
      Characterization of novel SF3b and 17S U2 snRNP proteins, including a
      human Prp5p homologue and an SF3b DEAD-box protein
  - type: Article
    id: bib127
    authors:
      - type: Person
        familyNames:
          - Wolfe
        givenNames:
          - AL
      - type: Person
        familyNames:
          - Singh
        givenNames:
          - K
      - type: Person
        familyNames:
          - Zhong
        givenNames:
          - 'Y'
      - type: Person
        familyNames:
          - Drewe
        givenNames:
          - P
      - type: Person
        familyNames:
          - Rajasekhar
        givenNames:
          - VK
      - type: Person
        familyNames:
          - Sanghvi
        givenNames:
          - VR
      - type: Person
        familyNames:
          - Mavrakis
        givenNames:
          - KJ
      - type: Person
        familyNames:
          - Jiang
        givenNames:
          - M
      - type: Person
        familyNames:
          - Roderick
        givenNames:
          - JE
      - type: Person
        familyNames:
          - Van
          - der
          - Meulen
        givenNames:
          - J
      - type: Person
        familyNames:
          - Schatz
        givenNames:
          - JH
      - type: Person
        familyNames:
          - Rodrigo
        givenNames:
          - CM
      - type: Person
        familyNames:
          - Zhao
        givenNames:
          - C
      - type: Person
        familyNames:
          - Rondou
        givenNames:
          - P
      - type: Person
        familyNames:
          - de
          - Stanchina
        givenNames:
          - E
      - type: Person
        familyNames:
          - Teruya-Feldstein
        givenNames:
          - J
      - type: Person
        familyNames:
          - Kelliher
        givenNames:
          - MA
      - type: Person
        familyNames:
          - Speleman
        givenNames:
          - F
      - type: Person
        familyNames:
          - Porco
        givenNames:
          - JA
      - type: Person
        familyNames:
          - Pelletier
        givenNames:
          - J
      - type: Person
        familyNames:
          - Rätsch
        givenNames:
          - G
      - type: Person
        familyNames:
          - Wendel
        givenNames:
          - HG
    datePublished: '2014'
    isPartOf:
      type: PublicationVolume
      pageEnd: 70
      pageStart: 65
      title: Nature
      volumeNumber: 513
    title: RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer
  - type: Article
    id: bib128
    authors:
      - type: Person
        familyNames:
          - Wu
        givenNames:
          - W
      - type: Person
        familyNames:
          - Rokutanda
        givenNames:
          - 'N'
      - type: Person
        familyNames:
          - Takeuchi
        givenNames:
          - J
      - type: Person
        familyNames:
          - Lai
        givenNames:
          - 'Y'
      - type: Person
        familyNames:
          - Maruyama
        givenNames:
          - R
      - type: Person
        familyNames:
          - Togashi
        givenNames:
          - 'Y'
      - type: Person
        familyNames:
          - Nishikawa
        givenNames:
          - H
      - type: Person
        familyNames:
          - Arai
        givenNames:
          - 'N'
      - type: Person
        familyNames:
          - Miyoshi
        givenNames:
          - 'Y'
      - type: Person
        familyNames:
          - Suzuki
        givenNames:
          - 'N'
      - type: Person
        familyNames:
          - Saeki
        givenNames:
          - 'Y'
      - type: Person
        familyNames:
          - Tanaka
        givenNames:
          - K
      - type: Person
        familyNames:
          - Ohta
        givenNames:
          - T
    datePublished: '2018'
    isPartOf:
      type: PublicationVolume
      pageEnd: 6385
      pageStart: 6371
      title: Cancer Research
      volumeNumber: 78
    title: >-
      HERC2 facilitates BLM and WRN helicase complex interaction with RPA to
      suppress G-Quadruplex DNA
  - type: Article
    id: bib129
    authors:
      - type: Person
        familyNames:
          - Wu
        givenNames:
          - 'Y'
      - type: Person
        familyNames:
          - Brosh
        givenNames:
          - RM
    datePublished: '2010'
    isPartOf:
      type: PublicationVolume
      pageEnd: 3488
      pageStart: 3470
      title: FEBS Journal
      volumeNumber: 277
    title: G-quadruplex nucleic acids and human disease
  - type: Article
    id: bib130
    authors:
      - type: Person
        familyNames:
          - Xu
        givenNames:
          - H
      - type: Person
        familyNames:
          - Di
          - Antonio
        givenNames:
          - M
      - type: Person
        familyNames:
          - McKinney
        givenNames:
          - S
      - type: Person
        familyNames:
          - Mathew
        givenNames:
          - V
      - type: Person
        familyNames:
          - Ho
        givenNames:
          - B
      - type: Person
        familyNames:
          - O'Neil
        givenNames:
          - NJ
      - type: Person
        familyNames:
          - Santos
        givenNames:
          - ND
      - type: Person
        familyNames:
          - Silvester
        givenNames:
          - J
      - type: Person
        familyNames:
          - Wei
        givenNames:
          - V
      - type: Person
        familyNames:
          - Garcia
        givenNames:
          - J
      - type: Person
        familyNames:
          - Kabeer
        givenNames:
          - F
      - type: Person
        familyNames:
          - Lai
        givenNames:
          - D
      - type: Person
        familyNames:
          - Soriano
        givenNames:
          - P
      - type: Person
        familyNames:
          - Banáth
        givenNames:
          - J
      - type: Person
        familyNames:
          - Chiu
        givenNames:
          - DS
      - type: Person
        familyNames:
          - Yap
        givenNames:
          - D
      - type: Person
        familyNames:
          - Le
        givenNames:
          - DD
      - type: Person
        familyNames:
          - Ye
        givenNames:
          - FB
      - type: Person
        familyNames:
          - Zhang
        givenNames:
          - A
      - type: Person
        familyNames:
          - Thu
        givenNames:
          - K
      - type: Person
        familyNames:
          - Soong
        givenNames:
          - J
      - type: Person
        familyNames:
          - Lin
        givenNames:
          - SC
      - type: Person
        familyNames:
          - Tsai
        givenNames:
          - AH
      - type: Person
        familyNames:
          - Osako
        givenNames:
          - T
      - type: Person
        familyNames:
          - Algara
        givenNames:
          - T
      - type: Person
        familyNames:
          - Saunders
        givenNames:
          - DN
      - type: Person
        familyNames:
          - Wong
        givenNames:
          - J
      - type: Person
        familyNames:
          - Xian
        givenNames:
          - J
      - type: Person
        familyNames:
          - Bally
        givenNames:
          - MB
      - type: Person
        familyNames:
          - Brenton
        givenNames:
          - JD
      - type: Person
        familyNames:
          - Brown
        givenNames:
          - GW
      - type: Person
        familyNames:
          - Shah
        givenNames:
          - SP
      - type: Person
        familyNames:
          - Cescon
        givenNames:
          - D
      - type: Person
        familyNames:
          - Mak
        givenNames:
          - TW
      - type: Person
        familyNames:
          - Caldas
        givenNames:
          - C
      - type: Person
        familyNames:
          - Stirling
        givenNames:
          - PC
      - type: Person
        familyNames:
          - Hieter
        givenNames:
          - P
      - type: Person
        familyNames:
          - Balasubramanian
        givenNames:
          - S
      - type: Person
        familyNames:
          - Aparicio
        givenNames:
          - S
    datePublished: '2017'
    isPartOf:
      type: PublicationVolume
      title: Nature Communications
      volumeNumber: 8
    title: >-
      CX-5461 is a DNA G-quadruplex stabilizer with selective lethality in
      BRCA1/2 deficient tumours
  - type: Article
    id: bib131
    authors:
      - type: Person
        familyNames:
          - Yadav
        givenNames:
          - P
      - type: Person
        familyNames:
          - Harcy
        givenNames:
          - V
      - type: Person
        familyNames:
          - Argueso
        givenNames:
          - JL
      - type: Person
        familyNames:
          - Dominska
        givenNames:
          - M
      - type: Person
        familyNames:
          - Jinks-Robertson
        givenNames:
          - S
      - type: Person
        familyNames:
          - Kim
        givenNames:
          - 'N'
    datePublished: '2014'
    isPartOf:
      type: PublicationVolume
      title: PLOS Genetics
      volumeNumber: 10
    title: >-
      Topoisomerase I plays a critical role in suppressing genome instability at
      a highly transcribed G-quadruplex-forming sequence
  - type: Article
    id: bib132
    authors:
      - type: Person
        familyNames:
          - Yang
        givenNames:
          - D
      - type: Person
        familyNames:
          - Hurley
        givenNames:
          - LH
    datePublished: '2006'
    isPartOf:
      type: PublicationVolume
      pageEnd: 968
      pageStart: 951
      title: 'Nucleosides, Nucleotides and Nucleic Acids'
      volumeNumber: 25
    title: Structure of the biologically relevant G-Quadruplex in the c-MYC promoter
  - type: Article
    id: bib133
    authors:
      - type: Person
        familyNames:
          - Yeats
        givenNames:
          - C
      - type: Person
        familyNames:
          - Maibaum
        givenNames:
          - M
      - type: Person
        familyNames:
          - Marsden
        givenNames:
          - R
      - type: Person
        familyNames:
          - Dibley
        givenNames:
          - M
      - type: Person
        familyNames:
          - Lee
        givenNames:
          - D
      - type: Person
        familyNames:
          - Addou
        givenNames:
          - S
      - type: Person
        familyNames:
          - Orengo
        givenNames:
          - CA
    datePublished: '2006'
    isPartOf:
      type: PublicationVolume
      title: Nucleic Acids Research
      volumeNumber: 34
    title: 'Gene3D: modelling protein structure, function and evolution'
  - type: Article
    id: bib134
    authors:
      - type: Person
        familyNames:
          - Yoshida
        givenNames:
          - T
      - type: Person
        familyNames:
          - Tanaka
        givenNames:
          - S
      - type: Person
        familyNames:
          - Mogi
        givenNames:
          - A
      - type: Person
        familyNames:
          - Shitara
        givenNames:
          - 'Y'
      - type: Person
        familyNames:
          - Kuwano
        givenNames:
          - H
    datePublished: '2004'
    isPartOf:
      type: PublicationVolume
      pageEnd: 256
      pageStart: 252
      title: Annals of Oncology
      volumeNumber: 15
    title: >-
      The clinical significance of cyclin B1 and Wee1 expression in
      non-small-cell lung cancer
  - type: Article
    id: bib135
    authors:
      - type: Person
        familyNames:
          - Zhao
        givenNames:
          - F
      - type: Person
        familyNames:
          - Gong
        givenNames:
          - X
      - type: Person
        familyNames:
          - Liu
        givenNames:
          - A
      - type: Person
        familyNames:
          - Lv
        givenNames:
          - X
      - type: Person
        familyNames:
          - Hu
        givenNames:
          - B
      - type: Person
        familyNames:
          - Zhang
        givenNames:
          - H
    datePublished: '2018'
    isPartOf:
      type: PublicationVolume
      pageEnd: 1143
      pageStart: 1136
      title: Biochemical and Biophysical Research Communications
      volumeNumber: 495
    title: >-
      Downregulation of Nedd4L predicts poor prognosis, promotes tumor growth
      and inhibits MAPK/ERK signal pathway in hepatocellular carcinoma
  - type: Article
    id: bib136
    authors:
      - type: Person
        familyNames:
          - Zhou
        givenNames:
          - X
      - type: Person
        familyNames:
          - Li
        givenNames:
          - X
      - type: Person
        familyNames:
          - Cheng
        givenNames:
          - 'Y'
      - type: Person
        familyNames:
          - Wu
        givenNames:
          - W
      - type: Person
        familyNames:
          - Xie
        givenNames:
          - Z
      - type: Person
        familyNames:
          - Xi
        givenNames:
          - Q
      - type: Person
        familyNames:
          - Han
        givenNames:
          - J
      - type: Person
        familyNames:
          - Wu
        givenNames:
          - G
      - type: Person
        familyNames:
          - Fang
        givenNames:
          - J
      - type: Person
        familyNames:
          - Feng
        givenNames:
          - 'Y'
    datePublished: '2014'
    isPartOf:
      type: PublicationVolume
      title: Nature Communications
      volumeNumber: 5
    title: >-
      BCLAF1 and its splicing regulator SRSF10 regulate the tumorigenic
      potential of colon cancer cells
  - type: Article
    id: bib137
    authors:
      - type: Person
        familyNames:
          - Zimmer
        givenNames:
          - J
      - type: Person
        familyNames:
          - Tacconi
        givenNames:
          - EMC
      - type: Person
        familyNames:
          - Folio
        givenNames:
          - C
      - type: Person
        familyNames:
          - Badie
        givenNames:
          - S
      - type: Person
        familyNames:
          - Porru
        givenNames:
          - M
      - type: Person
        familyNames:
          - Klare
        givenNames:
          - K
      - type: Person
        familyNames:
          - Tumiati
        givenNames:
          - M
      - type: Person
        familyNames:
          - Markkanen
        givenNames:
          - E
      - type: Person
        familyNames:
          - Halder
        givenNames:
          - S
      - type: Person
        familyNames:
          - Ryan
        givenNames:
          - A
      - type: Person
        familyNames:
          - Jackson
        givenNames:
          - SP
      - type: Person
        familyNames:
          - Ramadan
        givenNames:
          - K
      - type: Person
        familyNames:
          - Kuznetsov
        givenNames:
          - SG
      - type: Person
        familyNames:
          - Biroccio
        givenNames:
          - A
      - type: Person
        familyNames:
          - Sale
        givenNames:
          - JE
      - type: Person
        familyNames:
          - Tarsounas
        givenNames:
          - M
    datePublished: '2016'
    isPartOf:
      type: PublicationVolume
      pageEnd: 460
      pageStart: 449
      title: Molecular Cell
      volumeNumber: 61
    title: >-
      Targeting BRCA1 and BRCA2 deficiencies with G-Quadruplex-Interacting
      compounds
title: Genetic interactions of G-quadruplexes in humans
content:
  - type: Heading
    id: s1
    depth: 1
    content:
      - Introduction
  - type: Paragraph
    content:
      - >-
        G-quadruplex secondary structures (G4s) form in nucleic acids through
        the self-association of guanines (G) in G-rich sequences to form stacked
        tetrad structures (reviewed in 
      - type: Cite
        target: bib15
        content:
          - 'Bochman et al., 2012'
      - '; '
      - type: Cite
        target: bib99
        content:
          - 'Rhodes and Lipps, 2015'
      - '). In the human genome, over 700,000 G4s have been detected in vitro ('
      - type: Cite
        target: bib23
        content:
          - 'Chambers et al., 2015'
      - >-
        ). Sequences encoding G4s are enriched in regulatory regions consistent
        with roles in transcription and RNA regulation (
      - type: Cite
        target: bib63
        content:
          - 'Huppert and Balasubramanian, 2007'
      - '; '
      - type: Cite
        target: bib62
        content:
          - 'Huppert, 2008'
      - '), and their over-representation in oncogene promoters, such as '
      - type: Emphasis
        content:
          - 'MYC, KRAS'
      - ' and '
      - type: Emphasis
        content:
          - 'KIT,'
      - ' suggests that they are important in cancer and are potential therapeutic targets (reviewed in '
      - type: Cite
        target: bib7
        content:
          - 'Balasubramanian et al., 2011'
      - >-
        ). Computationally predicted G4s have also been linked to replication
        origins (
      - type: Cite
        target: bib10
        content:
          - 'Besnard et al., 2012'
      - ') and telomere homeostasis (reviewed in '
      - type: Cite
        target: bib88
        content:
          - 'Neidle, 2010'
      - >-
        ). In the transcriptome, more than 3000 mRNAs have been shown to contain
        G4 structures in vitro, particularly at 5’ and 3’ UTRs, suggestive of
        roles in posttranscriptional regulation (
      - type: Cite
        target: bib19
        content:
          - 'Bugaut and Balasubramanian, 2012'
      - '; '
      - type: Cite
        target: bib69
        content:
          - 'Kwok et al., 2016'
      - ).
  - type: Paragraph
    content:
      - G4-specific antibodies have been used to visualise G4s in protozoa (
      - type: Cite
        target: bib105
        content:
          - 'Schaffitzel et al., 2001'
      - ) and mammalian cells (
      - type: Cite
        target: bib11
        content:
          - 'Biffi et al., 2013'
      - '; '
      - type: Cite
        target: bib56
        content:
          - 'Henderson et al., 2014'
      - '; '
      - type: Cite
        target: bib76
        content:
          - 'Liu et al., 2016'
      - >-
        ). More G4s are detected in transformed versus primary cells, and in
        human stomach and liver cancers compared to non-neoplastic tissues,
        supporting an association between G4 structures and cancer (
      - type: Cite
        target: bib12
        content:
          - 'Biffi et al., 2014'
      - '; '
      - type: Cite
        target: bib54
        content:
          - 'Hänsel-Hertsch et al., 2016'
      - >-
        ). More recently, ChIP-seq was used to map endogenous G4 structure
        formation in chromatin revealing a link between G4s, promoters and
        transcription (
      - type: Cite
        target: bib54
        content:
          - 'Hänsel-Hertsch et al., 2016'
      - >-
        ). G4s are found predominately in nucleosome-depleted chromatin within
        promoters and 5’ UTRs of highly transcribed genes, including
        cancer-related genes and regions of somatic copy number alteration. G4s
        may therefore be part of a regulatory mechanism to switch between
        different transcriptional states. At telomeres, tandem G4-repeat
        structures also may help protect chromosome ends by providing binding
        sites for shelterin complex components (reviewed in 
      - type: Cite
        target: bib16
        content:
          - 'Brázda et al., 2014'
      - >-
        ). As G4 structures can pause or stall polymerases, they must be
        resolved by helicases to allow replication and transcription to proceed.
        Several helicases, including WRN, BLM, PIF1, DHX36 and RTEL1, have been
        shown to unwind G4-structures in vitro (
      - type: Cite
        target: bib17
        content:
          - 'Brosh, 2013'
      - '; '
      - type: Cite
        target: bib84
        content:
          - 'Mendoza et al., 2016'
      - >-
        ), and it is notable that fibroblasts from Werner (WRN) and Bloom (BLM)
        syndrome patients, who are predisposed to cancer, show altered gene
        expression that correlates with sites with potential to form G4s (
      - type: Cite
        target: bib33
        content:
          - 'Damerla et al., 2012'
      - ).
  - type: Paragraph
    content:
      - >-
        Small molecules that selectively bind and stabilise G4 formation in
        vitro have been used to probe G4 biological function. G4 ligands, such
        as pyridostatin (PDS), PhenDC3 and TMPyP4, can reduce transcription of
        many genes harbouring a promoter G4, including oncogenes such as 
      - type: Emphasis
        content:
          - 'MYC,'
      - ' in multiple cancer cell lines ('
      - type: Cite
        target: bib53
        content:
          - 'Halder et al., 2012'
      - '; '
      - type: Cite
        target: bib83
        content:
          - 'McLuckie et al., 2013'
      - '; '
      - type: Cite
        target: bib89
        content:
          - 'Neidle, 2017'
      - >-
        ). G4-stabilising ligands also interfere with telomere homeostasis by
        inducing telomere uncapping/DNA damage through the inhibition of
        telomere extension by telomerase leading to senescence or apoptosis
        (reviewed in 
      - type: Cite
        target: bib88
        content:
          - 'Neidle, 2010'
      - >-
        ). 5’ UTR RNA G4 structures may also be involved in eIF4A-dependent
        oncogene translation (
      - type: Cite
        target: bib127
        content:
          - 'Wolfe et al., 2014'
      - >-
        ) and their stabilisation by G4-ligands can inhibit translation in vitro
        (
      - type: Cite
        target: bib19
        content:
          - 'Bugaut and Balasubramanian, 2012'
      - '). Identification of several RNA G4-interacting proteins (reviewed in '
      - type: Cite
        target: bib20
        content:
          - 'Cammas and Millevoi, 2016'
      - '), including DEAD/DEAH helicases such as DDX3X, and DHX36 ('
      - type: Cite
        target: bib27
        content:
          - 'Chen et al., 2018'
      - '; '
      - type: Cite
        target: bib57
        content:
          - 'Herdy et al., 2018'
      - ) additionally suggests specific roles for G4 structures in RNA.
  - type: Paragraph
    content:
      - >-
        Some G4-stabilising ligands cause a DNA damage-response (DDR); for
        example, DNA damage sites induced by PDS in human lung fibroblasts
        mapped to genomic regions at G4s within several oncogenes including 
      - type: Emphasis
        content:
          - SRC
      - ' ('
      - type: Cite
        target: bib103
        content:
          - 'Rodriguez et al., 2012'
      - >-
        ). Subsequent studies demonstrated that homologous recombination (HR)
        repair deficiencies can be exploited to selectively kill
        BRCA1/2-deficient cancer cells with G4 ligands (
      - type: Cite
        target: bib83
        content:
          - 'McLuckie et al., 2013'
      - '; '
      - type: Cite
        target: bib137
        content:
          - 'Zimmer et al., 2016'
      - >-
        ). Recently, this concept has been applied to BRCA1/2-deficient breast
        cancers using CX-5461, a G4 ligand currently in clinical trials (
      - type: Cite
        target: bib130
        content:
          - 'Xu et al., 2017'
      - ) (
      - type: Link
        target: 'https://clinicaltrials.gov/show/NCT02719977'
        content:
          - NCT02719977
      - ' ClinicalTrials.gov). Overall, these initial studies demonstrate that specific genotypes can be selectively vulnerable to G4-stabilisation and raises the question as to what other genotypes might provide further such opportunities.'
  - type: Paragraph
    content:
      - We set out to address two main questions (
      - type: Link
        relation: fig
        target: '#fig1'
        content:
          - Figure 1
      - >-
        ): 1) which human genes and cellular pathways interact with G4s and 2)
        what genetic backgrounds selectively lead to enhanced cell killing in
        the presence of G4 stabilising ligands? We employed PDS and PhenDC3 as
        representative G4 ligands as these are chemically and structurally
        dissimilar, but each shows a broad specificity for different G4
        structural variants. Both ligands have been widely used as G4-targeting
        probes in biophysical (
      - type: Cite
        target: bib35
        content:
          - 'De Cian et al., 2007b'
      - '; '
      - type: Cite
        target: bib102
        content:
          - 'Rodriguez et al., 2008'
      - >-
        ) and biological studies in which they have been shown to impart
        transcriptional inhibition, telomere dysfunction and replication
        stalling (
      - type: Cite
        target: bib34
        content:
          - 'De Cian et al., 2007a'
      - '; '
      - type: Cite
        target: bib53
        content:
          - 'Halder et al., 2012'
      - '; '
      - type: Cite
        target: bib84
        content:
          - 'Mendoza et al., 2016'
      - ).
  - type: Figure
    id: fig1
    caption:
      - type: Heading
        id: s1
        depth: 1
        content:
          - >-
            Strategy identifying genetic vulnerabilities involved with G4
            biology.
      - type: Paragraph
        content:
          - "Genome-wide shRNA silencing combined with G4 structure stabilisation by small molecules identifies genes that when depleted compromise cell viability. Cells are infected with a genome-wide pool of shRNA lentiviruses targeting the protein coding genome followed by G4 ligand treatment to stabilise genomic and/or RNA G4 structures. Two general outcomes are possible: a gene is not required in a G4-dependent process so there is no effect on cell viability\_(left); or gene silencing results in cell death either due to loss of a direct G4 interaction (e.g. binding/unwinding) or indirectly through gene loss in a G4-dependent pathway\_(right). In absence of ligand, cells are viable in presence of the shRNA. Dotted boxes highlight genotypes of disease significance for possible G4-based therapies (blue) and genes and biological pathways that involve and/or interact with G4 structures (orange)."
    label: Figure 1.
    content:
      - type: ImageObject
        contentUrl: fig1.jpg
        format: image/tiff
        meta:
          inline: false
  - type: Heading
    id: s2
    depth: 1
    content:
      - Results
  - type: Heading
    id: s2-1
    depth: 2
    content:
      - >-
        Identification of genetic vulnerabilities to G4-ligands via genome-wide
        screening
  - type: Paragraph
    content:
      - >-
        An unbiased genome-wide shRNA screen was performed in A375 human
        melanoma cells to globally evaluate genetic vulnerabilities to
        G4-ligands and to identify genes and pathways involved with
        G4-structures (
      - type: Link
        relation: fig
        target: '#fig2'
        content:
          - Figure 2A
      - >-
        ). For this, the pyridine-2,6-bis-quinolino-dicarboxamide derivative,
        PDS (
      - type: Cite
        target: bib103
        content:
          - 'Rodriguez et al., 2012'
      - '), and bisquinolinium compound, PhenDC3 ('
      - type: Cite
        target: bib35
        content:
          - 'De Cian et al., 2007b'
      - ) were chosen (
      - type: Link
        relation: fig
        target: '#fig2'
        content:
          - Figure 2B
      - >-
        ). We used the latest generation shERWOOD-Ultramir shRNA pLMN retroviral
        library, comprising 132,000 shRNAs across 12 randomised pools targeting
        the protein coding genome, with an average of five optimised hairpins
        per gene (
      - type: Link
        relation: fig
        target: '#fig2'
        content:
          - Figure 2C
      - ) (
      - type: Cite
        target: bib66
        content:
          - 'Knott et al., 2014'
      - >-
        ). A375 melanoma cells were used due to their rapid doubling, stable
        ploidy and success in other shRNA-dropout screens (
      - type: Cite
        target: bib112
        content:
          - 'Sims et al., 2011'
      - '); they are TP53 wild-type and driven by oncogenic '
      - type: Emphasis
        content:
          - BRAF
      - ' (V600E) and '
      - type: Emphasis
        content:
          - CDKN2A
      - ' loss ('
      - type: Cite
        target: bib43
        content:
          - 'Forbes et al., 2015'
      - '). '
      - type: Link
        relation: fig
        target: '#fig2'
        content:
          - Figure 2D
      - ' outlines our shRNA screening strategy. To identify shRNAs that are lost between the initial (t0) and final (fF) timepoints, unique 3’-antisense sequences were recovered by PCR and quantified by sequencing. If a gene knockdown compromises cell viability then the associated shRNA will be depleted compared to those targeting non-essential genes: the tF sequence count will be less than t0 thus log'
      - type: Subscript
        content:
          - '2'
      - " fold change (FC, tF/t0) is negative. A pilot using one shRNA pool established that a tF of 15 population doublings can be used to reveal significant G4-ligand-mediated changes [false discovery rate (FDR)\_≤\_0.05] in shRNA levels using a ligand concentration resulting in 20% cell death (GI"
      - type: Subscript
        content:
          - '20'
      - ", see Materials\_and\_methods and "
      - type: Link
        relation: fig
        target: '#fig2s1'
        content:
          - Figure 2—figure supplement 1
      - ' for details).'
  - type: Collection
    parts:
      - type: Figure
        id: fig2
        caption:
          - type: Heading
            id: s2-1
            depth: 2
            content:
              - >-
                shRNA screening pipeline to uncover genetic vulnerabilities to
                G4 stabilisation.
          - type: Paragraph
            content:
              - (
              - type: Strong
                content:
                  - A
              - >-
                ) A G-tetrad with four interacting guanines (left), which stack
                to form G4 structures (right). (
              - type: Strong
                content:
                  - B
              - >-
                ) Structures of the G4-stabilising small molecule ligands PDS
                and PhenDC3. (
              - type: Strong
                content:
                  - C
              - >-
                ) Distribution of the numbers of shRNAs targeting each gene,
                with the average indicated by a red dotted line. (
              - type: Strong
                content:
                  - D
              - >-
                ) Overall screening approach illustrated for one library pool.
                Plasmids are retrovirally packaged and A375 cells are infected
                at multiplicity of infection (MOI) of 0.3 (30%). Following
                antibiotic selection, an initial time point (t0) is harvested
                and then cells are cultured for ‘n’ population doublings in
                DMSO, PDS or PhenDC3 before the final time point was harvested
                (tF).
        label: Figure 2.
        content:
          - type: ImageObject
            contentUrl: fig2.jpg
            format: image/tiff
            meta:
              inline: false
      - type: Figure
        id: fig2s1
        caption:
          - type: Heading
            id: s2-1
            depth: 2
            content:
              - Genome-wide shRNA screen parameter optimisation.
          - type: Paragraph
            content:
              - (
              - type: Strong
                content:
                  - A
              - >-
                ) Representative growth curves from shRNA pool eight showing
                cumulative population doublings for DMSO, PhenDC3 and PDS (mean
                and standard deviation from three cell counts per condition). (
              - type: Strong
                content:
                  - B
              - ") Comparison of significant hairpin hits (colours indicate significance at FDR\_≤\_0.05) for two end points: population doubling 7 (left) and 15 (right) for PDS (top) and PhenDC3 (bottom). ("
              - type: Strong
                content:
                  - C
              - ) Comparison of FDR and log
              - type: Subscript
                content:
                  - '2'
              - 'FC values for a hairpin targeting '
              - type: Emphasis
                content:
                  - XRN1
              - ' following DMSO, PDS or PhenDC3 treatment after 7 and 15 population doublings.'
        label: Figure 2—figure supplement 1.
        content:
          - type: ImageObject
            contentUrl: fig2-figsupp1.jpg
            format: image/tiff
            meta:
              inline: false
    meta:
      usage: figGroup
  - type: Paragraph
    content:
      - "To understand the complete spectrum of G4 vulnerabilities, we first considered the combined set of sensitivities to PDS and PhenDC3 together. For the whole library, when individual shRNAs are considered 9509 (~7%) G4-ligand-specific hairpins (i.e. those not in DMSO) were found to be depleted (FDR\_≤\_0.05; log"
      - type: Subscript
        content:
          - '2'
      - " FC\_<0, "
      - type: Link
        relation: fig
        target: '#fig3'
        content:
          - Figure 3A
      - ', '
      - type: Link
        relation: supplementary-material
        target: '#supp1'
        content:
          - Supplementary file 1
      - >-
        ). We then reasoned, for a gene knockdown to have compromised cell
        growth, that a minimum of either 50% or three shRNA hairpins should be
        significantly depleted for that gene (median log
      - type: Subscript
        content:
          - '2'
      - " FC\_<0). This resulted in the identification of 843 G4 ligand-specific gene knockdowns not present in DMSO ("
      - type: Link
        relation: fig
        target: '#fig3'
        content:
          - Figure 3B
      - >-
        ). We then denoted a more stringent preliminary list of 758 G4
        sensitisers as those having a median log
      - type: Subscript
        content:
          - '2'
      - ' FC ≤ −1 ('
      - type: Link
        relation: fig
        target: '#fig3'
        content:
          - Figure 3C
      - >-
        ). It is reassuring that in this list we independently validated the
        known G4 sensitisers 
      - type: Emphasis
        content:
          - 'BRCA1/2, ATRX and HERC2'
      - ' ('
      - type: Cite
        target: bib83
        content:
          - 'McLuckie et al., 2013'
      - '; '
      - type: Cite
        target: bib123
        content:
          - 'Wang et al., 2019'
      - '; '
      - type: Cite
        target: bib124
        content:
          - 'Watson et al., 2013'
      - '; '
      - type: Cite
        target: bib128
        content:
          - 'Wu et al., 2018'
      - '; '
      - type: Cite
        target: bib130
        content:
          - 'Xu et al., 2017'
      - ";\_"
      - type: Cite
        target: bib137
        content:
          - 'Zimmer et al., 2016'
      - ";\_"
      - type: Link
        relation: fig
        target: '#fig3'
        content:
          - Figure 3D
      - ).
  - type: Figure
    id: fig3
    caption:
      - type: Heading
        id: s2-1
        depth: 2
        content:
          - >-
            Genome-wide screening in A375 cells reveals deficiencies in known
            G4-associated genes as sensitive to G4-stabilising small molecules.
      - type: Paragraph
        content:
          - (
          - type: Strong
            content:
              - A–C
          - ') Venn diagrams for: ('
          - type: Strong
            content:
              - A
          - ") significantly differentially expressed individual shRNAs (FDR\_≤\_0.05); ("
          - type: Strong
            content:
              - B
          - ") significantly depleted genes (50% or three hairpins, FDR\_≤\_0.05, median log"
          - type: Subscript
            content:
              - '2'
          - "FC\_<\_0) following DMSO, PDS and PhenDC3 treatment and ("
          - type: Strong
            content:
              - C
          - >-
            ) Significant PDS and PhenDC3 sensitiser genes not in DMSO and after
            applying a median log
          - type: Subscript
            content:
              - '2'
          - FC ≤ −1 cut off. (
          - type: Strong
            content:
              - D–F
          - ) Tables showing the number of depleted hairpins and median log
          - type: Subscript
            content:
              - '2'
          - 'FC values for: ('
          - type: Strong
            content:
              - D
          - ') known G4 ligand sensitisers, '
          - type: Emphasis
            content:
              - 'ATRX, HERC2'
          - ', '
          - type: Emphasis
            content:
              - BRCA1
          - ' and '
          - type: Emphasis
            content:
              - 'BRCA2,'
          - ' that are independently validated in our screen; ('
          - type: Strong
            content:
              - E
          - >-
            ) sensitisers annotated with a G4-associated term in GO, UniprotKB
            or G4IPBD databases and (
          - type: Strong
            content:
              - F
          - ") sensitisers identified as G4-related by text-mining showing the associated PolySearch2 algorithm score and summary of the G4 association. Sensitisers are defined as a gene where 50% or three hairpins were significantly differentially expressed (FDR\_≤\_0.05) with median log"
          - type: Subscript
            content:
              - '2'
          - 'FC ≤ −1. See also '
          - type: Link
            relation: supplementary-material
            target: '#supp1'
            content:
              - Supplementary file 1
          - .
    label: Figure 3.
    content:
      - type: ImageObject
        contentUrl: fig3.jpg
        format: image/tiff
        meta:
          inline: false
  - type: Paragraph
    content:
      - >-
        We next explored further genes already implicated in G4 biology, but
        whose deficiency has not yet been linked with any enhanced sensitivity
        to G4 ligands. For genes annotated with G4-related terms in the
        UniprotKB, Gene Ontology (GO) and G4IPDB databases (
      - type: Cite
        target: bib85
        content:
          - 'Mishra et al., 2016'
      - '), an additional eight sensitisers ('
      - type: Emphasis
        content:
          - 'ADAR, DHX36, DNA2, FUS, MCRS1, RECQL4, SF3B3 and XRN1'
      - ) were uncovered (
      - type: Link
        relation: fig
        target: '#fig3'
        content:
          - Figure 3E
      - "). Text-mining with G4 search terms using PolySearch2 on PubMed abstracts and open access full texts (see Materials\_and\_methods;\_"
      - type: Cite
        target: bib75
        content:
          - 'Liu et al., 2015b'
      - >-
        ) revealed a further 12 sensitisers arising from our screen including
        helicases (
      - type: Emphasis
        content:
          - RTEL1
      - '), DDR components ('
      - type: Emphasis
        content:
          - 'CHEK1, RAD17'
      - '), transcriptional proteins ('
      - type: Emphasis
        content:
          - 'POLR1A, CNBP'
      - ) and replication factors (
      - type: Emphasis
        content:
          - 'ORC1, RPA3, TOP1'
      - ) (
      - type: Link
        relation: fig
        target: '#fig3'
        content:
          - Figure 3F
      - ).
  - type: Paragraph
    content:
      - >-
        Within the total 758 G4-sensitiser gene list, we uncovered five
        significant enriched KEGG pathway clusters (p<0.05): ‘cell cycle’,
        ‘ribosome’, ‘spliceosome’, ‘ubiquitin-mediated proteolysis’ and ‘DNA
        replication’ (
      - type: Link
        relation: fig
        target: '#fig4'
        content:
          - Figure 4A
      - ', '
      - type: Link
        relation: supplementary-material
        target: '#supp1'
        content:
          - Supplementary file 1
      - >-
        ). Within each cluster are gene targets common to both G4 ligands, as
        well as genes unique to each ligand. To gain functional insights,
        enriched GO ‘Biological Process’ and ‘Molecular Function’ terms were
        determined (
      - type: Link
        relation: fig
        target: '#fig4'
        content:
          - Figure 4B
      - '; '
      - type: Link
        relation: supplementary-material
        target: '#supp1'
        content:
          - Supplementary file 1
      - >-
        ) which showed 20 out of 45 of the former and all the latter terms into
        DNA or RNA classifications, consistent with PDS/PhenDC3 directly binding
        nucleic acid G4 targets. Furthermore, when protein domains were
        considered using GENE3D and PFAM databases (
      - type: Link
        relation: fig
        target: '#fig4'
        content:
          - Figure 4C
      - >-
        ), we discovered enrichments in helicase C-terminal domains, RNA
        recognition motifs including RRM, RBD and RNP domains, and DNA-binding
        domains including zinc fingers, bZIP motifs and HMG boxes. Consistent
        with the ubiquitin-mediated proteolysis KEGG cluster, enrichments in
        multifunctional ATPase domains and in ubiquitin hydrolase domains, were
        also found. These latter findings suggest important areas of biology not
        previously known to be affected by G4 intervention in mammalian cells.
  - type: Figure
    id: fig4
    caption:
      - type: Heading
        id: s2-1
        depth: 2
        content:
          - >-
            Pathways and processes showing sensitivity to G4-stabilising
            ligands.
      - type: Paragraph
        content:
          - (
          - type: Strong
            content:
              - A
          - ) Enriched KEGG pathways and (
          - type: Strong
            content:
              - B
          - ") Gene Ontology terms, GO Biological Processes (BP) and Molecular Functions (MF), for the 758 genome-wide G4-sensitiser genes. Blue- genes common to both ligands; black- genes unique to either PDS or PhenDC3. A right-sided enrichment test with Bonferroni correction used (see Materials\_and\_methods). ("
          - type: Strong
            content:
              - C
          - >-
            ) Enriched protein domains (p≤0.05) within GENE3D (black) and PFAM
            databases (grey) ordered by -Log10 (EASE p-value). See also 
          - type: Link
            relation: supplementary-material
            target: '#supp1'
            content:
              - Supplementary file 1
          - .
    label: Figure 4.
    content:
      - type: ImageObject
        contentUrl: fig4.jpg
        format: image/tiff
        meta:
          inline: false
  - type: Heading
    id: s2-2
    depth: 2
    content:
      - Cancer-associated gene depletion enhances sensitivity to G4-ligands
  - type: Paragraph
    content:
      - >-
        We next used the complete list of 758 genes, identified as stringent G4
        ligand sensitisers above, to discover new cancer-associated gene
        vulnerabilities to G4-stabilising ligands. For this, we searched this
        list for any significant enrichment in the COSMIC database (v83) of
        genes causally implicated in cancer (
      - type: Cite
        target: bib43
        content:
          - 'Forbes et al., 2015'
      - '). Of the 758 sensitisers, there was a two-fold enrichment (p=9.1×10'
      - type: Superscript
        content:
          - −6
      - >-
        ) for 50 cancer-associated genes, which increases to three-fold
        (p=2.5×10
      - type: Superscript
        content:
          - −3
      - ) when considering only sensitisers common to both G4 ligands (
      - type: Link
        relation: fig
        target: '#fig5'
        content:
          - 'Figure 5A,B'
      - ', '
      - type: Link
        relation: supplementary-material
        target: '#supp1'
        content:
          - Supplementary file 1
      - '). Notably, when STRING network analysis ('
      - type: Cite
        target: bib115
        content:
          - 'Szklarczyk et al., 2017'
      - >-
        ) was used to investigate functional interactions, this revealed a DDR
        cluster that included 
      - type: Emphasis
        content:
          - BRCA1
      - ' and '
      - type: Emphasis
        content:
          - BRCA2
      - ', as well as their interacting tumour suppressor partners '
      - type: Emphasis
        content:
          - PALB2
      - ' and '
      - type: Emphasis
        content:
          - BAP1
      - >-
        , two cancer-associated DDR genes not previously indicated as G4 ligand
        sensitisers. (
      - type: Link
        relation: fig
        target: '#fig5'
        content:
          - Figure 5C
      - >-
        ). This analysis also identified as sensitisers a cluster consisting of
        several chromatin modifiers including 
      - type: Emphasis
        content:
          - SMARCA4
      - ', '
      - type: Emphasis
        content:
          - SMARCB1
      - ' and '
      - type: Emphasis
        content:
          - SMARCE1
      - .
  - type: Figure
    id: fig5
    caption:
      - type: Heading
        id: s2-2
        depth: 2
        content:
          - >-
            Identification of cancer-associated genes whose loss promotes
            sensitivity to G4 ligands.
      - type: Paragraph
        content:
          - (
          - type: Strong
            content:
              - 'A, B'
          - ) Median log
          - type: Subscript
            content:
              - '2'
          - >-
            FC and number of significantly depleted hairpins for G4 sensitisers
            overlapping the COSMIC database for PDS (
          - type: Strong
            content:
              - A
          - ) and PhenDC3 (
          - type: Strong
            content:
              - B
          - '). Genes common to both are indicated in blue. See also '
          - type: Link
            relation: supplementary-material
            target: '#supp1'
            content:
              - Supplementary file 1
          - . (
          - type: Strong
            content:
              - C
          - ") Functional interaction network analysis using STRING for the 50 COSMIC proteins indicated in A and B. Clusters are shown using confidence interactions\_>\_0.4 from co-expression and experimental data. Box indicates the DDR cluster."
    label: Figure 5.
    content:
      - type: ImageObject
        contentUrl: fig5.jpg
        format: image/tiff
        meta:
          inline: false
  - type: Heading
    id: s2-3
    depth: 2
    content:
      - >-
        Focused G4-sensitiser shRNA screening reveals robust G4-ligand genetic
        vulnerabilities and potential therapeutic targets
  - type: Paragraph
    content:
      - >-
        To enable more rigorous and further comparative analyses that focus
        solely on G4 sensitisers, we developed a custom shRNA screening panel
        encompassing the gene sensitisers identified above plus additional
        G4-associated genes noted from the literature (
      - type: Link
        relation: fig
        target: '#fig6'
        content:
          - Figure 6A
      - ', '
      - type: Link
        relation: fig
        target: '#fig6s1'
        content:
          - Figure 6—figure supplement 1
      - ", see Materials\_and\_methods). This panel consisted of a single retroviral shRNA pool to allow all shRNAs to be screened simultaneously under standardised conditions and to minimise technical fluctuations. We first used this panel to recapitulate the findings of the genome-wide screen above and compare responses with different G4 ligands. Using A375 melanoma cells with PDS and PhenDC3, the custom panel recovered a total of 342 G4 sensitisers corresponding to 40.6% overlap (308 genes) with the complete genome-wide screen ("
      - type: Link
        relation: fig
        target: '#fig6'
        content:
          - 'Figure 6B,C'
      - >-
        ). From this, we identified 290 G4 sensitisers with 89 and 161 unique
        for PDS and PhenDC3, respectively, and 40 genes common for both ligands
        (
      - type: Link
        relation: fig
        target: '#fig6s1'
        content:
          - Figure 6—figure supplement 1E
      - >-
        ). Comparing PDS and PhenDC3 sensitisers by KEGG analysis shows that
        each ligand mostly interacts with different but related pathways (
      - type: Link
        relation: fig
        target: '#fig6'
        content:
          - 'Figure 6D,E'
      - >-
        ). Consistent with direct G4-targeting, nucleic-acid-related GO terms
        were enriched (
      - type: Link
        relation: fig
        target: '#fig6s1'
        content:
          - Figure 6—figure supplement 1F & G
      - ",\_"
      - type: Link
        relation: supplementary-material
        target: '#supp2'
        content:
          - Supplementary file 2
      - ").\_We next considered that the 40 sensitiser genes common between PDS and PhenDC3 reflected the most robust sensitisers for G4 ligands in general and it is notable that 27 out of 40 associated with DNA or RNA binding processes, such as chromatin modification, replication transcription, and translation ("
      - type: Link
        relation: fig
        target: '#fig6'
        content:
          - Figure 6F
      - >-
        ). Again, the ubiquitin processes, which previously were not linked with
        G4 biology, were also uncovered as a significant sensitiser pathway.
        Overall, these results clearly show the spectrum of biological
        vulnerabilities that underpin the observed enhanced sensitivities for
        each G4-targeting ligand.
  - type: Collection
    parts:
      - type: Figure
        id: fig6
        caption:
          - type: Heading
            id: s2-3
            depth: 2
            content:
              - >-
                A custom G4 sensitiser shRNA panel reveals unique and common G4
                ligand sensitivities.
          - type: Paragraph
            content:
              - (
              - type: Strong
                content:
                  - A
              - >-
                ) A shRNAs custom retroviral pool (~8000 hairpins) was used to
                infect A375 cells. Following antibiotic selection, the reference
                time point (t0) was taken and then cells were cultured for 15
                population doublings in DMSO, PDS or PhenDC3 before (tF). Three
                biological replicates were performed. (
              - type: Strong
                content:
                  - B
              - >-
                ) Significant sensitiser genes for the A375 focused screen (50%
                or three significantly depleted with median log
              - type: Subscript
                content:
                  - '2'
              - ' FC≤ −1). ('
              - type: Strong
                content:
                  - C
              - >-
                ) Overlap of the genome-wide (GW) with A375 focused screen for
                PDS and PhenDC3 G4-sensitisers combined (see also 
              - type: Link
                relation: fig
                target: '#fig6s1'
                content:
                  - Figure 6—figure supplement 1
              - ). (
              - type: Strong
                content:
                  - D–E
              - ) Enriched KEGG pathways for (
              - type: Strong
                content:
                  - D
              - ) PhenDC3 and (
              - type: Strong
                content:
                  - E
              - ") PDS sensitiser genes common to the genome-wide and A375 focused screens. A right-sided enrichment test with Bonferroni correction used (see Materials\_and\_methods). ("
              - type: Strong
                content:
                  - F
              - ") DAVID, STRING (experimental data, co-expression, medium confidence\_≥0.4) interaction and UniprotKB data were used to categorise biochemical roles for the 40 high-confidence G4 sensitisers common to both ligands. Genes in red indicate those found in the (DGIdb 2.0). *=genes in multiple categories. ("
              - type: Strong
                content:
                  - 'G, H'
              - ) Overlap of the all 290 robust G4 sensitisers (
              - type: Strong
                content:
                  - G
              - ) and the 40 G4 sensitisers common to both ligands (
              - type: Strong
                content:
                  - H
              - >-
                ) with the Drug Genome Interaction database. The druggable
                genome denotes genes with known or predicted drug interactions.
                Clinically actionable denotes genes used in targeted cancer
                clinical sequencing panels. See also 
              - type: Link
                relation: fig
                target: '#fig6s1'
                content:
                  - Figure 6—figure supplement 1
              - ', '
              - type: Link
                relation: supplementary-material
                target: '#supp1'
                content:
                  - Supplementary file 1
              - .
        label: Figure 6.
        content:
          - type: ImageObject
            contentUrl: fig6.jpg
            format: image/tiff
            meta:
              inline: false
      - type: Figure
        id: fig6s1
        caption:
          - type: Heading
            id: s2-3
            depth: 2
            content:
              - >-
                Focused A375 cell screening parallels findings from the
                genome-wide screen and highlights differences in individual G4
                ligand sensitivities.
          - type: Paragraph
            content:
              - (
              - type: Strong
                content:
                  - A
              - >-
                ) Cumulative population doublings for A375 cells for DMSO, PDS
                and PhenDC3 (mean and standard deviation from three cell counts
                per condition). (
              - type: Strong
                content:
                  - B
              - >-
                ) Number of shRNAs targeting each gene, with the maximum capped
                at seven per gene (
              - type: Strong
                content:
                  - C–E
              - ) Venn diagrams showing (
              - type: Strong
                content:
                  - C
              - ") significantly depleted shRNAs at t15 v t0 (FDR\_≤\_0.05) for DMSO, PDS and PhenDC3 treatment, ("
              - type: Strong
                content:
                  - D
              - >-
                ) significantly depleted genes (minimum 50% or three significant
                shRNAs) and (
              - type: Strong
                content:
                  - E
              - >-
                ) overlap of focused and genome-wide screens. For PDS and
                PhenDC3, there are 89 and 201 unique genes, respectively, that
                overlap between the two screens and 40 genes shared for PDS and
                PhenDC3. (
              - type: Strong
                content:
                  - F–G
              - >-
                ) Enriched Gene Ontology terms (GO Biological Processes and
                Molecular Functions) as determined by Bonferroni multiple
                hypothesis correction (p≤0.05) for (
              - type: Strong
                content:
                  - E
              - ) all 201 PhenDC3 and (
              - type: Strong
                content:
                  - F
              - >-
                ) all 129 PDS G4-hits validated by the A375 focused screen.
                Black bars reflect terms enriched in both PDS and PhenDC3. See
                also 
              - type: Link
                relation: supplementary-material
                target: '#supp2'
                content:
                  - Supplementary file 2
              - .
        label: Figure 6—figure supplement 1.
        content:
          - type: ImageObject
            contentUrl: fig6-figsupp1.jpg
            format: image/tiff
            meta:
              inline: false
    meta:
      usage: figGroup
  - type: Paragraph
    content:
      - >-
        We next reasoned that the robust set of 290 G4 ligand sensitiser genes
        above provides a suitable test bed for exploring the arising therapeutic
        potential for combinatorial pharmacological inhibition and G4-ligands.
        We therefore looked for the presence of these sensitisers genes within
        the druggable genome interaction database (DGIdb) (
      - type: Cite
        target: bib50
        content:
          - 'Griffith et al., 2013'
      - >-
        ). A total of 74 G4-sensitisers were found in the classifications
        ‘Druggable Genome’ (genes with known or predicted drug interactions) and
        ‘Clinically Actionable’ (genes used in targeted clinical cancer
        sequencing for precision medicine) with 13 being common to both
        classifications (
      - type: Link
        relation: fig
        target: '#fig6'
        content:
          - Figure 6G
      - ', '
      - type: Link
        relation: supplementary-material
        target: '#supp1'
        content:
          - Supplementary file 1
      - >-
        ). Notably, this included KEAP1, an E3 ubiquitin ligase adapter protein
        and highlights a new therapeutic domain for the application of G4-based
        drugs. Performing a similar analysis on the 40 most robust sensitisers
        common to both G4 ligands gave 12 genes within DGIdb (
      - type: Link
        relation: fig
        target: '#fig6'
        content:
          - Figure 6H
      - ', '
      - type: Link
        relation: supplementary-material
        target: '#supp1'
        content:
          - Supplementary file 1
      - '), including 5 ('
      - type: Emphasis
        content:
          - 'BRCA1, CHEK1, CDK12, TOP1, PDKP1'
      - >-
        ) common to both druggable and clinically actionable classifications.
        These results therefore open up new possibilities for cancer therapies
        based on vulnerabilities to G4 ligands.
  - type: Heading
    id: s2-4
    depth: 2
    content:
      - G4 sensitisers common to two independent cell lines
  - type: Paragraph
    content:
      - >-
        We next sought to extend the use of the custom shRNA lentiviral library
        to gain initial insights into possible commonalities and differences in
        the response to G4 ligands in cells from different lineages. We
        therefore applied the custom library to mesenchymal-derived HT1080
        fibrosarcoma cells (wild-type 
      - type: Emphasis
        content:
          - TP53
      - ', driven by activated '
      - type: Emphasis
        content:
          - NRAS
      - ' (Q61K) and '
      - type: Emphasis
        content:
          - IDH1
      - ' mutation (R132C)) and compared the results to those from ectodermal A375 melanoma cells above ('
      - type: Link
        relation: fig
        target: '#fig7'
        content:
          - Figure 7
      - ', '
      - type: Link
        relation: fig
        target: '#fig7s1'
        content:
          - Figure 7—figure supplement 1F & G
      - ', '
      - type: Link
        relation: supplementary-material
        target: '#supp1'
        content:
          - Supplementary files 1 & 2
      - >-
        ). The custom HT1080 screen recovered a total of 121 G4 ligand
        sensitisers, with the majority (73 genes, 58%) shared with those seen
        for each ligand in the A375 genome-wide screen. Cytoscape network
        analysis (
      - type: Link
        relation: fig
        target: '#fig7'
        content:
          - Figure 7A
      - >-
        ) revealed a core set of G4-associated genes/pathways for these genes in
        spliceosome, HR and ubiquitin-mediated proteolysis processes (p<0.0005).
        Overall, 29 PDS and 22 PhenDC3 gene sensitivities were found to be
        shared across all three screens (
      - type: Link
        relation: fig
        target: '#fig7'
        content:
          - 'Figure 7B,C'
      - >-
        ), and it is noteworthy that both G4 ligands targeted similar processes
        including transcription, splicing and ubiquitin-mediated proteolysis (
      - type: Link
        relation: fig
        target: '#fig7'
        content:
          - 'Figure 7D,E'
      - ).
  - type: Collection
    parts:
      - type: Figure
        id: fig7
        caption:
          - type: Heading
            id: s2-4
            depth: 2
            content:
              - G4 sensitivities in two different cell lines.
          - type: Paragraph
            content:
              - (
              - type: Strong
                content:
                  - A
              - ") Enriched KEGG and GO pathways for all G4 ligand-specific sensitisers (73 genes) shared between the genome-wide A375 and HT1080 screens. A right-sided enrichment test with Bonferroni correction used (see Materials\_and\_methods). ("
              - type: Strong
                content:
                  - B–C
              - >-
                ) Comparison of G4 sensitisers across A375 focused, A375
                genome-wide and HT1080 focused screens for (
              - type: Strong
                content:
                  - B
              - ) PhenDC3 and (
              - type: Strong
                content:
                  - C
              - ) PDS. (
              - type: Strong
                content:
                  - D–E
              - >-
                ) DAVID, STRING (experimental data, co-expression, medium
                confidence (≥0.4) interaction) and UniProtKB data analysis
                showing biochemical functions for common PhenDC3 (
              - type: Strong
                content:
                  - D
              - ) and PDS (
              - type: Strong
                content:
                  - E
              - >-
                ) sensitisers across all three screens. *=genes in multiple
                categories. Blue, four sensitisers common to both ligands. (
              - type: Strong
                content:
                  - F
              - >-
                ) Left, common sensitiser genes across all three screens. Right,
                number of depleted hairpins and median log
              - type: Subscript
                content:
                  - '2'
              - >-
                FC values for four key genes found as both PDS and PhenDC3
                sensitisers across all the three screens. See also 
              - type: Link
                relation: fig
                target: '#fig7s1'
                content:
                  - Figure 7—figure supplement 1
              - ', '
              - type: Link
                relation: supplementary-material
                target: '#supp1'
                content:
                  - Supplementary file 1
              - .
        label: Figure 7.
        content:
          - type: ImageObject
            contentUrl: fig7.jpg
            format: image/tiff
            meta:
              inline: false
      - type: Figure
        id: fig7s1
        caption:
          - type: Heading
            id: s2-4
            depth: 2
            content:
              - >-
                Focused HT1080 and A375 cell screening reveals shared PDS and
                PhenDC3 sensitivities.
          - type: Paragraph
            content:
              - (
              - type: Strong
                content:
                  - A
              - >-
                ) Cumulative population doublings for HT1080 cells for DMSO, PDS
                and PhenDC3 (mean and standard deviation from three cell counts
                per condition). (
              - type: Strong
                content:
                  - B
              - >-
                ) Comparison between the numbers of shRNAs targeting each gene,
                with the maximum capped at seven per gene. (
              - type: Strong
                content:
                  - C–E
              - ) Venn diagrams from the HT1080 focused screen showing (
              - type: Strong
                content:
                  - C
              - ") significantly depleted shRNAs at t15 v t0 (FDR\_≤\_0.05) for DMSO, PDS and PhenDC3 treatment, ("
              - type: Strong
                content:
                  - D
              - ") significantly depleted genes (minimum 50% or three significant shRNAs; FDR\_≤\_0.05) and ("
              - type: Strong
                content:
                  - E
              - >-
                ) sensitiser genes (significantly depleted in PDS or PhenDC3 but
                not DMSO and median log
              - type: Subscript
                content:
                  - '2'
              - FC ≤ −1). (
              - type: Strong
                content:
                  - F–G
              - >-
                ) Venn diagrams showing G4-ligand-specific sensitisers
                overlapping between (
              - type: Strong
                content:
                  - F
              - ) the genome-wide (GW) A375 and HT1080 focused screens and (
              - type: Strong
                content:
                  - G
              - >-
                ) the HT1080 and A375 focused screens (50% or three
                significantly depleted with a median log
              - type: Subscript
                content:
                  - '2'
              - 'FC ≤ −1). See also '
              - type: Link
                relation: supplementary-material
                target: '#supp2'
                content:
                  - Supplementary file 2
              - .
        label: Figure 7—figure supplement 1.
        content:
          - type: ImageObject
            contentUrl: fig7-figsupp1.jpg
            format: image/tiff
            meta:
              inline: false
    meta:
      usage: figGroup
  - type: Heading
    id: s2-5
    depth: 2
    content:
      - type: Emphasis
        content:
          - 'BRCA1, TOP1, DDX42'
      - ' and '
      - type: Emphasis
        content:
          - GAR1
      - ' are key G4 ligand sensitiser genes'
  - type: Paragraph
    content:
      - >-
        When we evaluated the data collectively from all screens, it was
        apparent that four genes were repeatedly found as G4 ligand
        sensitisers- 
      - type: Emphasis
        content:
          - 'BRCA1, TOP1, DDX42'
      - ' and '
      - type: Emphasis
        content:
          - 'GAR1,'
      - ' as they consistently appeared in both cell types and with both G4-ligands in all screens ('
      - type: Link
        relation: fig
        target: '#fig7'
        content:
          - Figure 7F
      - ', '
      - type: Link
        relation: fig
        target: '#fig7s1'
        content:
          - Figure 7—figure supplement 1F
      - >-
        ). To corroborate these genes as genuine G4 sensitisers, we developed an
        independent siRNA knockdown approach using a shorter timeframe (~6 days)
        to recapitulate ligand-induced growth inhibition (
      - type: Link
        relation: fig
        target: '#fig8'
        content:
          - Figure 8
      - '). Both A375 and HT1080 cells were transfected with siRNAs targeting '
      - type: Emphasis
        content:
          - 'BRCA1, TOP1, DDX42'
      - ' or '
      - type: Emphasis
        content:
          - GAR1
      - ' alongside non-targeting siRNA and non-transfected controls. Following 24 hr, cells were treated with two concentrations of PDS and PhenDC3 or vehicle control DMSO for 144 hr. Growth curves for non-transfected and non-targeting siRNA controls were similar across ligand treatments in both cell lines ('
      - type: Link
        relation: fig
        target: '#fig8s1'
        content:
          - Figure 8—figure supplements 1
      - ' and '
      - type: Link
        relation: fig
        target: '#fig8s2'
        content:
          - '2'
      - ). For both HT1080 (
      - type: Link
        relation: fig
        target: '#fig8'
        content:
          - Figure 8A & B
      - ) and A375 cells (
      - type: Link
        relation: fig
        target: '#fig8s3'
        content:
          - Figure 8—figure supplement 3A & B
      - >-
        ), protein depletion following siRNA transfection was confirmed after 48
        hr by immunoblotting cell lysates with the appropriate antibodies
        (average 76–92% knockdown for HT1080; 41–69% knockdown for A375 after 48
        hr). The percentage difference in confluency compared to non-targeting
        siRNA control cells was plotted (
      - type: Link
        relation: fig
        target: '#fig8s1'
        content:
          - Figure 8—figure supplement 1B–E
      - ' and '
      - type: Link
        relation: fig
        target: '#fig8s3'
        content:
          - Figure 8—figure supplement 3C–F
      - ') and compared to DMSO treatment at 72, 96 and 120 hr ('
      - type: Link
        relation: fig
        target: '#fig8'
        content:
          - Figure 8C–F
      - ', '
      - type: Link
        relation: fig
        target: '#fig8s3'
        content:
          - Figure 8—figure supplement 3G–J
      - ).
  - type: Collection
    parts:
      - type: Figure
        id: fig8
        caption:
          - type: Heading
            id: s2-5
            depth: 2
            content:
              - 'siRNA knockdowns validate '
              - type: Emphasis
                content:
                  - BRCA1
              - ', '
              - type: Emphasis
                content:
                  - TOP1
              - ', '
              - type: Emphasis
                content:
                  - DDX42
              - ' and '
              - type: Emphasis
                content:
                  - GAR1 as
              - ' key G4 ligand sensitiser genes.'
          - type: Paragraph
            content:
              - (
              - type: Strong
                content:
                  - A
              - >-
                ) HT1080 cells were treated with non-targeting (NT) or targeting
                (T) siRNAs for 
              - type: Emphasis
                content:
                  - BRCA1
              - ', '
              - type: Emphasis
                content:
                  - 'TOP1, DDX42'
              - ' and '
              - type: Emphasis
                content:
                  - GAR1
              - >-
                . 48 hr and 144 hr after transfection, cell lysates and a
                non-transfected cell lysate (U) were probed with appropriate
                antibodies and actin control by western blotting. (
              - type: Strong
                content:
                  - B
              - ") Protein levels for targeting (T) and non-targeting (NT) 48 hr lysates were normalised to the internal actin control and then normalised to NT levels for three biological replicates (mean\_±\_standard deviation). ("
              - type: Strong
                content:
                  - C–F
              - ") HT1080 cells were transfected with targeting siRNAs for 24 hr before PDS, PhenDC3 or DMSO treatment. Comparative box plots of confluency differences and significance (unpaired parametric t-test) at selected timepoints for \uFEFF("
              - type: Strong
                content:
                  - C
              - ') '
              - type: Emphasis
                content:
                  - BRCA1
              - ', ('
              - type: Strong
                content:
                  - D
              - ') '
              - type: Emphasis
                content:
                  - TOP1
              - ', ('
              - type: Strong
                content:
                  - E
              - ') '
              - type: Emphasis
                content:
                  - DDX42
              - ', ('
              - type: Strong
                content:
                  - F
              - ') '
              - type: Emphasis
                content:
                  - GAR
              - " (ns\_=\_not significant) for three separate siRNA transfections. See also "
              - type: Link
                relation: fig
                target: '#fig8s1'
                content:
                  - Figure 8—figure supplements 1
              - ', '
              - type: Link
                relation: fig
                target: '#fig8s2'
                content:
                  - '2'
              - ' and '
              - type: Link
                relation: fig
                target: '#fig8s3'
                content:
                  - '3'
              - .
          - type: Paragraph
            content:
              - 10.7554/eLife.46793.017
              - Figure 8—source data 1.
          - type: Heading
            id: s2-5
            depth: 2
            content:
              - Source files for western blots.
          - type: Paragraph
            content:
              - (
              - type: Strong
                content:
                  - A
              - ) Full length western blots and (
              - type: Strong
                content:
                  - B
              - >-
                ) capillary traces obtained from Compass Software (Simple
                Western) for results shown in 
              - type: Link
                relation: fig
                target: '#fig8'
                content:
                  - Figure 8A
              - .
          - type: MediaObject
            contentUrl: elife-46793-fig8-data1-v1.pdf
            format: application/pdf
        label: Figure 8.
        content:
          - type: ImageObject
            contentUrl: fig8.jpg
            format: image/tiff
            meta:
              inline: false
      - type: Figure
        id: fig8s1
        caption:
          - type: Heading
            id: s2-5
            depth: 2
            content:
              - >-
                Short-term siRNA knockdowns of four key sensitisers in HT1080
                cells show dose-dependent growth inhibition with G4-ligands.
          - type: Paragraph
            content:
              - (
              - type: Strong
                content:
                  - A
              - ") HT1080 cells were transfected with targeting siRNAs (orange) against BRCA1, TOP1, DDX42 or GAR1 for 24 hr before treatment with PDS (0.25 μM and 0.5 μM), PhenDC3 (20 μM and 40 μM) or vehicle control (DMSO). For each knockdown, confluency over 144 hr was monitored and plotted against confluency of non-transfected cells (blue) and cells transfected with a non-targeting control siRNA (green). Experiments were performed in triplicate and average confluency accumulation shown (mean\_±\_standard deviation). ("
              - type: Strong
                content:
                  - B–D
              - ") Confluency differences (mean\_±\_standard deviation) compared to NT siRNA were plotted across three replicates for ("
              - type: Strong
                content:
                  - B
              - ') '
              - type: Emphasis
                content:
                  - BRCA1
              - ', ('
              - type: Strong
                content:
                  - C
              - ') '
              - type: Emphasis
                content:
                  - TOP1
              - ', ('
              - type: Strong
                content:
                  - D
              - ') '
              - type: Emphasis
                content:
                  - DDX42
              - ', ('
              - type: Strong
                content:
                  - E
              - ') '
              - type: Emphasis
                content:
                  - GAR1
              - .
        label: Figure 8—figure supplement 1.
        content:
          - type: ImageObject
            contentUrl: fig8-figsupp1.jpg
            format: image/tiff
            meta:
              inline: false
      - type: Figure
        id: fig8s2
        caption:
          - type: Heading
            id: s2-5
            depth: 2
            content:
              - >-
                Short-term siRNA knockdowns of four key G4-sensitisers in A375
                cells show dose-dependent growth inhibition with G4-ligands.
          - type: Paragraph
            content:
              - "A375 cells were transfected with targeting siRNAs (orange) against BRCA1, TOP1, DDX42 or GAR1 for 24 hr before treatment with PDS (5 μM and 10 μM), PhenDC3 (20 μM and 40 μM) or vehicle control (DMSO). For each knockdown, confluency over 144 hr was monitored and plotted against confluency of non-transfected cells (blue) and cells transfected with a non-targeting control siRNA (green). Experiments were performed in triplicate and average confluency accumulation shown (mean\_±\_standard deviation)."
        label: Figure 8—figure supplement 2.
        content:
          - type: ImageObject
            contentUrl: fig8-figsupp2.jpg
            format: image/tiff
            meta:
              inline: false
      - type: Figure
        id: fig8s3
        caption:
          - type: Heading
            id: s2-5
            depth: 2
            content:
              - >-
                Short-term siRNA knockdowns validate four key sensitivities from
                the shRNA screening in A375 cells.
          - type: Paragraph
            content:
              - (
              - type: Strong
                content:
                  - A
              - ') For '
              - type: Emphasis
                content:
                  - BRCA1
              - ', '
              - type: Emphasis
                content:
                  - TOP1
              - ', '
              - type: Emphasis
                content:
                  - DDX42
              - ' and '
              - type: Emphasis
                content:
                  - GAR1
              - >-
                , A375 cells were transfected with non-targeting (NT) or
                targeting (T) siRNAs. 48 hr and 144 hr after transfection,
                lysates were probed appropriate antibodies alongside a
                non-transfected lysate (U). (
              - type: Strong
                content:
                  - B
              - ") BRCA1, TOP1, DDX42 and GAR1 protein levels for targeting (T) and non-targeting (NT) lysates were normalised to the internal actin control and then normalised to NT levels for three independent blots 48 hr (top) and two independent blots 144 hr (bottom) after transfection (mean\_±\_standard deviation). ("
              - type: Strong
                content:
                  - C–F
              - ") A375 cells were transfected with the targeting siRNAs for 24 hr before PDS, PhenDC3 or DMSO treatment. Average confluency difference (mean\_±\_standard deviation) compared to NT siRNA plotted across three replicates for ("
              - type: Strong
                content:
                  - C
              - ') BRCA1, ('
              - type: Strong
                content:
                  - D
              - ') TOP1, ('
              - type: Strong
                content:
                  - E
              - ') DDX42, ('
              - type: Strong
                content:
                  - F
              - >-
                ) GAR1. Confluency differences at 72, 96 and 120 hr plotted for
                comparison for (
              - type: Strong
                content:
                  - G
              - ') BRCA1, ('
              - type: Strong
                content:
                  - H
              - ') TOP1, ('
              - type: Strong
                content:
                  - I
              - ') DDX42, ('
              - type: Strong
                content:
                  - J
              - ) GAR1.
          - type: Paragraph
            content:
              - 10.7554/eLife.46793.016
              - Figure 8—figure supplement 3—source data 1.
          - type: Heading
            id: s2-5
            depth: 2
            content:
              - Source files for western blots.
          - type: Paragraph
            content:
              - (
              - type: Strong
                content:
                  - A
              - ) Full length western blots and (
              - type: Strong
                content:
                  - B
              - >-
                ) capillary traces obtained from Compass Software (Simple
                Western) for results shown in 
              - type: Link
                relation: fig
                target: '#fig8s3'
                content:
                  - Figure 8—figure supplement 3A
              - .
          - type: MediaObject
            contentUrl: elife-46793-fig8-figsupp3-data1-v1.pdf
            format: application/pdf
        label: Figure 8—figure supplement 3.
        content:
          - type: ImageObject
            contentUrl: fig8-figsupp3.jpg
            format: image/tiff
            meta:
              inline: false
    meta:
      usage: figGroup
  - type: Paragraph
    content:
      - >-
        Mirroring the shRNA screen findings, siRNA knockdown of all four genes
        in HT1080 cells imparted significant increases in sensitivity with PDS
        or PhenDC3 compared to DMSO. Some differences between the ligands and
        individual gene knockdowns were noted. For 
      - type: Emphasis
        content:
          - BRCA1
      - ' and '
      - type: Emphasis
        content:
          - TOP1
      - ' the lowest concentration of PDS resulted in the most sensitisation and this was evident early at 72 hr, whereas both PhenDC3 concentrations resulted in similar growth inhibition and was apparent later ('
      - type: Link
        relation: fig
        target: '#fig8'
        content:
          - Figure 8C & D
      - ",\_"
      - type: Link
        relation: fig
        target: '#fig8s1'
        content:
          - Figure 8—figure supplement 1
      - ").\_For DDX42 and GAR1, growth inhibition was mostly manifest from 96 hr, with both ligands and concentrations being broadly similar ("
      - type: Link
        relation: fig
        target: '#fig8'
        content:
          - Figure 8E & F
      - ', '
      - type: Link
        relation: fig
        target: '#fig8s1'
        content:
          - Figure 8—figure supplement 1
      - >-
        ). Results with the A375 cells also lend support to our observations,
        although there were some differences compared to HT1080 cells (
      - type: Link
        relation: fig
        target: '#fig8s2'
        content:
          - Figure 8—figure supplements 2
      - ' and '
      - type: Link
        relation: fig
        target: '#fig8s3'
        content:
          - '3'
      - '). While '
      - type: Emphasis
        content:
          - GAR1
      - ' knockdown showed a similar sensitivity profile, '
      - type: Emphasis
        content:
          - BRCA1
      - ' and '
      - type: Emphasis
        content:
          - TOP1
      - ' deficiencies were sensitive to PDS but not PhenDC3. '
      - type: Emphasis
        content:
          - DDX42
      - ' knockdown in A375 cells did not reflect the screens ligand sensitivities and this may in part be due to lower knockdown efficiency compared (~40%). Nonetheless, these independent siRNA short-term assays substantiate that '
      - type: Emphasis
        content:
          - 'BRCA1, TOP1, DDX42'
      - ' and '
      - type: Emphasis
        content:
          - GAR1
      - ' are genetic vulnerabilities to G4 ligands and these may open up future possibilities for therapeutic development.'
  - type: Heading
    id: s2-6
    depth: 2
    content:
      - >-
        G4-targeting ligands plus pharmacological inhibitors of G4 sensitiser
        genes demonstrate synergistic cell killing
  - type: Paragraph
    content:
      - "One of our aims was to identify potential cancer genotypes where G4-ligands could be therapeutically exploited. Cancers deficient in our newly discovered G4 sensitisers may be preferentially sensitive to G4-ligands as single agents. Alternatively, rather than exploiting a genetic deficiency per se, it may be possible to use pharmacological inhibition of a critical cancer gene\_product that phenocopies the deficiency in combination with G4 ligands as an orthogonal approach ("
      - type: Link
        relation: fig
        target: '#fig9'
        content:
          - Figure 9A
      - "). As proof-of-principle, we systematically evaluated cell death potentiation with the G4 ligand PDS in combination with pharmacological inhibitors for two new G4 sensitisers gene\_products, the WEE1 kinase or the deubiquitinase USP1 ("
      - type: Link
        relation: fig
        target: '#fig9'
        content:
          - Figure 9B
      - ). WEE1 is a crucial G2/M regulator overexpressed in several cancers (
      - type: Cite
        target: bib80
        content:
          - 'Matheson et al., 2016'
      - >-
        ), and USP1 is involved in DDR regulation and is overexpressed in
        non-small cell lung and other cancers (reviewed in 
      - type: Cite
        target: bib46
        content:
          - 'García-Santisteban et al., 2013'
      - >-
        ). For our studies, we used MK1775 (AZD1775), a WEE1 kinase inhibitor
        that is being clinically evaluated in several cancers (
      - type: Cite
        target: bib100
        content:
          - 'Richer et al., 2017'
      - '), and pimozide a potent USP1-targeting drug ('
      - type: Cite
        target: bib25
        content:
          - 'Chen et al., 2011a'
      - >-
        ). HT1080 and A375 cells were cultured in matrix combinations of PDS
        with MK1775 or pimozide at concentrations surrounding the GI
      - type: Subscript
        content:
          - '50'
      - ' values and cell viability measured after 96 hr using an end-point ATP luminescence-based assay (CellTiter-Glo, Promega). Combenefit software ('
      - type: Cite
        target: bib37
        content:
          - 'Di Veroli et al., 2016'
      - >-
        ) was then used to calculate synergy for different treatment
        combinations in which the percentage growth inhibition compared to
        single agent controls is used to plot a 3D-dose-response surface of
        synergy distribution in concentration space (
      - type: Link
        relation: fig
        target: '#fig9'
        content:
          - Figure 9C–F
      - >-
        ). In HT1080 cells, synergy was found for both PDS and MK1775 or
        pimozide combinations (
      - type: Link
        relation: fig
        target: '#fig9'
        content:
          - 'Figure 9C,D'
      - ', '
      - type: Link
        relation: fig
        target: '#fig9s1'
        content:
          - Figure 9—figure supplement 1
      - >-
        ) with peak synergies of 21% and 24% at 156 nM PDS with 21 nM MK1775 or
        6.25 μM pimozide, respectively (GI
      - type: Subscript
        content:
          - '50'
      - " for PDS, MK1775 and pimozide alone\_=\_322 nM, 59 nM and 8.4 μM, respectively). A375 cells showed lower synergy with PDS and MK1775 combination ("
      - type: Link
        relation: fig
        target: '#fig9'
        content:
          - Figure 9E
      - ', '
      - type: Link
        relation: fig
        target: '#fig9s1'
        content:
          - Figure 9—figure supplement 1
      - '), with peak synergy of 15% at 8 μM PDS, 444 nM MK1775 (GI'
      - type: Subscript
        content:
          - '50'
      - " for PDS, MK1775 and pimozide alone\_=\_8.5 μM, 625 nM and 12.2 μM, respectively). The greatest synergy was seen in combinations of PDS and pimozide in A375 cells ("
      - type: Link
        relation: fig
        target: '#fig9'
        content:
          - Figure 9F
      - ', '
      - type: Link
        relation: fig
        target: '#fig9s1'
        content:
          - Figure 9—figure supplement 1
      - >-
        ) with a peak synergy of 61% at 5.33 μM PDS, 6.25 μM pimozide.
        Furthermore, long-term clonogenic survival assays revealed a similar
        potentiation of growth inhibition, albeit at lower compound
        concentrations, for PDS/MK1775 and PDS/pimozide drug combinations for
        both cell lines tested (
      - type: Link
        relation: fig
        target: '#fig9s2'
        content:
          - Figure 9—figure supplement 2
      - >-
        ). Altogether, these results validate that appropriate drug combinations
        can synergistical act as a surrogate for gene deficiencies in the
        presence of G4 ligands and thus complements the findings uncovered by
        our genetic screening approach.
  - type: Collection
    parts:
      - type: Figure
        id: fig9
        caption:
          - type: Heading
            id: s2-6
            depth: 2
            content:
              - >-
                Cell death potentiation mediated by pharmacological inhibition
                of WEE1 or USP1 with the G4-stabilising ligand PDS.
          - type: Paragraph
            content:
              - (
              - type: Strong
                content:
                  - A
              - >-
                ) Cell death potentiation with G4-stabilising ligands in
                combination with either gene deficiencies, such as
                shRNA-mediated knockdown (top), or pharmacological inhibition of
                a protein (bottom). (
              - type: Strong
                content:
                  - B
              - ) Numbers of depleted shRNA hairpins and median log
              - type: Subscript
                content:
                  - '2'
              - >-
                FC values for WEE1 and USP1 in the genome-wide and focused
                screens. (
              - type: Strong
                content:
                  - C–F
              - ) Synergy plots for HT1080 (
              - type: Strong
                content:
                  - 'C, D'
              - ) and A375 (
              - type: Strong
                content:
                  - 'E, F'
              - ) cells treated with PDS in combination with MK1775 (
              - type: Strong
                content:
                  - 'C, E'
              - ) or pimozide (
              - type: Strong
                content:
                  - 'D, F'
              - >-
                ). To determine any synergy in cell killing, 3D response surface
                plots were calculated using Combenefit software with the BLISS
                model for an average of three biological replicas. Heat bar-
                blue shading indicates synergy combinations, red indicates
                antagonism (see also 
              - type: Link
                relation: fig
                target: '#fig9s1'
                content:
                  - Figure 9—figure supplements 1
              - ' and '
              - type: Link
                relation: fig
                target: '#fig9s2'
                content:
                  - '2'
              - ).
        label: Figure 9.
        content:
          - type: ImageObject
            contentUrl: fig9.jpg
            format: image/tiff
            meta:
              inline: false
      - type: Figure
        id: fig9s1
        caption:
          - type: Heading
            id: s2-6
            depth: 2
            content:
              - Synergy calculations for PDS with MK1775 and pimozide.
          - type: Paragraph
            content:
              - (
              - type: Strong
                content:
                  - A–D
              - >-
                ) Cell viability Cell-Titer Glo 96 hr luminescent values for
                HT1080 and A375 treated with PDS and MK1775 or PDS and pimozide,
                were normalised to the untreated controls (denoted 100%
                viability) and the viability of each condition expressed as a
                percentage of the untreated cells. These input values are then
                analysed using the BLISS model within the Combenefit software
                package to create a matrix of how the treatment ‘controls’ cell
                viability. Brown denotes high control, thus low viability. (
              - type: Strong
                content:
                  - E–H
              - >-
                ) 2D BLISS synergy matrix derived from ‘control’ input. Each
                dose combination is given a synergy score. Blue and a high
                percentage indicates synergy.
        label: Figure 9—figure supplement 1.
        content:
          - type: ImageObject
            contentUrl: fig9-figsupp1.jpg
            format: image/tiff
            meta:
              inline: false
      - type: Figure
        id: fig9s2
        caption:
          - type: Heading
            id: s2-6
            depth: 2
            content:
              - >-
                Clonogenic cell survival assay demonstrates enhanced cell death
                upon treatment with PDS in combination MK1775 or pimozide.
          - type: Paragraph
            content:
              - >-
                Clonogenic survival of HT1080 and A375 cells after 8-day
                exposure to the indicated drug combinations. (
              - type: Strong
                content:
                  - A–D
              - >-
                ) Colony intensity values, determined by ColonyArea Image J
                plugin, were expressed as a percentage of untreated (DMSO only)
                controls. (
              - type: Strong
                content:
                  - E–H
              - ") BLISS synergy matrix derived using Combenefit software package from normalised colony intensity values. Mean\_±\_standard deviation shown ("
              - type: Strong
                content:
                  - I–L
              - ) Representative SRB-stained colonies for A375 (
              - type: Strong
                content:
                  - K
              - ' and '
              - type: Strong
                content:
                  - L
              - ) and HT1080 (
              - type: Strong
                content:
                  - I
              - ' and '
              - type: Strong
                content:
                  - J
              - ) cells. Three biological replicates were performed.
        label: Figure 9—figure supplement 2.
        content:
          - type: ImageObject
            contentUrl: fig9-figsupp2.jpg
            format: image/tiff
            meta:
              inline: false
    meta:
      usage: figGroup
  - type: Heading
    id: s2-7
    depth: 2
    content:
      - Identification of DDX42 as a new G4-binding protein
  - type: Paragraph
    content:
      - >-
        Another of our aims was to use the findings of our shRNA screen to
        identify proteins that may bind and/or regulate G4 structures in cells,
        such as G4 helicases. Indeed, DHX36 and DHX9, known G4 helicases (
      - type: Cite
        target: bib47
        content:
          - 'Giri et al., 2011'
      - '; '
      - type: Cite
        target: bib27
        content:
          - 'Chen et al., 2018'
      - '; '
      - type: Cite
        target: bib22
        content:
          - 'Chakraborty and Grosse, 2011'
      - ";\_"
      - type: Cite
        target: bib30
        content:
          - 'Creacy et al., 2008'
      - "\_; "
      - type: Cite
        target: bib120
        content:
          - 'Vaughn et al., 2005'
      - >-
        ) and the DEAD box protein DDX3X, that was recently shown to bind RNA
        G4s (
      - type: Cite
        target: bib57
        content:
          - 'Herdy et al., 2018'
      - >-
        ), were identified as G4 sensitisers in our screen. Further members of
        the DDX/DHX helicase family also appeared as G4 sensitisers (
      - type: Link
        relation: fig
        target: '#fig10'
        content:
          - Figure 10A
      - >-
        ), raising the question of whether these represent previously
        uncharacterized G4-binding proteins. To address this directly, we chose
        to investigate DDX42 as this was one of the four key G4 sensitisers
        identified above. DDX42 is a non-processive RNA helicase (
      - type: Cite
        target: bib118
        content:
          - 'Uhlmann-Schiffler et al., 2006'
      - ) and has been associated with splicing (
      - type: Cite
        target: bib126
        content:
          - 'Will et al., 2002'
      - >-
        ); however, this protein remains largely uncharacterised. By
        immunoblotting of nuclear and cytoplasmic sub-cellular fractions (
      - type: Link
        relation: fig
        target: '#fig10'
        content:
          - Figure 10B–E
      - >-
        ), we first established that DDX42 predominantly localises to the
        nucleus (~4 to 9-fold greater than cytoplasmic levels) in three
        independent cell lines, (HT1080, HEK293 and HeLa). As controls for
        fractionation, LaminB1 and GAPDH were found to partition as expected
        into nuclear and cytoplasmic fractions, respectively (
      - type: Link
        relation: fig
        target: '#fig10'
        content:
          - 'Figure 10C,D'
      - ).
  - type: Collection
    parts:
      - type: Figure
        id: fig10
        caption:
          - type: Heading
            id: s2-7
            depth: 2
            content:
              - DDX42 is a predominantly nuclear G4-binding protein.
          - type: Paragraph
            content:
              - (
              - type: Strong
                content:
                  - A
              - ) Number of depleted hairpins and median log
              - type: Subscript
                content:
                  - '2'
              - >-
                FC values for DEAH/DEAD-box helicase genes within the 758 genes
                identified in the genome-wide screen. Those highlighted in blue
                caused sensitivity to both PDS and PhenDC3. (
              - type: Strong
                content:
                  - B
              - >-
                ) Representative immunoblots showing cytoplasmic (C) and nuclear
                (
              - type: Strong
                content:
                  - 'N'
              - >-
                ) lysates for HT1080, human embryonic kidney (HEK) and HeLa
                cells probed for DDX42, laminB1 and GAPDH2. (
              - type: Strong
                content:
                  - 'C, D'
              - ) GAPDH and laminB1 protein levels for (
              - type: Strong
                content:
                  - C
              - ) cytoplasmic and (
              - type: Strong
                content:
                  - D
              - ") nuclear lysates (mean for two biological replicates\_±\_standard deviation). ("
              - type: Strong
                content:
                  - E
              - ") DDX42 nuclear protein levels (normalised to cytoplasmic levels, mean for two biological replicates\_±\_standard deviation). ("
              - type: Strong
                content:
                  - 'F, G'
              - ) DDX42 binding curves G4s by ELISA. (
              - type: Strong
                content:
                  - F
              - >-
                ) NRAS 5’ UTR RNA G4 (rG4), mutated G4 sequence (rG4 mut) and
                RNA hairpin. (
              - type: Strong
                content:
                  - G
              - ) MYC DNA G4 (dG4) and mutated control (dG4 mut). Apparent K
              - type: Subscript
                content:
                  - d
              - ' is calculated from five replicates (values are indicative as the model assumes saturation kinetics).'
          - type: Paragraph
            content:
              - 10.7554/eLife.46793.023
              - Figure 10—source data 1.
          - type: Heading
            id: s2-7
            depth: 2
            content:
              - Source files for western blots.
          - type: Paragraph
            content:
              - (
              - type: Strong
                content:
                  - A
              - ) Full-length western blots and (
              - type: Strong
                content:
                  - B
              - >-
                ) capillary traces obtained from Compass Software (Simple
                Western) for results shown in 
              - type: Link
                relation: fig
                target: '#fig10'
                content:
                  - Figure 10A
              - .
          - type: MediaObject
            contentUrl: elife-46793-fig10-data1-v1.pdf
            format: application/pdf
        label: Figure 10.
        content:
          - type: ImageObject
            contentUrl: fig10.jpg
            format: image/tiff
            meta:
              inline: false
      - type: Figure
        id: fig10s1
        caption:
          - type: Heading
            id: s2-7
            depth: 2
            content:
              - Circular dichroism spectroscopy for G4 oligonucleotides.
          - type: Paragraph
            content:
              - >-
                Circular dichroism spectra for G4-forming oligonucleotides (red)
                and mutated controls (blue) annealed in 100 mM KCl. G4
                structures show a characteristic signature with a positive peak
                at 264 nm and negative peak at 241 nm. (
              - type: Strong
                content:
                  - A
              - ) NRAS 5’UTR RNA G4 and (
              - type: Strong
                content:
                  - B
              - ) MYC promoter DNA G4.
        label: Figure 10—figure supplement 1.
        content:
          - type: ImageObject
            contentUrl: fig10-figsupp1.jpg
            format: image/tiff
            meta:
              inline: false
    meta:
      usage: figGroup
  - type: Paragraph
    content:
      - >-
        As DDX42 is known to bind RNA, we next set out to demonstrate DDX42
        affinity for a RNA-G4 structure as this has not previously been
        documented. For this, a G4 RNA oligonucleotide from the NRAS 5’UTR
        sequence, which forms a stable parallel G4 (
      - type: Cite
        target: bib68
        content:
          - 'Kumari et al., 2007'
      - >-
        ), was used together with a mutated oligonucleotide unable to form a G4
        structure and also a RNA hairpin as negative controls (
      - type: Cite
        target: bib57
        content:
          - 'Herdy et al., 2018'
      - >-
        ). Oligonucleotides were folded in 100 mM KCl to promote G4 structure
        formation and the resultant structures confirmed by circular dichroism
        (CD) spectroscopy (
      - type: Link
        relation: fig
        target: '#fig10s1'
        content:
          - Figure 10—figure supplement 1
      - >-
        ). The affinity of recombinant DDX42 was then investigated by Enzyme
        Linked Immunosorbent Assay (ELISA, 
      - type: Link
        relation: fig
        target: '#fig10'
        content:
          - Figure 10F
      - >-
        ) and binding parameters calculated using a non-linear regression model,
        assuming one-site-specific binding and saturation kinetics using Prism
        software. DDX42 bound the NRAS G4 folded in KCl with an apparent K
      - type: Subscript
        content:
          - d
      - " of 71.1\_±\_3.5 nM and did not bind detectably to the mutant oligonucleotide or RNA hairpin controls."
  - type: Paragraph
    content:
      - >-
        Given the nuclear localisation of DDX42 and as some DDX proteins also
        have DNA helicase activity (
      - type: Cite
        target: bib65
        content:
          - 'Kikuma et al., 2004'
      - >-
        ), the DDX42 affinity for a DNA G4 structure was investigated. For this,
        an oligonucleotide corresponding to the stable parallel G4 structure in
        the promoter of 
      - type: Emphasis
        content:
          - MYC
      - ' ('
      - type: Cite
        target: bib48
        content:
          - 'González and Hurley, 2010'
      - '; '
      - type: Cite
        target: bib132
        content:
          - 'Yang and Hurley, 2006'
      - >-
        ), and a non-G4 forming control, were used. The oligonucleotides were
        folded in 100 mM KCl and structures verified by CD spectroscopic
        analysis (
      - type: Link
        relation: fig
        target: '#fig10s1'
        content:
          - Figure 10—figure supplement 1B
      - ). DDX42 affinity by ELISA (
      - type: Link
        relation: fig
        target: '#fig10'
        content:
          - Figure 10G
      - ) showed that DDX42 binds to the MYC DNA G4 with an apparent K
      - type: Subscript
        content:
          - d
      - " of 232.9\_±\_23.5 nM with little binding to the mutant control. Thus, the G4 sensitiser screen has enabled us to identify and classify DDX42 as a G4-interacting protein as a new finding."
  - type: Heading
    id: s3
    depth: 1
    content:
      - Discussion
  - type: Paragraph
    content:
      - G4 structures are emerging as promising clinical targets in cancer (
      - type: Cite
        target: bib130
        content:
          - 'Xu et al., 2017'
      - >-
        ) but the range of disease-associated genetic backgrounds that
        potentiate G4 ligand effects has yet to be defined. Here, we have
        discovered many genes that when depleted enhance cell killing with the
        G4 ligands PDS and/or PhenDC3. The majority of these have no documented
        link to G4 biology and the use of low ligand concentrations is likely to
        favour discovery of gene losses that are the most sensitive in imparting
        selective cell killing. Validating the success of our approach, we
        independently identified G4-associated protein coding genes known to be
        genetic vulnerabilities to G4 ligands including 
      - type: Emphasis
        content:
          - 'BRCA1/2, HERC2'
      - ' and '
      - type: Emphasis
        content:
          - ATRX
      - ' ('
      - type: Cite
        target: bib83
        content:
          - 'McLuckie et al., 2013'
      - '; '
      - type: Cite
        target: bib123
        content:
          - 'Wang et al., 2019'
      - '; '
      - type: Cite
        target: bib124
        content:
          - 'Watson et al., 2013'
      - '; '
      - type: Cite
        target: bib128
        content:
          - 'Wu et al., 2018'
      - '; '
      - type: Cite
        target: bib130
        content:
          - 'Xu et al., 2017'
      - ";\_"
      - type: Cite
        target: bib137
        content:
          - 'Zimmer et al., 2016'
      - >-
        ). We now report for the first time genetic vulnerabilities in 20 other
        known G4-associated genes that promote sensitivity to G4-stabilising
        ligands. These include direct nucleic acid binders and/or unwinders,
        such as ADAR, DHX36, DNA2, FUS, MCRS1, RECQL4, SF3B3 and XRN1.
  - type: Paragraph
    content:
      - >-
        The clinical PARP inhibitor, olaparib has exemplified the concept of
        synthetic lethality in BRCA-deficient cells (
      - type: Cite
        target: bib18
        content:
          - 'Bryant et al., 2005'
      - '; '
      - type: Cite
        target: bib41
        content:
          - 'Farmer et al., 2005'
      - "), and it is notable that BRCA\_deficiencies were isolated as one of the top genetic vulnerabilities for both G4 ligands in both A375 and HT1080 cells. While PDS and PhenDC3 have not been optimised by medicinal chemistry, the findings of Zimmer et al showing similar efficacy of PDS and olaparib in several BRCA-deficient models ("
      - type: Cite
        target: bib137
        content:
          - 'Zimmer et al., 2016'
      - >-
        ) lends further support that our screen detects robust, biologically
        relevant effects.
  - type: Paragraph
    content:
      - >-
        In dropout screens, dissociating minor from robust growth effects is
        important and is highly dependent on parameters such as compound dose,
        genotype and cell line selected. Our screen was designed with stringent
        parameters to detect genes deficiencies worthy of further exploration.
        Indeed, we demonstrate potent growth inhibition of up to 80% of the four
        top G4 sensitisers genes in a parallel siRNA approach.
  - type: Paragraph
    content:
      - >-
        The gene sensitivities uncovered here have potential to be exploited
        chemotherapeutically in cancer by deploying a G4-stabilising drug as a
        single-agent therapy. Alternatively, in the absence of a particular gene
        deficiency, pharmacological inhibition of a critical oncogene could
        phenocopy the genetic sensitivities described here and be used in
        combinatorial treatments with G4-stabilising drugs. This may be
        attractive as cells are less likely to simultaneously develop resistance
        against two drugs (reviewed in 
      - type: Cite
        target: bib24
        content:
          - 'Chan and Giaccia, 2011'
      - >-
        ). Furthermore, as lower drug doses are used, this increases the
        therapeutic window and has less adverse side effects. As
        proof-as-principle for this, we selected the WEE1 cell cycle kinase and
        the deubiquitinase USP1, and demonstrated that their pharmacological
        inhibition, with MK1775 and pimozide, respectively, leads to the
        potentiation of cell death in conjunction with the G4 ligand PDS. For
        example, 5.3 μM PDS or 6.25 μM pimozide alone impart little growth
        inhibition (14% and 6% respectively), but together they lead to strong
        growth inhibition (79%). 
      - type: Link
        relation: table
        target: '#table1'
        content:
          - Table 1
      - ' highlights further potential combinatorial opportunities for cancer-associated genes with clinical and/or experimental drugs. Additional therapeutic possibilities for other gene sensitivities that are largely still to be explored from a pharmacological perspective are illustrated in '
      - type: Link
        relation: table
        target: '#table2'
        content:
          - Table 2
      - .
  - type: Table
    id: table1
    rows:
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - Gene
          - type: TableCell
            content:
              - Oncogene/tumour suppressor
          - type: TableCell
            content:
              - Combinatorial/single agent
          - type: TableCell
            content:
              - Available drug treatments
          - type: TableCell
            content:
              - 'Cancer association '
              - ' '
              - summary
          - type: TableCell
            content:
              - Reference
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - BRCA1/2
          - type: TableCell
            content:
              - Tumour suppressor
          - type: TableCell
            content:
              - Single agent
          - type: TableCell
            content:
              - Olaparib CX-5461
          - type: TableCell
            content:
              - 'Deficient in ovarian,breast and colorectal cancer.'
          - type: TableCell
            content:
              - type: Cite
                target: bib72
                content:
                  - 'Lee et al., 2014'
              - '; '
              - ' '
              - type: Cite
                target: bib130
                content:
                  - 'Xu et al., 2017'
              - ";\_"
              - type: Cite
                target: bib83
                content:
                  - 'McLuckie et al., 2013'
              - '; '
              - type: Cite
                target: bib137
                content:
                  - 'Zimmer et al., 2016'
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - CCDC6
          - type: TableCell
            content:
              - Tumour suppressor
          - type: TableCell
            content:
              - Single agent
          - type: TableCell
            content:
              - Olaparib
          - type: TableCell
            content:
              - >-
                Inactivated in thyroid and lung cancers. CCDC6-deficient tumours
                are cisplatin-resistant but olaparib sensitive.
          - type: TableCell
            content:
              - type: Cite
                target: bib97
                content:
                  - 'Puxeddu et al., 2005'
              - '; '
              - type: Cite
                target: bib86
                content:
                  - 'Morra et al., 2015'
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - CDK12
          - type: TableCell
            content:
              - Oncogene
          - type: TableCell
            content:
              - Combinatorial
          - type: TableCell
            content:
              - Dinaclib (SCH77965)
          - type: TableCell
            content:
              - >-
                High-grade serous ovariancancer, often exhibits gain-of-function
                CDK12.
          - type: TableCell
            content:
              - type: Cite
                target: bib96
                content:
                  - 'Parry et al., 2010'
              - '; '
              - type: Cite
                target: bib6
                content:
                  - 'Bajrami et al., 2014'
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - KEAP1
          - type: TableCell
            content:
              - Oncogene/Tumour suppressor
          - type: TableCell
            content:
              - Combinatorial/single agent
          - type: TableCell
            content:
              - CDDO-Me CPUY192018
          - type: TableCell
            content:
              - >-
                KEAP1 inactivated in multiple cancers including thoracic and
                endometrial; also hasoncogenic role, CDDO-Me used forleukaemia
                and sold tumours.
          - type: TableCell
            content:
              - type: Cite
                target: bib104
                content:
                  - 'Sanchez-Vega et al., 2018'
              - ";\_"
              - type: Cite
                target: bib1
                content:
                  - 'Abed et al., 2015'
              - ";\_"
              - type: Cite
                target: bib77
                content:
                  - 'Lu et al., 2016'
              - ";\_"
              - type: Cite
                target: bib122
                content:
                  - 'Wang et al., 2014'
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - PSMC2
          - type: TableCell
            content:
              - Oncogene
          - type: TableCell
            content:
              - Combinatorial
          - type: TableCell
            content:
              - 'Proteosome inhibitors: Bortezomib CEP187710 Carfizomib'
          - type: TableCell
            content:
              - >-
                Ubiquitin is emerging aschemotherapeutic target, and general
                proteasome inhibitors clinically are used against multiple
                myeloma.
          - type: TableCell
            content:
              - type: Cite
                target: bib25
                content:
                  - 'Chen et al., 2011a'
              - '; '
              - type: Cite
                target: bib81
                content:
                  - 'Mattern et al., 2012'
              - ";\_"
              - type: Cite
                target: bib40
                content:
                  - 'Edelmann et al., 2011'
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - SMAD4
          - type: TableCell
            content:
              - Tumour suppressor
          - type: TableCell
            content:
              - Single agent
          - type: TableCell
            content:
              - 'GSKi: NCT01632306 NCT01214603 NCT01287520'
          - type: TableCell
            content:
              - >-
                Inactivated in 50% of pancreatic adenocarcinomas.
                Negativelyregulated by GSK, GSKis in clinical trials for
                metastatic pancreatic cancer and acute leukaemia.
          - type: TableCell
            content:
              - type: Cite
                target: bib106
                content:
                  - 'Schutte et al., 1996'
              - ";\_"
              - type: Cite
                target: bib52
                content:
                  - 'Hahn et al., 1996'
              - '; '
              - type: Cite
                target: bib36
                content:
                  - 'Demagny and De Robertis, 2016'
              - '; '
              - type: Cite
                target: bib82
                content:
                  - 'McCubrey et al., 2014'
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - SRSF10
          - type: TableCell
            content:
              - Oncogene
          - type: TableCell
            content:
              - Combinatorial
          - type: TableCell
            content:
              - E7107 1C8
          - type: TableCell
            content:
              - >-
                Over-expressed in colon cancer. 1C8 inhibits SRSF10 and impairs
                HIV replication. FUS interactingprotein. E7107 is a
                splicinginhibitor preventing spliceosome assembly.
          - type: TableCell
            content:
              - type: Cite
                target: bib136
                content:
                  - 'Zhou et al., 2014'
              - ";\_"
              - type: Cite
                target: bib111
                content:
                  - 'Shkreta et al., 2017'
              - '; '
              - type: Cite
                target: bib28
                content:
                  - 'Cheung et al., 2016'
              - ";\_"
              - type: Cite
                target: bib67
                content:
                  - 'Kotake et al., 2007'
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - UBA3
          - type: TableCell
            content:
              - Oncogene
          - type: TableCell
            content:
              - Combinatorial
          - type: TableCell
            content:
              - MLN4924
          - type: TableCell
            content:
              - >-
                Upregulated in AML and multiple solid cancers. MLN4924 is in
                Phase Iclinical trials.
          - type: TableCell
            content:
              - type: Cite
                target: bib113
                content:
                  - 'Soucy et al., 2009'
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - USP1
          - type: TableCell
            content:
              - Oncogene/Tumour suppressor
          - type: TableCell
            content:
              - Combinatorial/single agent
          - type: TableCell
            content:
              - Pimozide
          - type: TableCell
            content:
              - >-
                Over-expressed inmelanoma, gastric, cervical and NSCLC;
                under-expressed in leukaemia and lymphoma. Pimozide is a potent
                USP1-targeting drug.
          - type: TableCell
            content:
              - type: Cite
                target: bib46
                content:
                  - 'García-Santisteban et al., 2013'
              - '; '
              - ' '
              - type: Cite
                target: bib26
                content:
                  - 'Chen et al., 2011b'
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - WEE1
          - type: TableCell
            content:
              - Oncogene/Tumour suppressor
          - type: TableCell
            content:
              - Combinatorial/single agent
          - type: TableCell
            content:
              - AZDMK1775
          - type: TableCell
            content:
              - 'Over-expressed in several cancers, some NSCLC are deficient.'
          - type: TableCell
            content:
              - type: Cite
                target: bib80
                content:
                  - 'Matheson et al., 2016'
              - ";\_"
              - type: Cite
                target: bib100
                content:
                  - 'Richer et al., 2017'
              - ";\_"
              - type: Cite
                target: bib5
                content:
                  - 'Backert et al., 1999'
              - '; '
              - type: Cite
                target: bib134
                content:
                  - 'Yoshida et al., 2004'
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - WHSC1
          - type: TableCell
            content:
              - Oncogene
          - type: TableCell
            content:
              - Combinatorial
          - type: TableCell
            content:
              - DA3003-1 PF-03882845 Chaetocin TC-LPA5-4 ABT-199
          - type: TableCell
            content:
              - >-
                Over-expressed in prostate cancer, multiple myeloma and mantle
                cell lymphoma. five potent candidate inhibitors.
          - type: TableCell
            content:
              - type: Cite
                target: bib29
                content:
                  - 'Coussens et al., 2017'
              - '; '
              - type: Cite
                target: bib9
                content:
                  - 'Bennett et al., 2017'
    title: >-
      Possible chemotherapeutic combinations for G4-stabilising ligands with
      clinically relevant pharmacological drugs
    content: []
  - type: Table
    id: table2
    rows:
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - Gene category
          - type: TableCell
            content:
              - Gene name
          - type: TableCell
            content:
              - Function/pathway Summary
          - type: TableCell
            content:
              - 'Cancer '
              - ' '
              - association summary
          - type: TableCell
            content:
              - References
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - DNA damage repair
          - type: TableCell
            content:
              - PALB2
          - type: TableCell
            content:
              - Homologous recombination; binds BRCA2
          - type: TableCell
            content:
              - 'Inactivating mutations predispose patients to '
              - ' '
              - 'myeloid leukaemia, Wilm’s tumour '
              - ' '
              - and Fanconi anaemia.
          - type: TableCell
            content:
              - type: Cite
                target: bib55
                content:
                  - 'Harrigan et al., 2018'
              - '; '
              - ' '
              - type: Cite
                target: bib91
                content:
                  - 'Nepomuceno et al., 2017'
              - ' '
              - ' '
              - ' '
              - ' '
              - ' '
      - type: TableRow
        cells:
          - type: TableCell
            content:
              -  BAP1
          - type: TableCell
            content:
              - >-
                Homologous recombination; binds BRCA1, deubiquitinase for
                Histone 2A and tumour suppressor HCFC-1
          - type: TableCell
            content:
              - Inactivating mutations foundin uveal melanoma and mesotheliomas.
          - type: TableCell
            content:
              - type: Cite
                target: bib55
                content:
                  - 'Harrigan et al., 2018'
              - '; '
              - type: Cite
                target: bib21
                content:
                  - 'Carbone et al., 2013'
      - type: TableRow
        cells:
          - type: TableCell
            content:
              -  USP1
          - type: TableCell
            content:
              - >-
                Fanconi anaemia and translesion synthesis DDR; deubiquitinase
                required for FANCD2, FANCI and PCNA localisation to sites of
                DNA 
              - ' '
              - damage
          - type: TableCell
            content:
              - >-
                USP1 mRNA over-expressed in melanoma, gastric, cervical and
                NSCLC; under-expressed in leukaemia and lymphoma.
          - type: TableCell
            content:
              - type: Cite
                target: bib55
                content:
                  - 'Harrigan et al., 2018'
              - '; '
              - ' '
              - type: Cite
                target: bib92
                content:
                  - 'Nijman et al., 2005'
              - '; '
              - ' '
              - type: Cite
                target: bib58
                content:
                  - 'Huang et al., 2006'
              - '; '
              - ' '
              - type: Cite
                target: bib46
                content:
                  - 'García-Santisteban et al., 2013'
      - type: TableRow
        cells:
          - type: TableCell
            content:
              -  TOP1
          - type: TableCell
            content:
              - >-
                Relieves torsional stress during DNA replication; suppresses
                genomic instability at actively transcribed exogenous G4-forming
                sequences
          - type: TableCell
            content:
              - 'Common cancer target, to '
              - ' '
              - >-
                induces DNA damage following pharmacological inhibition, lethal
                to cells.
          - type: TableCell
            content:
              - type: Cite
                target: bib131
                content:
                  - 'Yadav et al., 2014'
              - '; '
              - ' '
              - type: Cite
                target: bib121
                content:
                  - 'Wang, 2002'
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - Helicase activity
          - type: TableCell
            content:
              - RECQL4 RTEL1
          - type: TableCell
            content:
              - Previously identified G4-helicases
          - type: TableCell
            content:
              - >-
                RECQL4 (Rothmund-Thomsun syndrome) and RTEL1
                (Hoyeraal-Hreidarsson Syndrome), deficiencies impart increased
                risks of cancer cancer, autoimmunity and premature ageing.
          - type: TableCell
            content:
              - type: Cite
                target: bib17
                content:
                  - 'Brosh, 2013'
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - Chromatin remodellers
          - type: TableCell
            content:
              - ANKRD11
          - type: TableCell
            content:
              - Transcription factor; Recruits histone deacetylases
          - type: TableCell
            content:
              - Tumour suppressor epigenetically silenced in breast cancers.
          - type: TableCell
            content:
              - type: Cite
                target: bib73
                content:
                  - 'Lim et al., 2012'
              - ' '
              - type: Cite
                target: bib90
                content:
                  - 'Neilsen et al., 2008'
              - ' '
              - type: Cite
                target: bib94
                content:
                  - 'Noll et al., 2012'
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - MLL4
          - type: TableCell
            content:
              - H3K4 lysine methyl transferase
          - type: TableCell
            content:
              - Frequently inactivated in several cancers.
          - type: TableCell
            content:
              - type: Cite
                target: bib44
                content:
                  - 'Froimchuk et al., 2017'
              - type: Cite
                target: bib64
                content:
                  - 'Kadoch et al., 2013'
              - '; '
              - ' '
              - type: Cite
                target: bib98
                content:
                  - 'Rao and Dou, 2015'
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - SMARCA4 SMARCB1 SMARCE1
          - type: TableCell
            content:
              - SWI/SNF ATP-dependent chromatin remodellers
          - type: TableCell
            content:
              - >-
                Mutated in 20% of human cancers; doxorubicin resistant
                triple-negative breast cancer is associated with loss of
                SMARCB1, SMARCA4, or KEAP1 (a BRCA1 interactor).
          - type: TableCell
            content:
              - type: Cite
                target: bib64
                content:
                  - 'Kadoch et al., 2013'
              - '; '
              - ' '
              - type: Cite
                target: bib108
                content:
                  - 'Shain and Pollack, 2013'
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - Ubiquitin
          - type: TableCell
            content:
              - USP37
          - type: TableCell
            content:
              - Deubiquitinating enzyme which stabilises MYC
          - type: TableCell
            content:
              - Upregulated in lung cancer.
          - type: TableCell
            content:
              - type: Cite
                target: bib95
                content:
                  - 'Pan et al., 2015'
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - NEDD4L
          - type: TableCell
            content:
              - E3 ubiquitin ligase
          - type: TableCell
            content:
              - >-
                Expression correlates with poor patient outcome in
                hepatocellular and gastric carcinomas.
          - type: TableCell
            content:
              - type: Cite
                target: bib135
                content:
                  - 'Zhao et al., 2018'
              - '; '
              - ' '
              - type: Cite
                target: bib45
                content:
                  - 'Gao et al., 2012'
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - RNF20
          - type: TableCell
            content:
              - E3 ubiquitin ligase; chromatin remodelling and DDR
          - type: TableCell
            content:
              - >-
                Tumour supressor down-regulated in several cancers. Deletion is
                main contributor to chromosomal instability in colorectal
                cancer.
          - type: TableCell
            content:
              - type: Cite
                target: bib87
                content:
                  - 'Moyal et al., 2011'
              - '; '
              - ' '
              - type: Cite
                target: bib110
                content:
                  - 'Shema et al., 2008'
              - '; '
              - ' '
              - type: Cite
                target: bib8
                content:
                  - 'Barber et al., 2008'
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - Splicing
          - type: TableCell
            content:
              - FUS
          - type: TableCell
            content:
              - Splicing component and known G4-interactor
          - type: TableCell
            content:
              - >-
                Over-expressed in colon, breast and liposarcoma cancers,
                respectively.
          - type: TableCell
            content:
              - type: Cite
                target: bib31
                content:
                  - 'Crozat et al., 1993'
              - '; '
              - ' '
              - type: Cite
                target: bib39
                content:
                  - 'Dvinge et al., 2016'
              - '; '
              - type: Cite
                target: bib116
                content:
                  - 'Takahama et al., 2013'
    title: Examples of cancer-associated genetic vulnerabilities to G4 ligands.
    content: []
  - type: Paragraph
    content:
      - "While the custom HT1080 screen recovered 58% of sensitisers seen for each ligand in the A375 genome-wide screen, it is striking that this increases to 93% (i.e. 112 out of 121) when considering all screens irrespective of G4 ligand, suggesting remarkable consistency when comparing G4 ligand effects globally. Differences in individual ligand sensitives may arise from variances in cellular uptake and dose, for\_example, the GI20 dose of PhenDC3 is ten-fold higher for A375 compared to HT1080; G4 ligand-dependent molecular preference for G-tetrad end binding ("
      - type: Cite
        target: bib71
        content:
          - 'Le et al., 2015'
      - >-
        ) and/or the accessibility of G4s in the chromatin of individual cell
        lines (
      - type: Cite
        target: bib54
        content:
          - 'Hänsel-Hertsch et al., 2016'
      - >-
        ). These points plus differences in protein knockdown efficiency,
        especially in A375 cells, may contribute to the differences in G4 ligand
        growth inhibition in our siRNA experiments. In the siRNA experiments,
        the G4 ligand-induced growth inhibition of both A375 and HT1080 appear
        not to follow a ‘typical’ dose response where higher concentrations lead
        to greater effects. This may in part be due to there being an optimum G4
        ligand dose for a particular gene loss leading to enhanced cell death.
        Indeed, it is thought that lower drug concentrations better fall within
        a ‘synthetic lethality window’ (
      - type: Cite
        target: bib93
        content:
          - 'Nijman, 2011'
      - >-
        ). Higher doses may mask these effects, by targeting more G4s that are
        not dependent on the particular gene lost and/or be due to other
        off-target effects. This is also supported by the experiments in 
      - type: Link
        relation: fig
        target: '#fig9'
        content:
          - Figure 9
      - ' that show synergy is only apparent at defined concentrations.'
  - type: Paragraph
    content:
      - >-
        Our data additionally provides insights into the possible functions of
        the identified G4 sensitisers and indicates roles in DNA damage response
        (DDR), transcription/chromatin remodelling, nucleic acid unwinding,
        splicing and ubiquitin-mediated proteolysis. Our findings substantially
        advance our knowledge of G4 interactions with DDR beyond 
      - type: Emphasis
        content:
          - BRCA1/2
      - ' as several key HR genes were identified as novel G4-sensitisers including '
      - type: Emphasis
        content:
          - PALB2
      - ', '
      - type: Emphasis
        content:
          - BAP1
      - ' and the deubiquitinase '
      - type: Emphasis
        content:
          - USP1
      - >-
        . Importantly, this highlights that such HR repair mechanisms are an
        integral and important cellular response in preventing cell death
        induced through the increased persistence of G4s. Persistent G4
        structures are also inhibitory to DNA replication/cell cycle progression
        (reviewed in 
      - type: Cite
        target: bib119
        content:
          - 'Valton and Prioleau, 2016'
      - ' ), and it is of note that we also uncovered many cell cycle/DNA replication sensitivities such as '
      - type: Emphasis
        content:
          - 'PCNA, CHEK1, CCND1, CDC7, RFC2'
      - ' and '
      - type: Emphasis
        content:
          - RFC4.
      - ' Taken together these suggest that G4 stabilisation with small molecules could be an attractive therapeutic strategy to inhibit cell growth.'
  - type: Paragraph
    content:
      - >-
        Deficits in G4-unwinding helicases are predicted to increase the
        persistence of G4 structures resulting in heightened sensitivity to G4
        ligands. Several known G4-associated helicase deficiencies were
        recovered, including 
      - type: Emphasis
        content:
          - RECQL4
      - ', '
      - type: Emphasis
        content:
          - RTEL1
      - ' and '
      - type: Emphasis
        content:
          - DHX36
      - ', alongside many others with no known G4 link (see '
      - type: Link
        relation: fig
        target: '#fig10'
        content:
          - Figure 10A
      - >-
        ). Here, we demonstrate for the first time that the DDX42 DEAD/DEAH
        helicase is in fact a previously unidentified structure-specific
        G4-binding protein. On a wider level, this acts as proof-of-principle
        that other specific G4 interacting proteins exist within the sensitiser
        list of over 700 proteins. Other known G4-helicases such as BLM, WRN,
        PIF1 and FANCJ (reviewed in 
      - type: Cite
        target: bib129
        content:
          - 'Wu and Brosh, 2010'
      - >-
        ) were not identified as sensitisers, which may reflect functional
        redundancy (
      - type: Cite
        target: bib114
        content:
          - 'Spillare et al., 2006'
      - '), or a low ligand concentrations and/or cell type effects.'
  - type: Paragraph
    content:
      - >-
        Our findings highlight the ubiquitin-protesome pathway and modifications
        such, as neddylation as unexplored areas with respect to G4s. The only
        documented ubiquitin-G4 relationship in human cells is with HERC2, an E3
        ubiquitin ligase that is implicated in G4 resolution whose loss
        sensitises cells to G4 ligands (
      - type: Cite
        target: bib128
        content:
          - 'Wu et al., 2018'
      - '). We also independently validate '
      - type: Emphasis
        content:
          - HERC2
      - ' as a G4 sensitiser in our screen and extend our observations to cover the full breadth of the proteosomal degradation pathway, including members of E1 ligase ('
      - type: Emphasis
        content:
          - 'UBA3, UBA2, SAE1'
      - '), E2 ligase ('
      - type: Emphasis
        content:
          - UBE2H
      - '), E3 ligase ('
      - type: Emphasis
        content:
          - 'NEDD4L, RBX1'
      - ', '
      - type: Emphasis
        content:
          - 'CUL1, RNF20'
      - '), deubiquitinating enzyme ('
      - type: Emphasis
        content:
          - USP1
      - ' and '
      - type: Emphasis
        content:
          - USP37
      - ) and proteosome (
      - type: Emphasis
        content:
          - PSMC2)
      - ' families (see '
      - type: Link
        relation: table
        target: '#table2'
        content:
          - Table 2
      - ")\_("
      - type: Cite
        target: bib107
        content:
          - 'Senft et al., 2018'
      - ";\_"
      - type: Cite
        target: bib125
        content:
          - 'Wei and Lin, 2012'
      - >-
        ) Given the involvement of ubiquitin-proteasomal regulation in pathways,
        such as DDR and cell cycle, that are generally deregulated in cancer (
      - type: Cite
        target: bib55
        content:
          - 'Harrigan et al., 2018'
      - >-
        ), this opens up an interesting intersection between ubiquitin
        regulation and G4s. As ubiquitin components are being targeted for
        anticancer therapies (
      - type: Cite
        target: bib61
        content:
          - 'Huang and Dixit, 2016'
      - >-
        ), their efficacy might be enhanced through simultaneous G4 targeting
        and here we have provided strong proof-of-principle of this using
        synergistic combinations of pimozide (targeting UPS1) and the G4 ligand
        PDS.
  - type: Paragraph
    content:
      - >-
        In contrast to other genetic screens identifying sensitiser genes that
        enhance the efficacy of anticancer agents (
      - type: Cite
        target: bib4
        content:
          - 'Azorsa et al., 2009'
      - '; '
      - type: Cite
        target: bib78
        content:
          - 'Martens-de Kemp et al., 2017'
      - >-
        ), our work suggests that persistent G4s are problematic for splicing.
        We identified several cancer-associated splicing factors as G4
        sensitisers, including SRSF10, HNRNPM and the known G4-interactor FUS,
        which is overexpressed in several cancers (
      - type: Cite
        target: bib31
        content:
          - 'Crozat et al., 1993'
      - ";\_"
      - type: Cite
        target: bib39
        content:
          - 'Dvinge et al., 2016'
      - '; '
      - type: Cite
        target: bib116
        content:
          - 'Takahama et al., 2013'
      - '). For the latter, a drug inhibiting general spliceosome assembly ('
      - type: Link
        relation: table
        target: '#table1'
        content:
          - Table 1
      - ) has been pharmacologically explored (
      - type: Cite
        target: bib67
        content:
          - 'Kotake et al., 2007'
      - >-
        ) raising the possibility of potentiation by G4-stabilising ligand
        combinatorial treatment.
  - type: Paragraph
    content:
      - We designated four of the genetic vulnerabilities as ‘key’ genes (
      - type: Emphasis
        content:
          - BRCA1
      - ', '
      - type: Emphasis
        content:
          - TOP1
      - ', '
      - type: Emphasis
        content:
          - DDX42
      - ', and '
      - type: Emphasis
        content:
          - GAR1)
      - ' whose deficiencies stood out with respect to consistent sensitivity to PDS and PhenDC3 in both cell lines tested. Given this, we postulate that deficiencies in any of these four genes will impart significant G4 ligand sensitivity for a range of cell types and/or with other G4 ligands. As GAR1-deficiencies are implicated in chronic lymphocytic leukaemia and contribute to telomere dysfunction ('
      - type: Cite
        target: bib38
        content:
          - 'Dos Santos et al., 2017'
      - >-
        ), we suggest that this cancer may be acutely sensitive to
        G4-stabilisation by small molecules.
  - type: Paragraph
    content:
      - >-
        In conclusion, we have revealed genes and pathways that interact with
        stabilised G4 structures. This information provides new insights into
        G4-related biology, especially into the functional pathways and roles as
        G4-interacting proteins. Furthermore, this work reveals novel
        disease-related genetic vulnerabilities for G4-ligands. Overall, these
        data provide a unique and comprehensive resource that can be further
        explored to understand biology that may involve G4s and also inspire new
        therapeutic possibilities.
  - type: Heading
    id: s4
    depth: 1
    content:
      - Materials and methods
  - type: Table
    id: keyresource
    rows:
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - 'Reagent type '
              - ' '
              - '(species) or '
              - ' '
              - resource
          - type: TableCell
            content:
              - Designation
          - type: TableCell
            content:
              - Source or reference
          - type: TableCell
            content:
              - Identifiers
          - type: TableCell
            content:
              - 'Additional '
              - ' '
              - information
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - Cell line (
              - type: Emphasis
                content:
                  - H. Sapiens
              - )
          - type: TableCell
            content:
              - A375
          - type: TableCell
            content:
              - ATCC
          - type: TableCell
            content:
              - 'Cat# CRL-1619, RRID:'
              - type: Link
                target: 'https://scicrunch.org/resolver/CVCL_0132'
                content:
                  - CVCL_0132
          - type: TableCell
            content: []
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - Cell line (
              - type: Emphasis
                content:
                  - H. Sapiens
              - )
          - type: TableCell
            content:
              - HT1080
          - type: TableCell
            content:
              - ATCC
          - type: TableCell
            content:
              - 'Cat# CCL-121, RRID:'
              - type: Link
                target: 'https://scicrunch.org/resolver/CVCL_0317'
                content:
                  - CVCL_0317
          - type: TableCell
            content: []
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - Cell line (
              - type: Emphasis
                content:
                  - H. Sapiens
              - )
          - type: TableCell
            content:
              - Plat-A
          - type: TableCell
            content:
              - Cell Biolabs Inc
          - type: TableCell
            content:
              - 'Cat# RV-102, RRID:'
              - type: Link
                target: 'https://scicrunch.org/resolver/CVCL_B489'
                content:
                  - CVCL_B489
          - type: TableCell
            content: []
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - Antibody
          - type: TableCell
            content:
              - Mouse monoclonal anti-Beta Actin
          - type: TableCell
            content:
              - Merck
          - type: TableCell
            content:
              - 'Cat# A5441, RRID:'
              - type: Link
                target: 'https://scicrunch.org/resolver/AB_476744'
                content:
                  - AB_476744
          - type: TableCell
            content:
              - 'WB (1:250)'
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - Antibody
          - type: TableCell
            content:
              - Mouse polyclonal anti-DDX42
          - type: TableCell
            content:
              - Abcam
          - type: TableCell
            content:
              - 'Cat# ab80975, RRID:'
              - type: Link
                target: 'https://scicrunch.org/resolver/AB_2041042'
                content:
                  - AB_2041042
          - type: TableCell
            content:
              - 'WB (1:250)'
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - Antibody
          - type: TableCell
            content:
              - Rabbit monoclonal anti-Beta Actin
          - type: TableCell
            content:
              - Cell Signalling Technology
          - type: TableCell
            content:
              - 'Cat# 4970, RRID:'
              - type: Link
                target: 'https://scicrunch.org/resolver/AB_2223172'
                content:
                  - AB_2223172
          - type: TableCell
            content:
              - 'WB (1:500)'
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - Antibody
          - type: TableCell
            content:
              - Rabbit polyclonal anti-BRCA1
          - type: TableCell
            content:
              - Cell Signalling Technology
          - type: TableCell
            content:
              - 'Cat# 9010, RRID:'
              - type: Link
                target: 'https://scicrunch.org/resolver/AB_2228244'
                content:
                  - AB_2228244
          - type: TableCell
            content:
              - 'WB (1:50)'
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - Antibody
          - type: TableCell
            content:
              - Rabbit monoclonal anti-GAPDH
          - type: TableCell
            content:
              - Cell Signalling Technology
          - type: TableCell
            content:
              - 'Cat# 5174, RRID:'
              - type: Link
                target: 'https://scicrunch.org/resolver/AB_10622025'
                content:
                  - AB_10622025
          - type: TableCell
            content:
              - 'WB (1:50)'
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - Antibody
          - type: TableCell
            content:
              - Rabbit polyclonal anti-GAR1
          - type: TableCell
            content:
              - NovusBio
          - type: TableCell
            content:
              - 'Cat# NBP2-31742, RRID:'
              - type: Link
                target: 'https://scicrunch.org/resolver/AB_2801566'
                content:
                  - AB_2801566
          - type: TableCell
            content:
              - 'WB (1:100)'
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - Antibody
          - type: TableCell
            content:
              - 'Rabbit polyclonal anti-GST, HRP-conjugated'
          - type: TableCell
            content:
              - Abcam
          - type: TableCell
            content:
              - 'Cat# ab3416, RRID:'
              - type: Link
                target: 'https://scicrunch.org/resolver/AB_30378'
                content:
                  - AB_30378
          - type: TableCell
            content:
              - 'ELISA (1:10,000)'
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - Antibody
          - type: TableCell
            content:
              - Rabbit monoclonal anti-LaminB1
          - type: TableCell
            content:
              - Cell Signalling Technology
          - type: TableCell
            content:
              - 'Cat# 12586, RRID:'
              - type: Link
                target: 'https://scicrunch.org/resolver/AB_2650517'
                content:
                  - AB_2650517
          - type: TableCell
            content:
              - 'WB (1:250)'
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - Antibody
          - type: TableCell
            content:
              - Rabbit monoclonal anti-TOP1
          - type: TableCell
            content:
              - Abcam
          - type: TableCell
            content:
              - 'Cat# ab109374, RRID:'
              - type: Link
                target: 'https://scicrunch.org/resolver/AB_10861978'
                content:
                  - AB_10861978
          - type: TableCell
            content:
              - 'WB (1:250)'
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - Recombinant DNA reagent
          - type: TableCell
            content:
              - pCMV-VSV-G plasmid
          - type: TableCell
            content:
              - Addgene
          - type: TableCell
            content:
              - 'Cat # 8454, RRID:'
              - type: Link
                target: 'https://scicrunch.org/resolver/Addgene_8454'
                content:
                  - Addgene_8454
          - type: TableCell
            content:
              - plasmid
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - Recombinant DNA reagent
          - type: TableCell
            content:
              - G-quadruplex focused shRNA plasmid library
          - type: TableCell
            content:
              - 'transOMIC technologies, this paper'
          - type: TableCell
            content: []
          - type: TableCell
            content:
              - >-
                supplied as a glycerol stock, Materials and methods subsection:
                ‘Composition and recombinant DNA reproduction of shRNA
                libraries’
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - Recombinant DNA reagent
          - type: TableCell
            content:
              - transOMIC LMN genome-wide shRNA plasmid library
          - type: TableCell
            content:
              - transOMIC technologies
          - type: TableCell
            content: []
          - type: TableCell
            content:
              - supplied as multiple glycerol stocks
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - Sequence-based reagent
          - type: TableCell
            content:
              - Biotinylated oligonucleotides
          - type: TableCell
            content:
              - type: Cite
                target: bib11
                content:
                  - Biffi et al. (2013)
              - ', '
              - type: Cite
                target: bib57
                content:
                  - Herdy et al. (2018)
              - ', this paper'
          - type: TableCell
            content: []
          - type: TableCell
            content:
              - Materials andmethods subsection ‘Oligonucleotide annealing’
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - Sequence-based reagent
          - type: TableCell
            content:
              - Genomic qPCR primers
          - type: TableCell
            content:
              - this paper
          - type: TableCell
            content: []
          - type: TableCell
            content:
              - >-
                Materials and methods subsection ‘Barcode recovery, adapter
                ligation and sequencing’
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - Sequence-based reagent
          - type: TableCell
            content:
              - Pasha/DGCR8 siRNA
          - type: TableCell
            content:
              - Qiagen
          - type: TableCell
            content:
              - 'Cat# 1027423'
          - type: TableCell
            content: []
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - Sequence-based reagent
          - type: TableCell
            content:
              - siRNAs
          - type: TableCell
            content:
              - this paper
          - type: TableCell
            content: []
          - type: TableCell
            content:
              - >-
                Materials and methods subsection ‘siRNA validation experiments –
                transfection, experimental outline, immunoblotting’
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - 'Peptide, recombinant protein'
          - type: TableCell
            content:
              - Recombinant human DDX42
          - type: TableCell
            content:
              - NovusBio
          - type: TableCell
            content:
              - 'Cat# H0001325-P01'
          - type: TableCell
            content: []
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - Commercial assay or kit
          - type: TableCell
            content:
              - BluePippin 2% Internal Standard Marker Kit
          - type: TableCell
            content:
              - Sage Science
          - type: TableCell
            content:
              - 'Cat# BDF2010'
          - type: TableCell
            content: []
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - Commercial assay or kit
          - type: TableCell
            content:
              - CellTitre-Glo One Solution Assay Reagent
          - type: TableCell
            content:
              - Promega
          - type: TableCell
            content:
              - 'Cat# G8461'
          - type: TableCell
            content: []
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - Commercial assay or kit
          - type: TableCell
            content:
              - KAPA library quantification kit for Illumina platforms
          - type: TableCell
            content:
              - Kapa Biosystems
          - type: TableCell
            content:
              - 'Cat# 07960140001'
          - type: TableCell
            content: []
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - Commercial assay or kit
          - type: TableCell
            content:
              - KOD Hot Start DNA polymerase
          - type: TableCell
            content:
              - Merck
          - type: TableCell
            content:
              - 'Cat# 710864'
          - type: TableCell
            content: []
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - Commercial assay or kit
          - type: TableCell
            content:
              - Lipofectamine RNAiMAX
          - type: TableCell
            content:
              - ThermoFisher Scientific
          - type: TableCell
            content:
              - 'Cat# 13778150'
          - type: TableCell
            content: []
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - Commercial assay or kit
          - type: TableCell
            content:
              - Muse Count and Viability kit
          - type: TableCell
            content:
              - Merck
          - type: TableCell
            content:
              - 'Cat# MCH600103'
          - type: TableCell
            content: []
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - Commercial assay or kit
          - type: TableCell
            content:
              - QIAmp DNA Blood Maxi Kit
          - type: TableCell
            content:
              - Qiagen
          - type: TableCell
            content:
              - 'Cat# 51194'
          - type: TableCell
            content: []
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - Commercial assay or kit
          - type: TableCell
            content:
              - QIAquick PCR purification kit
          - type: TableCell
            content:
              - Qiagen
          - type: TableCell
            content:
              - 'Cat# 28104'
          - type: TableCell
            content: []
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - Commercial assay or kit
          - type: TableCell
            content:
              - Qubit dsDNA HS assay kit
          - type: TableCell
            content:
              - ThermoFisher Scientific
          - type: TableCell
            content:
              - 'Cat# Q32851'
          - type: TableCell
            content: []
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - Commercial assay or kit
          - type: TableCell
            content:
              - RIPA lysis buffer
          - type: TableCell
            content:
              - ThermoFisher Scientific
          - type: TableCell
            content:
              - 'Cat# 8990'
          - type: TableCell
            content: []
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - Commercial assay or kit
          - type: TableCell
            content:
              - ZR GigaPrep Kit
          - type: TableCell
            content:
              - Zymo Research
          - type: TableCell
            content:
              - 'Cat# D4057'
          - type: TableCell
            content: []
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - 'Chemical compound, drug'
          - type: TableCell
            content:
              - Ampicillin
          - type: TableCell
            content:
              - Merck
          - type: TableCell
            content:
              - 'Cat# A5354'
          - type: TableCell
            content: []
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - 'Chemical compound, drug'
          - type: TableCell
            content:
              - Chloroquine diphosphate
          - type: TableCell
            content:
              - Acros organics
          - type: TableCell
            content:
              - 'Cat# 455240250'
          - type: TableCell
            content: []
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - 'Chemical compound, drug'
          - type: TableCell
            content:
              - cOmplete mini protease inhibitor
          - type: TableCell
            content:
              - Roche
          - type: TableCell
            content:
              - 'Cat# 11836153001'
          - type: TableCell
            content: []
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - 'Chemical compound, drug'
          - type: TableCell
            content:
              - DMSO
          - type: TableCell
            content:
              - ThermoFisher Scientific
          - type: TableCell
            content:
              - 'Cat# 20688'
          - type: TableCell
            content: []
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - 'Chemical compound, drug'
          - type: TableCell
            content:
              - Geneticin
          - type: TableCell
            content:
              - Gibco
          - type: TableCell
            content:
              - 'Cat# 10131035'
          - type: TableCell
            content: []
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - 'Chemical compound, drug'
          - type: TableCell
            content:
              - MK1775
          - type: TableCell
            content:
              - Cambridge Bioscience
          - type: TableCell
            content:
              - 'Cat# CAY21266'
          - type: TableCell
            content: []
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - 'Chemical compound, drug'
          - type: TableCell
            content:
              - PenStrep
          - type: TableCell
            content:
              - ThermoFisher Scientific
          - type: TableCell
            content:
              - 'Cat# 1507063'
          - type: TableCell
            content: []
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - 'Chemical compound, drug'
          - type: TableCell
            content:
              - PhenDC3
          - type: TableCell
            content:
              - In-house synthesis
          - type: TableCell
            content:
              - type: Cite
                target: bib34
                content:
                  - 'De Cian et al., 2007a'
          - type: TableCell
            content: []
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - 'Chemical compound, drug'
          - type: TableCell
            content:
              - Pimozide
          - type: TableCell
            content:
              - Merck
          - type: TableCell
            content:
              - 'Cat# P1793-500MG'
          - type: TableCell
            content: []
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - 'Chemical compound, drug'
          - type: TableCell
            content:
              - "Pyridostatin\_(PDS)"
          - type: TableCell
            content:
              - In-house synthesis
          - type: TableCell
            content:
              - type: Cite
                target: bib102
                content:
                  - Rodriguez et al. (2008)
          - type: TableCell
            content: []
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - 'Chemical compound, drug'
          - type: TableCell
            content:
              - Sodium Butyrate
          - type: TableCell
            content:
              - Merck
          - type: TableCell
            content:
              - 'Cat# 303410'
          - type: TableCell
            content: []
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - 'Chemical compound, drug'
          - type: TableCell
            content:
              - TMB substrate
          - type: TableCell
            content:
              - Merck
          - type: TableCell
            content:
              - 'Cat# T4444'
          - type: TableCell
            content: []
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - 'Software, algorithm'
          - type: TableCell
            content:
              - Bowtie 2 v2.2.6
          - type: TableCell
            content:
              - type: Cite
                target: bib70
                content:
                  - 'Langmead and Salzberg, 2012'
          - type: TableCell
            content:
              - type: Link
                target: 'http://bowtie-bio.sourceforge.net/bowtie2/index.shtml'
                content:
                  - 'http://bowtie-bio.sourceforge.net/bowtie2/index.shtml'
          - type: TableCell
            content: []
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - 'Software, algorithm'
          - type: TableCell
            content:
              - ClueGO v3.5.1
          - type: TableCell
            content:
              - type: Cite
                target: bib13
                content:
                  - 'Bindea et al., 2009'
              - '; '
              - ' '
              - type: Cite
                target: bib14
                content:
                  - 'Bindea et al., 2013'
          - type: TableCell
            content:
              - type: Link
                target: 'http://www.ici.upmc.fr/cluego/cluegoDownload.shtml'
                content:
                  - 'http://www.ici.upmc.fr/cluego/cluegoDownload.shtml'
          - type: TableCell
            content: []
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - 'Software, algorithm'
          - type: TableCell
            content:
              - ColonyArea
          - type: TableCell
            content:
              - type: Cite
                target: bib51
                content:
                  - 'Guzmán et al., 2014'
          - type: TableCell
            content:
              - Image J plugin
          - type: TableCell
            content: []
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - 'Software, algorithm'
          - type: TableCell
            content:
              - Code used for shRNA screen data analysis
          - type: TableCell
            content:
              - This paper
          - type: TableCell
            content:
              - 'All scripts are available at: '
              - type: Link
                target: 'https://github.com/sblab-bioinformatics/GWscreen_G4sensitivity'
                content:
                  - >-
                    https://github.com/sblab-bioinformatics/GWscreen_G4sensitivity
          - type: TableCell
            content: []
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - 'Software, algorithm'
          - type: TableCell
            content:
              - Combenefit
          - type: TableCell
            content:
              - type: Cite
                target: bib37
                content:
                  - 'Di Veroli et al., 2016'
          - type: TableCell
            content:
              - type: Link
                target: 'https://sourceforge.net/projects/combenefit/'
                content:
                  - 'https://sourceforge.net/projects/combenefit/'
          - type: TableCell
            content: []
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - 'Software, algorithm'
          - type: TableCell
            content:
              - Cytoscape v3.6.0
          - type: TableCell
            content:
              - type: Cite
                target: bib109
                content:
                  - 'Shannon et al., 2003'
          - type: TableCell
            content:
              - type: Link
                target: 'http://www.cytoscape.org/'
                content:
                  - 'http://www.cytoscape.org/'
          - type: TableCell
            content: []
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - 'Software, algorithm'
          - type: TableCell
            content:
              - edgeR v3.6
          - type: TableCell
            content:
              - type: Cite
                target: bib101
                content:
                  - 'Robinson et al., 2010'
          - type: TableCell
            content:
              - type: Link
                target: 'http://bioconductor.org/packages/release/bioc/html/edgeR.html'
                content:
                  - >-
                    http://bioconductor.org/packages/release/bioc/html/edgeR.html
          - type: TableCell
            content: []
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - 'Software, algorithm'
          - type: TableCell
            content:
              - DAVID
          - type: TableCell
            content:
              - type: Cite
                target: bib59
                content:
                  - 'Huang et al., 2009a'
              - ', '
              - type: Cite
                target: bib60
                content:
                  - 'Huang et al., 2009b'
          - type: TableCell
            content:
              - type: Link
                target: 'https://david.ncifcrf.gov'
                content:
                  - 'https://david.ncifcrf.gov'
          - type: TableCell
            content: []
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - 'Software, algorithm'
          - type: TableCell
            content:
              - FastQC v0.11.3
          - type: TableCell
            content:
              - type: Cite
                target: bib2
                content:
                  - 'Andrews, 2010'
          - type: TableCell
            content:
              - type: Link
                target: 'http://www.bioinformatics.babraham.ac.uk/projects/fastqc'
                content:
                  - 'http://www.bioinformatics.babraham.ac.uk/projects/fastqc'
          - type: TableCell
            content: []
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - 'Software, algorithm'
          - type: TableCell
            content:
              - FASTX-Toolkit v0.0.14
          - type: TableCell
            content:
              - type: Cite
                target: bib49
                content:
                  - 'Gordon and Hannon, 2010'
          - type: TableCell
            content:
              - type: Link
                target: 'http://hannonlab.cshl.edu/fastx_toolkit.html'
                content:
                  - 'http://hannonlab.cshl.edu/fastx_toolkit.html'
          - type: TableCell
            content: []
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - 'Software, algorithm'
          - type: TableCell
            content:
              - Graphpad Prism
          - type: TableCell
            content:
              - GraphPad Prism (
              - type: Link
                target: 'https://graphpad.com'
                content:
                  - 'https://graphpad.com'
              - )
          - type: TableCell
            content:
              - 'RRID:'
              - type: Link
                target: 'https://scicrunch.org/resolver/SCR_015807'
                content:
                  - SCR_015807
          - type: TableCell
            content:
              - Version 6
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - 'Software, algorithm'
          - type: TableCell
            content:
              - PolySearch2
          - type: TableCell
            content:
              - type: Cite
                target: bib74
                content:
                  - 'Liu et al., 2015a'
          - type: TableCell
            content:
              - type: Link
                target: 'http://polysearch.cs.ualberta.ca/'
                content:
                  - 'http://polysearch.cs.ualberta.ca/'
          - type: TableCell
            content: []
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - 'Software, algorithm'
          - type: TableCell
            content:
              - Python programming language v2.7.10
          - type: TableCell
            content:
              - type: Link
                target: 'https://www.python.org'
                content:
                  - 'https://www.python.org'
          - type: TableCell
            content: []
          - type: TableCell
            content: []
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - 'Software, algorithm'
          - type: TableCell
            content:
              - R programming language v3.2.1
          - type: TableCell
            content:
              - type: Link
                target: 'https://cran.r-project.org/'
                content:
                  - 'https://cran.r-project.org/'
          - type: TableCell
            content: []
          - type: TableCell
            content: []
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - 'Software, algorithm'
          - type: TableCell
            content:
              - 'Unix tools (cat, cut, awk, sort and uniq)'
          - type: TableCell
            content:
              - type: Link
                target: 'https://opengroup.org/unix'
                content:
                  - 'https://opengroup.org/unix'
          - type: TableCell
            content: []
          - type: TableCell
            content: []
  - type: Heading
    id: s4-1
    depth: 2
    content:
      - Cell lines
  - type: Paragraph
    content:
      - 'HT1080 (RRID: '
      - type: Link
        target: 'https://scicrunch.org/resolver/CRL-1619'
        content:
          - CRL-1619
      - ') and A375 (RRID: '
      - type: Link
        target: 'https://scicrunch.org/resolver/CRL-121'
        content:
          - CRL-121
      - >-
        ) were obtained from the American Type Culture Collection repository
        (ATCC) (LGC Standards, United Kingdom) and Plat-A (RRID: 
      - type: Link
        target: 'https://scicrunch.org/resolver/RV-102'
        content:
          - RV-102
      - >-
        ) was obtained from Cell Biolabs Incorporation. All cell lines were
        cultured in DMEM medium (ThermoFisher Scientific, cat #41966029)
        supplemented with 10% (v/v) heat inactivated FBS (ThermoFisher
        Scientific, cat #10500064) and grown at 37°C in a 5% CO
      - type: Subscript
        content:
          - '2'
      - ' humidified atmosphere. Cell lines were authenticated using small tandem repeat (STR) profiling and regularly checked to be mycoplasma-free by RNA-capture ELISA. All cell lines tested negative for '
      - type: Emphasis
        content:
          - Mycoplasma
      - ' contamination. None of the cell lines used in our studies was mentioned in the list of commonly misidentified cell lines maintained by the International Cell Line Authentication Committee.'
  - type: Heading
    id: s4-2
    depth: 2
    content:
      - Quantification of live cell numbers
  - type: Paragraph
    content:
      - >-
        Live cell numbers (e.g. for plating cells for CellTitre-Glo assays, the
        screens and Incucyte experiments) were determined using the Muse Cell
        Analyzer (Merck), ‘Count and Viability’ assay according to
        manufacturer’s instructions. Cells were diluted either 1:10 or 1:20 in
        ‘Muse Count and Viability kit’ solution (Merck, cat # MCH60013), to give
        a viable cell concentration of 1–2 × 10
      - type: Superscript
        content:
          - '6'
      - ' cells/mL, with ‘Events to Acquire’ parameter set at 1000 events. Three cell counts were recorded.'
  - type: Heading
    id: s4-3
    depth: 2
    content:
      - Determination of G4 ligand concentration for shRNA screens
  - type: Paragraph
    content:
      - "PDS and PhenDC3 (both synthesised in-house)\_("
      - type: Cite
        target: bib35
        content:
          - 'De Cian et al., 2007b'
      - '; '
      - type: Cite
        target: bib102
        content:
          - 'Rodriguez et al., 2008'
      - >-
        ) were used as 100 mM stocks, dissolved in DMSO (Thermofisher
        Scientific, cat # 20688). GI
      - type: Subscript
        content:
          - '20'
      - ' values were calculated by treating A375 and HT1080 cells with serial dilutions of PDS and PhenDC3 for 96 hr and determining cell death via a CellTitre-Glo One Solution assay (Promega, cat # G8461) according to manufacturer’s protocol. Each serial dilution was replicated four times for two-cell-seeding densities (1000/1500 cells per well). For both densities, curves were plotted averaging the four replicates in Prism (GraphPad v6) using a Non-Linear regression model, ‘dose-response – inhibition’ equation [log(inhibitor) vs. normalised response – variable slope] and GI'
      - type: Subscript
        content:
          - '20'
      - ' values calculated. The GI'
      - type: Subscript
        content:
          - '20'
      - ' concentrations used represent an average of three separate assays per cell line and yielded the following concentrations used for the screens - A375: 10 μM PhenDC3 and 1.5 μM PDS; HT1080: 1 μM PhenDC3 and 0.5 μM PDS.'
  - type: Heading
    id: s4-4
    depth: 2
    content:
      - Composition and recombinant DNA production of shRNA libraries
  - type: Paragraph
    content:
      - "The genome-wide screen uses the transOMIC LMN shRNA library against the human protein coding genome, consisting of 113,002 total shRNAs, split between 12 pools for ease-of-handling (approximately 10,000 shRNAs per pool) with an average number of five optimised hairpins per gene. The G4 focused screen consists of a custom shRNA pool (transOMIC\_technologies) with the same LMN vector (8018 shRNAs); this includes 1247 genes (7436 shRNAs) uncovered in the genome-wide screen (751 sensitisers and 496 upregulated genes), 116 additional genes identified from the literature as potentially G4-associated (439 shRNAs) and shRNAs targeting 37 olfactory receptors as non-targeting controls (143 shRNAs). 496 upregulated genes (FDR\_≤\_0.05, 50% or three hairpins; log"
      - type: Subscript
        content:
          - '2'
      - "FC\_≥\_1) were included to mimic the genome-wide screen on a smaller scale by maintaining the population ratio of sensitisation and resistance. In this custom pool, unlike the commercially available genome-wide library, we capped the number of shRNAs at seven per gene. The backbone of both libraries contains Neo"
      - type: Superscript
        content:
          - R
      - " and ZsGreen markers to allow monitoring of infected cell lines by Geneticin (Gibco, cat # 10131035) selection and fluorescence (MacsQUANT), respectively. Both libraries were provided as glycerol stocks. Bacterial density was determined by calculating the colony-forming units (CFU) from dilutions of the original glycerol stock after plating on agar plates (overnight, 37°C, 100 μg/mL ampicillin). Glycerol stocks were thawed completely with sufficient volume taken (based on CFU) to ensure a minimum of 1000-fold hairpin representation and inoculated into liquid culture (LB media\_+\_100 μg/mL ampicillin). Plasmid DNA was isolated using ZR Gigaprep kit D4057 (Zymo research) according to manufacturer’s protocol and DNA quantified by Nanodrop One"
      - type: Superscript
        content:
          - c
      - ' (Thermo Fisher Scientific).'
  - type: Heading
    id: s4-5
    depth: 2
    content:
      - shRNA stable cell line creation
  - type: Paragraph
    content:
      - >-
        For the genome-wide screen, each pool was treated independently,
        necessitating the creation of 12 different polymorphic cell lines each
        containing an average of 10,000 shRNAs, for both HT1080 and A375, per
        replica (three replicas, 36 polymorphic cell lines). Virus was produced
        using the Platinum-A packaging cell line (4–6 × 15 cm plates per pool)
        and calcium phosphate transfection. 24 hr after plating Platimum-A cells
        (70–80% confluency), media was replaced with DMEM medium supplemented
        with 1% (v/v) PenStrep (Thermo Fisher Scientific, cat # 150763) and 10%
        (v/v) heat inactivated FBS, shRNA library plasmid (75 μg) was then mixed
        with pCMV-VSV-G plasmid (7.5 μg, Addgene cat # 8454), Pasha/DGCR8 siRNA
        (2.7 μM, Qiagen cat # 1027423) to increase viral titre and 0.25 M CaCl
      - type: Subscript
        content:
          - '2'
      - ' in a total volume of 1.5 mL per 15 cm dish and bubbled with 1.5 mL 2 x HBS (50 mM HEPES, 10 mM KCl, 12 mM Dextrose, 280 mM NaCl, 1.5 mM Na'
      - type: Subscript
        content:
          - '2'
      - PO
      - type: Subscript
        content:
          - '4'
      - " at pH 7.00) and added to the Platinum-A cells (containing 17mL media) in a dropwise fashion. Immediately before adding the DNA-Pasha-transfection mixture to the Platinum-A cells, chloroquine diphosphate (lysosomal inhibitor, Acros Organics cat # 455200250) was added to the plates at a final concentration 2.5 μM. 14–16 hr after transfection, fresh media was added with 1:1000 1\_M sodium butyrate (Merck, cat # 303410) for enhanced mammalian expression of the shRNA LMN plasmid. Virus was then harvested 48 hr after transfection and filter sterilised (0.45 μM) and stored at 4°C for a maximum of 7 days. Viral titre was determined by performing mock infections and quantifying fluorescent cells, via flow cytometry (MacsQUANT, Miltenyi Biotec Ltd.) 48 hr after infection. For both the genome-wide and focused-screen, 3.6 × 10"
      - type: Superscript
        content:
          - '6'
      - ' target cells were infected with a viral volume predicted to cause 30% infection (MOI 0.3) to minimise multiple shRNA integrations per cell. This provides approximately 10 × 10'
      - type: Superscript
        content:
          - '6'
      - ' shRNA expressing cells (1000-fold shRNA representation). Virus was diluted in serum free media plus polybrene (8 μg/mL) with infections carried out in triplicate and treated as independent replicates hereafter. 48 hr after infection cells antibiotic selection was performed with 800 μg/mL (HT1080) and 1000 μg/mL (A375) geneticin for 7–9 days (antibiotic concentrations were determined from 7-day toxicity curves prior to transfection setup).'
  - type: Heading
    id: s4-6
    depth: 2
    content:
      - 'Cell culture for pilot, genome-wide and focused shRNAs pools'
  - type: Paragraph
    content:
      - >-
        Following complete antibiotic selection, a reference time point was
        harvested (t0) and cells were split into 3 × 15 cm plates per replica:
        PDS, PhenDC3 and DMSO vehicle control, each containing 8–10 × 10
      - type: Superscript
        content:
          - '6'
      - ' cells to maintain 1000-fold hairpin representation. Every 72 hr, cells were trypsinised, counted via Muse Cell Analyzer to determine the number of population doublings, and 10 × 10'
      - type: Superscript
        content:
          - '6'
      - ' (A375 genome-wide and focused) or 8 × 10'
      - type: Superscript
        content:
          - '6'
      - ' (HT1080) cells per replica re-plated in fresh drug/DMSO and media (17 mL media per plate). At all times, sufficient cell numbers were used so that a minimum of 1000 or 800 cells per shRNA was maintained (A375 and HT1080, respectively), to ensure maximal potential for uncovering phenotypic effects from each shRNA hairpin tested ('
      - type: Cite
        target: bib66
        content:
          - 'Knott et al., 2014'
      - >-
        ). The volume of DMSO used in the ‘vehicle’ condition is equal to the
        volume for 10 μM PhenDC3. The remaining drug treatments were
        supplemented with DMSO to match this volume to keep the same DMSO
        concentration between treatment cell lines and screens. For the pilot
        screen, two final timepoints were harvested after 7 and 15 population
        doublings (t7 and t15), pellets extracted and analysed as described
        below. Based on the pilot screen, discussed below, a final time point
        (tF) was harvested after 15 population doublings for subsequent
        genome-wide and focused screen. For each pool of the genome-wide screen,
        12 samples were generated (t0, DMSO tF, PDS tF, PhenDC3 tF; three
        replicas each). Therefore, 144 samples of 10 × 10
      - type: Superscript
        content:
          - '6'
      - ' cells were generated to cover the entire screen. For each cell line of the focused screen, 12 samples were generated (t0, DMSO tF, PDS tF, PhenDC3 tF, three replicas each).'
  - type: Heading
    id: s4-7
    depth: 2
    content:
      - Pilot screen technique to determine genome-wide parameters
  - type: Paragraph
    content:
      - >-
        To determine the most appropriate tF for the genome-wide screen, cells
        (from shRNA pool 8) were harvested after 7 and 15 population doublings
        (t7 and t15 respectively) and the average log
      - type: Subscript
        content:
          - '2'
      - "FC (tF/t0) counts for each hairpin were determined as described below. For t7, 13 and 115 shRNAs were significantly altered following PDS and PhenDC3 treatment respectively (FDR\_≤\_0.05). At t15, more hairpins were significantly depleted following PDS and PhenDC3 treatment (746 and 93 shRNAs respectively, excluding those significantly changed in DMSO)."
  - type: Heading
    id: s4-8
    depth: 2
    content:
      - 'Barcode recovery, adapter ligation and sequencing'
  - type: Paragraph
    content:
      - >-
        All PCR and sequencing oligonucleotides (Merck) are summarised in the
        table below. Cell pellets (10 × 10
      - type: Superscript
        content:
          - '6'
      - ' cells) were resuspended in PBS and genomic DNA extracted using QIAmp DNA Blood Maxi Kit (Qiagen, cat # 51194) according to the manufacturer’s spin protocol, eluted in a final volume of 1200 μL and quantified by Qubit DNA HS Assay Kit (Thermo Fisher Scientific, cat # Q32851). The shRNA inserts were PCR-amplified from all DNA in each sample, in multiple 50 μL reactions each using 1.5 μg gDNA, with KOD Hot Start DNA Polymerase (Merck, cat # 710864) and the following reagents (included within the kit): 5 μL 10 x buffer, 5 μL 2 mM each dNTPs, 4 μL MgSO'
      - type: Subscript
        content:
          - '4'
      - " (25 mM), 1.5 μL polymerase, 4 μL DMSO. Forward (Mir-F) and reverse (PGKpro-R) primers flanking the loop and antisense sequence of the hairpin region were used at a final concentration of 300 nM. PCR was performed under the following conditions: 98°C for 5 min, then for 25 cycles of 98°C for 35 s, 58°C 35 s\_and 72°C for 35 s, followed by a final extension at 72°C for 5 min. 1.2 mL of pooled PCR reaction were cleaned-up using QIAquick PCR purification kit (Qiagen, cat # 28104) according to manufacturer’s protocol. 2 μg purified PCR product were PCR amplified in a second step, using forward (P5-Seq-P-Mir-Loop) and reverse (P7-Index-n-TruSeq-PGKpro-R) primers containing the P5 and P7 flowcell adapters, respectively. PCR was performed in 8 × 50 μL reactions each with 500 ng template DNA. The reverse primer contains TruSeq adapter small RNA Indexes for multiplexing and a 6-nucleotide barcode, denoted ‘nnnnnn’ below. PCR reagents were as for the first PCR, with the exception of the primers, which were used at a final concentration 1.5 μM. The second PCR was performed under the following conditions: 98°C for 5 min, then for 25 cycles of 94°C for 35 s, 52°C 35 s\_and 72°C for 35 s, followed by a final extension at 72°C for 5 min. 200 μL of pooled secondary PCR product was cleaned up as previously and the desired product (~340 bp) was extracted using BluePippin (Sage Science) 2% Internal Standard Marker Kit (DF marker 100–600 bp; Sage Science, BDF2010), according to manufacturer’s protocol using a broad range elution (300–400 bp). Individual samples were quantified with a KAPA library quantification kit (KAPA Biosystems, cat # 0796-6014-0001) using a BioRad CFX96 Real Time PCR instrument with no Rox according to manufacturer’s protocols. Libraries were diluted to 4 nM in RNAse free water. For the genome-wide screen samples, 24 libraries (12 pools) and for the focused screen samples, 24 libraries (both cell lines) were combined to create a pooled 4 nM stock, with each sample having a unique TruSeq adapter. The genome-wide screen samples were sequenced in six batches; all focused screen samples were sequenced simultaneously. DNA-Seq libraries were prepared from these samples using the NextSeq Illumina Platform v2 High Output Kit 75 cycles, followed by 36 base pair single-read sequencing performed on an Illumina NextSeq instrument, using a custom sequencing primer."
  - type: Paragraph
    content: []
  - type: Table
    id: inlinetable1
    rows:
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - Oligo name
          - type: TableCell
            content:
              - Description
          - type: TableCell
            content:
              - Sequence 5’−3’
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - Mir5-F
          - type: TableCell
            content:
              - Primary PCR Forward Primer
          - type: TableCell
            content:
              - 5’-CAGAATCGTTGCCTGCACATCTTGGAAAC- 3’
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - PGKpro-R
          - type: TableCell
            content:
              - Primary PCR Reverse Primer
          - type: TableCell
            content:
              - 5’ -CTGCTAAA GCGCATGCTCCAGACTGC- 3’
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - P5-Seq-P-Mir-Loop
          - type: TableCell
            content:
              - Secondary PCR forward Primer
          - type: TableCell
            content:
              - >-
                5’-AATGATACGGCGACCACCGAGATCTACACT
                AGCCTGCGCACGTAGTGAAGCCACAGATGTA-3’
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - P7-Index-n-Truseq-PGKpro-R
          - type: TableCell
            content:
              - Secondary PCR barcoded reverse primer
          - type: TableCell
            content:
              - '5’-CAAGCAGAAGACGGCATACGAGAT '
              - type: Strong
                content:
                  - nnnnnn
              - >-
                GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTCTGCTAAAGCGCATGCTCCAGACTGC –
                3’
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - SeqPrimer MirLoop
          - type: TableCell
            content:
              - Custom sequencing primer
          - type: TableCell
            content:
              - 5’-TAGCCTGCGCACGTAGTGAAGCCACAGATGTA-3
  - type: Heading
    id: s4-9
    depth: 2
    content:
      - 'Sequencing, read processing, alignment and counting of shRNAs'
  - type: Paragraph
    content:
      - Sequencing data have been deposited in ArrayExpress (
      - type: Link
        target: 'https://www.ebi.ac.uk/arrayexpress/'
        content:
          - 'https://www.ebi.ac.uk/arrayexpress/'
      - ') under accession number '
      - type: Emphasis
        content:
          - E-MTAB-6367.
      - ' Reads were trimmed to 22 nucleotides, base qualities were evaluated with FastQC v0.11.3 ('
      - type: Cite
        target: bib2
        content:
          - 'Andrews, 2010'
      - >-
        ) and bases were filtered from the 3' end with a Phred quality threshold
        of 33 using the FASTX-Toolkit v0.0.14 (
      - type: Cite
        target: bib49
        content:
          - 'Gordon and Hannon, 2010'
      - >-
        ). Trimmed reads were aligned to the 113,002 reference shRNA sequences
        provided by transOMIC technologies (
      - type: Cite
        target: bib66
        content:
          - 'Knott et al., 2014'
      - ) using Bowtie 2 v2.2.6 with default parameters (
      - type: Cite
        target: bib70
        content:
          - 'Langmead and Salzberg, 2012'
      - >-
        ), which resulted in overall alignment rates of 90–95% with an average
        of 98% of reference sequences detected. The generated SAM files were
        processed to obtain shRNA counts using Unix tools (
      - type: Link
        target: 'https://opengroup.org/unix'
        content:
          - 'https://opengroup.org/unix'
      - ') and Python scripts (v2.7.10, '
      - type: Link
        target: 'https://www.python.org'
        content:
          - 'https://www.python.org'
      - >-
        ), and library purity and potential contaminations were investigated
        with stacked bar plots and multidimensional scaling (MDS) using the R
        programming language v3.2.1 (
      - type: Link
        target: 'https://cran.r-project.org'
        content:
          - 'https://cran.r-project.org'
      - >-
        ). The code and scripts developed during the development of the project
        are available in our group’s GitHub website (
      - type: Cite
        target: bib79
        content:
          - 'Martínez Cuesta, 2019'
      - '; copy archived at '
      - type: Link
        target: 'https://github.com/elifesciences-publications/GWscreen_G4sensitivity'
        content:
          - 'https://github.com/elifesciences-publications/GWscreen_G4sensitivity'
      - ).
  - type: Heading
    id: s4-10
    depth: 2
    content:
      - >-
        Filtering, normalisation, differential representation analysis and
        defining sensitisation
  - type: Paragraph
    content:
      - "To discard shRNAs bearing low counts, each library was filtered based on a counts-per-million threshold of 0.5 for all initial time points (t0), for\_example in a library of 10M reads, shRNAs with at least five counts for all initial time points will pass this filter. Normalisation factors were calculated to scale the raw library sizes using the weighted trimmed mean of M-values (TMM) approach ("
      - type: Cite
        target: bib101
        content:
          - 'Robinson et al., 2010'
      - >-
        ). To compare groups of replicates (time points and chemical treatments)
        for each pool, differential representation analysis of shRNA counts was
        performed using edgeR (
      - type: Cite
        target: bib101
        content:
          - 'Robinson et al., 2010'
      - >-
        ). Common and shRNA-specific dispersions were estimated to allow the
        fitting of a negative binomial generalised linear model to the treatment
        counts. Contrasts between the initial time point and the treatments were
        defined (PDS-t0, PhenDC3-t0, and DMSO-t0) and likelihood ratio tests
        were carried out accordingly (
      - type: Cite
        target: bib32
        content:
          - 'Dai et al., 2014'
      - "). Fold changes (FC) were then computed for every shRNA, and false discovery rates (FDR) were estimated using the Benjamini-Hochberg method. A gene was defined as significantly differentially represented for a given treatment if at least 50% or a minimum of 3 shRNAs were significant (FDR\_≤\_0.05); sensitisation was additionally determined by applying a log"
      - type: Subscript
        content:
          - '2'
      - FC ≤ −1.
  - type: Heading
    id: s4-11
    depth: 2
    content:
      - Exploring genes associated to G4s in databases and biomedical literature
  - type: Paragraph
    content:
      - >-
        Three different approaches were developed to uncover genes linked to G4s
        in the literature and molecular biology databases. 18 high confidence
        G4-related genes were obtained by scanning for genes in which the
        corresponding UniprotKB (
      - type: Cite
        target: bib117
        content:
          - 'The UniProt Consortium, 2017'
      - >-
        ) entry is annotated with the term 'quadruplex' or genes annotated with
        at least one of the following 11 GO terms with any evidence assertion
        method (
      - type: Cite
        target: bib3
        content:
          - 'Ashburner et al., 2000'
      - '):'
  - type: Paragraph
    content: []
  - type: Table
    id: inlinetable2
    rows:
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - GO id
          - type: TableCell
            content:
              - Name
          - type: TableCell
            content:
              - Type
          - type: TableCell
            content:
              - Link
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - 'GO:0051880'
          - type: TableCell
            content:
              - G-quadruplex DNA binding
          - type: TableCell
            content:
              - Molecular function
          - type: TableCell
            content:
              - type: Link
                target: 'https://www.ebi.ac.uk/QuickGO/term/GO:0051880'
                content:
                  - 'https://www.ebi.ac.uk/QuickGO/term/GO:0051880'
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - 'GO:0002151'
          - type: TableCell
            content:
              - G-quadruplex RNA binding
          - type: TableCell
            content:
              - Molecular function
          - type: TableCell
            content:
              - type: Link
                target: 'https://www.ebi.ac.uk/QuickGO/term/GO:0002151'
                content:
                  - 'https://www.ebi.ac.uk/QuickGO/term/GO:0002151'
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - 'GO:0061849'
          - type: TableCell
            content:
              - telomeric G-quadruplex DNA binding
          - type: TableCell
            content:
              - Molecular function
          - type: TableCell
            content:
              - type: Link
                target: 'https://www.ebi.ac.uk/QuickGO/term/GO:0061849'
                content:
                  - 'https://www.ebi.ac.uk/QuickGO/term/GO:0061849'
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - 'GO:0071919'
          - type: TableCell
            content:
              - G-quadruplex DNA formation
          - type: TableCell
            content:
              - Biological process
          - type: TableCell
            content:
              - type: Link
                target: 'https://www.ebi.ac.uk/QuickGO/term/GO:0071919'
                content:
                  - 'https://www.ebi.ac.uk/QuickGO/term/GO:0071919'
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - 'GO:0044806'
          - type: TableCell
            content:
              - G-quadruplex DNA unwinding
          - type: TableCell
            content:
              - Biological process
          - type: TableCell
            content:
              - type: Link
                target: 'https://www.ebi.ac.uk/QuickGO/term/GO:0044806'
                content:
                  - 'https://www.ebi.ac.uk/QuickGO/term/GO:0044806'
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - 'GO:1905493'
          - type: TableCell
            content:
              - regulation of G-quadruplex DNA binding
          - type: TableCell
            content:
              - Biological process
          - type: TableCell
            content:
              - type: Link
                target: 'https://www.ebi.ac.uk/QuickGO/term/GO:1905493'
                content:
                  - 'https://www.ebi.ac.uk/QuickGO/term/GO:1905493'
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - 'GO:1905494'
          - type: TableCell
            content:
              - negative regulation of G-quadruplex DNA binding
          - type: TableCell
            content:
              - Biological process
          - type: TableCell
            content:
              - type: Link
                target: 'https://www.ebi.ac.uk/QuickGO/term/GO:1905494'
                content:
                  - 'https://www.ebi.ac.uk/QuickGO/term/GO:1905494'
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - 'GO:1905495'
          - type: TableCell
            content:
              - positive regulation of G-quadruplex DNA binding
          - type: TableCell
            content:
              - Biological process
          - type: TableCell
            content:
              - type: Link
                target: 'https://www.ebi.ac.uk/QuickGO/term/GO:1905495'
                content:
                  - 'https://www.ebi.ac.uk/QuickGO/term/GO:1905495'
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - 'GO:1905465'
          - type: TableCell
            content:
              - regulation of G-quadruplex DNA unwinding
          - type: TableCell
            content:
              - Biological process
          - type: TableCell
            content:
              - type: Link
                target: 'https://www.ebi.ac.uk/QuickGO/term/GO:1905465'
                content:
                  - 'https://www.ebi.ac.uk/QuickGO/term/GO:1905465'
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - 'GO:1905466'
          - type: TableCell
            content:
              - negative regulation of G-quadruplex DNA unwinding
          - type: TableCell
            content:
              - Biological process
          - type: TableCell
            content:
              - type: Link
                target: 'https://www.ebi.ac.uk/QuickGO/term/GO:1905466'
                content:
                  - 'https://www.ebi.ac.uk/QuickGO/term/GO:1905466'
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - 'GO:1905467'
          - type: TableCell
            content:
              - positive regulation of G-quadruplex DNA unwinding
          - type: TableCell
            content:
              - Biological process
          - type: TableCell
            content:
              - type: Link
                target: 'https://www.ebi.ac.uk/QuickGO/term/GO:1905467'
                content:
                  - 'https://www.ebi.ac.uk/QuickGO/term/GO:1905467'
  - type: Paragraph
    content:
      - >-
        Furthermore, 55 confirmed human G4-interacting proteins as defined by
        the G4IPB database (
      - type: Cite
        target: bib85
        content:
          - 'Mishra et al., 2016'
      - ) (
      - type: Link
        target: 'http://bsbe.iiti.ac.in/bsbe/ipdb/index.php'
        content:
          - 'http://bsbe.iiti.ac.in/bsbe/ipdb/index.php'
      - >-
        ) were also used to determine predefined G4-interacting proteins from
        the genome-wide shRNA screen. For this, gene entries were removed where
        the only G4-relationship was a predicted G4-forming sequence in the mRNA
        or DNA (i.e. not a direct protein interaction) or where the protein was
        not human. To extend the list of G4-interacting proteins, text-mining
        using PolySearch2 (
      - type: Cite
        target: bib75
        content:
          - 'Liu et al., 2015b'
      - >-
        ) was used. Human protein-coding gene names and G4-terms and synonyms
        are defined using the corresponding MeSH term id D054856 (
      - type: Link
        target: 'https://www.ncbi.nlm.nih.gov/mesh/68054856'
        content:
          - 'https://www.ncbi.nlm.nih.gov/mesh/68054856'
      - >-
        ) and the thesaurus of gene names obtained from the PolySearch2 website
        (
      - type: Link
        target: 'http://polysearch.cs.ualberta.ca/'
        content:
          - 'http://polysearch.cs.ualberta.ca/'
      - >-
        ). A relevancy score measures the strength of association between two
        text groups, and higher the score, the more likely terms from the two
        groups co-occur within the same abstract; the score also accounts for
        the distance between terms from the two groups. A total of 5477 pieces
        of text were identified in PubMed and PubMed Central where any of the G4
        terms co-occur with more than 500 human gene names. Overall, this
        generated 526 G4-associated genes, with 54 (10%) uncovered as
        G4-sensitisers (
      - type: Link
        target: 'https://github.com/sblab-bioinformatics/GWscreen_G4sensitivity'
        content:
          - 'https://github.com/sblab-bioinformatics/GWscreen_G4sensitivity'
      - >-
        ), which were manually edited to 16 genes as discussed in the main text
        and figures.
  - type: Heading
    id: s4-12
    depth: 2
    content:
      - 'KEGG pathway, gene ontology and protein domain enrichment analysis'
  - type: Paragraph
    content:
      - The ClueGO v2.3.3 (
      - type: Cite
        target: bib13
        content:
          - 'Bindea et al., 2009'
      - '; '
      - type: Cite
        target: bib14
        content:
          - 'Bindea et al., 2013'
      - ) plugin for Cytoscape (
      - type: Cite
        target: bib109
        content:
          - 'Shannon et al., 2003'
      - >-
        ) (v3.5.1) was used to determine networks of enriched KEGG pathways and
        Gene Ontology terms (Biological Process and Molecular Function) for
        significantly depleted genes upon G4 ligand treatment. Specifically, a
        right-sided (Enrichment) test based on the hyper-geometric distribution
        was performed on the corresponding Entrez gene IDs for each gene list
        and the Bonferroni adjustment (p<0.05) was applied to correct for
        multiple hypothesis testing. Only experimental evidence codes (EXP, IDA,
        IPI, IMP, IGI, IEP) were used. The Kappa-statistics score threshold was
        set to 0.4 and GO term fusion was used to diminish redundancy of terms
        shared by similar proteins. Other parameters include: GO level intervals
        (3–8 genes) and Group Merge (50%). Protein domains were investigated
        using DAVID (v6.8) to integrate GENE3D crystallographic data and PFAM
        sequence information and enrichment was considered significant if the
        EASE score p<0.05 (
      - type: Cite
        target: bib42
        content:
          - 'Finn et al., 2016'
      - '; '
      - type: Cite
        target: bib133
        content:
          - 'Yeats et al., 2006'
      - ).
  - type: Heading
    id: s4-13
    depth: 2
    content:
      - COSMIC analysis
  - type: Paragraph
    content:
      - >-
        Cancer mutation data (CosmicMutantExport.tsv) from the COSMIC database
        v82 (
      - type: Cite
        target: bib43
        content:
          - 'Forbes et al., 2015'
      - ") was used to investigate the association between G4 sensitisers and cancer genes.\_~150,000 were mutations available in COSMIC for 702 (93%) sensitiser genes, with some predicted to be pathogenic by the FATHMM algorithm embedded within the COSMIC database. The Cancer Gene Census ("
      - type: Link
        target: 'http://cancer.sanger.ac.uk/census'
        content:
          - 'http://cancer.sanger.ac.uk/census'
      - >-
        ) was used to investigate whether G4 sensitisers are enriched in genes
        containing mutations causally implicated in cancer. Fisher’s exact tests
        as implemented in R were used to calculate fold enrichment significance
        of sensitisers that are cancer genes in COSMIC (compared to the
        percentage of protein-coding genes in COSMIC – 3.3%).
  - type: Heading
    id: s4-14
    depth: 2
    content:
      - >-
        siRNA validation experiments – transfection, experimental outline,
        immunoblotting
  - type: Paragraph
    content:
      - "ON-TARGETplus siRNAs (Dharmacon/GE healthcare) were used as summarised in the table below. Cells were transfected with either targeting or non-targeting control siRNAs using lipofectamine RNAiMAX (Thermo Fisher Scientific, cat # 13778150) and OptiMEM reduced serum medium (Thermo Fisher Scientific) according to the manufacturer’s protocol (reagent protocol 2013) alongside a non-transfected control. 24 hr after transfection, cells were trypsinised, counted and re-plated in media supplemented with PDS, PhenDC3 or DMSO vehicle control (minimum two biological replicates per condition) in a 48-well plate format (seeding density - 8,000 cells per well A375; 4,000 cells per well HT1080). Cell growth was monitored for 144 hr using IncuCyteZOOM live cell analysis (Sartorius) and cell confluency calculated as a percentage of the well area covered. Scans were performed every 3 hr; nine scans per well. To monitor protein levels, cells transfected simultaneously with the same siRNA-reagent mixture were harvested 48 hr and 144 hr after transfection, by cell scraping and lysed on ice (30 min) with RIPA lysis buffer with protease inhibitor\_+EDTA (Thermo Fisher Scientific, cat # 8990). Lysates were analysed by capillary electrophoresis via the Protein Simple Wes platform according to manufacturer’s protocol with antibodies summarised in the key resource table above. Lysates from non-transfected and siRNA-treated (targeting and non-targeting) samples were probed with antibodies against BRCA1 (Cell Signalling Technology, cat # 4970-CST), TOP1 (Abcam, cat # AB109374), GAR1 (NovusBio cat #NBP2-31742) or DDX42 (Abcam cat #AB80975), plus anti-beta actin antibody (mouse Merck cat # A5441; rabbit cat # 4970-CST) by multiplexing. For non-targeting and targeting lysates, the area of the desired band was normalised to beta-actin and then normalised to the protein level in the non-targeting sample, for three (48 hr after transfection lysates) or two independent Wes runs (144 hr after transfection). Protein depletion is expressed as an average of these normalised values. All lysates were used at a concentration of 0.8 mg/mL and antibody dilutions as follows: BRCA1 1:50; TOP1 1:250; GAR1 1:100; DDX42 1:250; rabbit-actin 1:500; mouse-actin 1:250."
  - type: Paragraph
    content: []
  - type: Table
    id: inlinetable3
    rows:
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - siRNA
          - type: TableCell
            content:
              - Catalogue number
          - type: TableCell
            content:
              - Sequence 5’−3’
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - Non-targeting 2
          - type: TableCell
            content:
              - D-001810-02-05
          - type: TableCell
            content:
              - UGGUUUACAUGUUGUGUGA
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - BRCA1 (A375)
          - type: TableCell
            content:
              - J-003461–09
          - type: TableCell
            content:
              - CAACAUGCCCACAGAUCAA
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - BRCA1 (HT1080)
          - type: TableCell
            content:
              - J-003461–12
          - type: TableCell
            content:
              - GAAGGAGCUUUCAUCAUUUC
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - TOP1 (both cell lines)
          - type: TableCell
            content:
              - J-005278–08
          - type: TableCell
            content:
              - CGAAGAAGGUAGUAGAGUC
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - DDX42 (both cell lines)
          - type: TableCell
            content:
              - J-012393–11
          - type: TableCell
            content:
              - GGAGAUCGACUAACGGCAA
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - GAR1 (both cell lines)
          - type: TableCell
            content:
              - J-013386–06
          - type: TableCell
            content:
              - UCCAGAACGUGUAGUCUUA
  - type: Heading
    id: s4-15
    depth: 2
    content:
      - G4 ligand and drug treatments
  - type: Paragraph
    content:
      - >-
        10 mM stocks in DMSO of PDS (in house synthesis), MK1775 (Cambridge
        Bioscience, cat# CAY21266) and pimozide (Merck, cat# P1793-500MG) were
        used as for synergy experiment. Cells were seeded in Corning, Tissue
        Culture-treated 96-well clear bottom plates (Thermofisher,
        cat#07-200-587) for HT1080 (1000 cells per well) and A375 (1500 cells
        per well) cell lines. 24 hr after plating, media was removed and cells
        were treated with different concentrations of PDS and MK1775 or pimozide
        in media in a final volume of 150 μL, alongside non-treated and
        solvent-treated controls. After 96 hr, cell death was determined via a
        CellTitre-Glo One Solution assay (Promega, cat # G8461) according to
        manufacturer’s protocol using the PHERAstar FS (BMG labtech) to detect
        luminescence, using the recommended settings. Values were normalised to
        and expressed as a percentage of the untreated controls. This was
        performed for three biological replicas. Data were analysed via
        Combenefit software using the BLISS independence model since the
        molecule have independent targets (
      - type: Cite
        target: bib37
        content:
          - 'Di Veroli et al., 2016'
      - >-
        ) to determine synergy. For the clonogenic cell survival assay, A375
        (300 cells per well) and HT1080 (400 cells per well) were plated as
        single cells in 12-well plates. The next day, cells were treated with
        DMSO or the indicated doses of PDS, pimozide and/or MK1775 in media.
        After 8 days, colonies were fixed with 3% trichloroacetic acid (TCA) for
        90 min at 4°C, washed with MiliQ, air dried and then stained with 0.057%
        (v/v) Sulforhodamine B solution (Merck, cat # 230162–5G) for 30 min at
        room temperature. Plates were then washed four times with 1% acetic
        acid, air dried and colonies visualised using GelCount (Oxford
        Optronix). Colony growth was determined using the ‘colony intensity
        percentage’ parameter in the ColonyArea Image J plugin (
      - type: Cite
        target: bib51
        content:
          - 'Guzmán et al., 2014'
      - >-
        ), which considers both the intensity and percentage of area covered by
        the colonies. Values were normalised to and expressed as a percentage of
        the untreated controls and then further processed by Combenefit
        software, as described above, to determine synergy. A total of three
        independent biological replicates were performed.
  - type: Heading
    id: s4-16
    depth: 2
    content:
      - Sub-cellular localisation of DDX42
  - type: Paragraph
    content:
      - >-
        HT1080, HEK and HeLa cells were harvested from a 70% confluent 15 cm
        plate by cell scraping in PBS on ice and pelleted by centrifugation (500
        g, 5 min, 4°C). Pellets were resuspended in three volumes of low-salt
        buffer (20 mM HEPES pH7.4, 10 mM NaCl, 3 mM MgCl
      - type: Subscript
        content:
          - '2'
      - >-
        , 0.2 mM EDTA, 1 mM DTT) plus protease inhibitor (cOmplete mini, Roche
        cat#11836153001), lysed on ice (15 min) and 0.5% Igepal added. Samples
        were vortexed (1 min) and centrifuged (900 g, 15 min, 4°C) and the
        supernatant collected for cytoplasmic extracts. Nuclear pellets were
        washed in low-salt buffer, supernatant discarded and then resuspended in
        high-salt buffer (20 mM HEPES pH7.4, 500 mM NaCl, 3 mM MgCl
      - type: Subscript
        content:
          - '2'
      - >-
        , 0.5% Igepal, 0.2 mM EDTA, 1 mM DTT) plus protease inhibitors, followed
        by lysis on ice with intermittent vortexing (30 min). Lysates were
        passed through a syringe needle to promote lysis and shear genomic DNA
        and followed by centrifugation (13,000 g, 10 min, 4°C). Lysis confirmed
        by trypan blue staining according to manufacturer’s protocols
        (Thermofisher Scientific cat#15250061). The supernatant was then
        collected as nuclear extract. Cytoplasmic and nuclear lysates were
        quantified on a Direct Detect platform (Merck) and DDX42 expression
        analysed by immunoblotting using the Protein Simple Wes instrument as
        described above with a lysate concentration of 0.5 mg/mL. Samples were
        also immunoblotted with antibodies against nuclear laminB1 (CST 12586;
        1:250) and cytoplasmic GAPDH to confirm subcellular fractionation
        efficiency (CST 5174, 1:50).
  - type: Heading
    id: s4-17
    depth: 2
    content:
      - Oligonucleotide annealing
  - type: Paragraph
    content:
      - >-
        Biotinylated oligonucleotides for G4 and non-G4 forming sequences (IDT
        technologies; see Table below) were annealed in 10 mM TrisHCl pH 7.4,
        100 mM KCl by heating at 95°C, 10 min followed by slow cooling to room
        temperature overnight at a controlled rate of 0.2°C/min. Annealed
        oligonucleotides were stored at 4°C for maximum 1 month.
  - type: Paragraph
    content: []
  - type: Table
    id: inlinetable4
    rows:
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - Oligo
          - type: TableCell
            content:
              - Rna/DNA
          - type: TableCell
            content:
              - Sequence
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - NRAS G4
          - type: TableCell
            content:
              - RNA
          - type: TableCell
            content:
              - '5’ [Btn] UGU GGG AGG GGC GGG UCU GGG UGC 3’'
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - NRAS mut
          - type: TableCell
            content:
              - RNA
          - type: TableCell
            content:
              - '5’ [Btn] UGU AGA AAG AGC AGA UCU AGA UG 3’'
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - Stem loop
          - type: TableCell
            content:
              - RNA
          - type: TableCell
            content:
              - '5’ [Btn] ACA GGG CUC CGC GAU GGC GGA GCC CAA 3’'
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - Myc G4
          - type: TableCell
            content:
              - DNA
          - type: TableCell
            content:
              - '5’ [Btn] TGA GGG T GGG TA GGG T GGG TAA 3’'
      - type: TableRow
        cells:
          - type: TableCell
            content:
              - Myc mut
          - type: TableCell
            content:
              - DNA
          - type: TableCell
            content:
              - '5’ [Btn] TGA GAG T GAG TA GAG T GAG TAA 3’'
  - type: Heading
    id: s4-18
    depth: 2
    content:
      - Enzyme-Linked immunosorbent assay
  - type: Paragraph
    content:
      - >-
        Recombinant human DDX42 with an N-terminal GST tag was purchased from
        NovusBio (cat# H0001325-P01). Streptavidin-Coated High-Binding Capacity
        96-well plates (ThermoScientific prod #15501) were hydrated with PBS (30
        min) and coated with 50 nM biotinylated oligonucleotides (1 hr, shaking
        450 rpm). Wells were washed three times with ELISA buffer (50 mM K
      - type: Subscript
        content:
          - '2'
      - HPO
      - type: Subscript
        content:
          - '4'
      - ' pH 7.4 and 100 mM KCl/100 mM LiCl); 1 min shaking, 450 rpm. Wells were then blocked with 3% (w/v) BSA (Merck, cat# A7030) in ELISA buffer for 1 hr, at room temperature and then incubated with serial dilutions of DDX42 up to 200 nM for 1 hr. Wells were washed three times with 0.1% TWEEN-20 in ELISA buffer and then incubated for 1 hr with anti-GST HRP-conjugated antibody (Abcam AB3416) diluted 1:10,000 in blocking buffer. Wells were again washed three times with ELISA-Tween, and the bound anti-GST HRP detected with TMB substrate (Merck,cat#T4444) for 2 min. Reactions were stopped with 2 M HCl. Absorbance at 450 nm was measured with PheraSTAR plate reader (BMG labtech). Binding curves with standard error of the mean (SEM) were fitted using GraphPad Prism software, using a non-linear regression fit, one site, specific binding model with saturation kinetics. The following equation was used: y=(Bmax*x)/(K'
      - type: Subscript
        content:
          - d
      - "\_+x), where x\_=\_concentration of DDX42 (nM) and Bmax is the maximum specific binding (i.e. saturation)."
  - type: Heading
    id: s4-19
    depth: 2
    content:
      - Circular dichroism spectroscopy
  - type: Paragraph
    content:
      - >-
        200 μL of 10 μM oligonucleotide were prepared in assay buffer and
        annealed as described above. CD spectra were recorded on an Applied
        Photo-physics Chirascan CD spectropolarimeter using a 1 mm path length
        quartz cuvette. CD measurements were performed at 298 K over a range of
        200–320 nm using a response time of 0.5 s, 1 nm pitch and 0.5 nm
        bandwidth. The recorded spectra represent a smoothed average of three
        scans, zero-corrected at 320 nm (Molar ellipticity 
      - type: Emphasis
        content:
          - θ
      - ' is quoted in 10'
      - type: Superscript
        content:
          - '5'
      - ' deg cm'
      - type: Superscript
        content:
          - '2'
      - ' dmol'
      - type: Superscript
        content:
          - −1
      - >-
        ). The absorbance of the buffer was subtracted from the recorded
        spectra.
